United States      Prevention, Pesticides    EPA 738-R-95-025
        Environmental Protection   And Toxic Substances    September 1995
        Agency	(7508W)	
SEPA Reregistration
        Eligibility Decision (RED)

        Sodium Fluoroacetate

-------

-------
        \        UNITED STATES ENVIRONMENTAL PROTECTION AGENCY
         *                       WASHINGTON, D.C. 20460
                                                                            OCT  I  6 1995
CERTIFIED MAIL

                                                                              OFFICE OF
                                                                       PREVENTION. PESTICIDES AND
                                                                           TOXIC SUBSTANCES
Dear Registrant:

       I am pleased to announce that the Environmental Protection Agency has completed its
reregistration eligibility review and decisions on the pesticide chemical sodium fluoroacetate.
The enclosed Reregistration Eligibility Decision (RED) contains the Agency's evaluation of
the data base of this chemical., its conclusions of the potential human health and
environmental risks of the current product's use, and its decisions and conditions under
which this use and products will be eligible for reregistration.  The RED includes the data
and labeling requirements for products for reregistration. It may also include requirements
for additional data (generic) on the active ingredients to confirm the risk assessments.

       To assist you with a proper response, read the enclosed document entitled  "Summary
of Instructions for Responding to the RED".  This summary also refers to other enclosed
documents which include further instructions.  You must follow all instructions and submit
complete and timely responses.  The first set of required responses are due 90 days from
the date of this letter. The second set of required responses are due 8 months from the
date of this letter. Complete and timely responses will avoid the Agency taking  the
enforcement action of suspension against your products.

       If you have questions on the product specific data requirements or wish to  meet with
the Agency, please contact the Special Review and Reregistration Division representative
Frank Rubis at (703) 308-8008.  Address any questions on  required generic data to the
Special Review and Reregistration Division representative Leonard Ryan at (703)  308-8067.

                                                      Sincerely yours,
                                                      Lois Rossi, Director
                                                      Special Review
                                                        and Reregistration Division
Enclosures
             Recycled/Recyclable -Printed with Vegetable Oil Based Inks on 100% Recyded Paper (40% Postconsumer)

-------

-------
               SUMMARY OF INSTRUCTIONS FOR RESPONDING TO
              THE REREGISTRATION ELIGIBILITY DECISION (RED)

 1  DATA CALL-IN (PCI) OR "90-DAY RESPONSE"-If generic data are required for
 reregistration, a DCI letter will be enclosed describing such data. If product specific data
 are required, another DCI letter will be enclosed listing such requirements.  If both generic
 and product specific data are required, a combined Generic and Product Specific letter will
 be enclosed describing such data.  Complete the two response forms provided with each DCI
 letter (or four forms for the combined) by following the instructions provided.  You must
 submit the response forms for each product and for each  DCI within 90 days of the date
 of this letter (RED issuance date); otherwise, your product may be suspended.

 2  TIME EXTENSIONS AND DATA WAIVER REQUESTS -No time extension requests
 will be granted for the  90-day response. Time extension requests may be submitted only with
 respect to actual data submissions. Requests for data waivers must be submitted as part of the
 90-day response.  Requests for time extensions should be submitted in the 90-day response,
 but certainly no later than the 8-month response date. All data waiver and time extension '
 requests must be accompanied by a full justification. All waivers and time extensions must be
 granted by EPA in order to go into effect.

 3 APPLICATION FOR REREGISTRATION OR "8-MONTH RESPONSE"-You must
 submit the following items for each product within eight months of the date of this letter
 (RED issuance date).

       a.  Application for Reregistration (EPA  Form 8570-1). Use only an original
 application form.  Mark it "Application  for Reregistration."  Send your Application for
 Reregistration (along with the other forms listed in b-e below) to the address listed in item 5.

      b.  Five copies of draft labeling which complies with the RED and current regulations
 and requirements.  Only make labeling changes which are required by the RED and current
 regulations (40 CFR 156.10) and policies.  Submit any other  amendments (such as formulation
 changes, or labeling changes not related to reregistration) separately.  You may delete uses
 which the RED says are ineligible for reregistration. For further labeling guidance, refer to
 the labeling section of the EPA publication "General Information on Applying for Registration
 in the U.S., Second Edition, August  1992" (available from the National Technical Information
 Service, publication #PB92-221811; telephone number 703-487-4650).

      c. Generic or Product Specific Data. Submit all data in a format which complies
 with PR Notice 86-5, and/or submit citations of data already submitted and give the  EPA
 identifier (MRID)  numbers. Before citing these studies, you  must make sure that they meet
the Agency's acceptance criteria (attached to the DCI).

      d. Two copies of the  Confidential Statement of Formula (CSF) for each basic  and
each alternate formulation.  The labeling and CSF which you  submit for each product must
comply with P.R. Notice 91-2 by declaring the active ingredient as the nominal
concentration.  You have two options for submitting a CSF:  (1) accept the standard certified

-------
limits (see 40 CFR §158.175) or (2) provide certified limits that are supported by the analysis
of five batches. If you choose the second option, you must submit or cite the data for the five
batches along with a certification statement as described in 40 CFR §158.175(e).  A copy of
the CSF is enclosed; follow the instructions on its back.

      e. Certification With Respect to Data Compensation Requirements.  Complete and
sign EPA form 8570-31 for each product.

4. COMMENTS IN RESPONSE TO FEDERAL REGISTER NOTICE-Comments
pertaining to the content of the RED may be submitted  to the address  shown in the Federal
Register Notice which announces the availability of this RED.

5. WHERE TO SEND PRODUCT SPECIFIC PCI RESPONSES  (90-DAY) AND
APPLICATIONS FOR REREGISTRATION (8-MONTH RESPONSES)

By U.S. Mail:

      Document Processing Desk (RED-SRRD-PRB)
      Office of Pesticide Programs (7504C)
      EPA, 401 M St. S.W.
      Washington, D.C. 20460-0001

By express:

   Document Processing Desk (RED-SRRD-PRB)
      Office of Pesticide Programs (7504C)
      Room 266A, Crystal Mall 2
      1921 Jefferson Davis Hwy.
      Arlington, VA 22202

6. EPA'S REVIEWS-EPA will screen all submissions for completeness; those which are not
complete will be returned with a request for corrections. EPA will try to respond to data
waiver and time extension requests within 60 days.  EPA will also try to respond to all 8-
month submissions with a final reregistration determination within 14  months after the RED
has been issued.

-------
                 United States
                 Environmental Protection
                 Agency	
                      Prevention, Pesticides
                      And Toxic Substances
                      (7508W)	
EPA-738-F-95-022
June 1995
                 R.E.D.   FACTS
     Pesticide
Reregistration
                 Sodium
                 Fluoroacetate
     All pesticides sold or distributed in the United States must be
registered by EPA, based on scientific studies showing that they can be used
without posing unreasonable risks to people or the environment. Because of
advances in scientific knowledge, the law requires that pesticides which
were first registered years ago be reregistered to ensure that they meet
today's more stringent standards.
                     In evaluating pesticides for reregistration, EPA obtains and reviews a
                 complete set of studies from pesticide producers, describing the human
                 health and environmental effects of each pesticide. The Agency imposes
                 any regulatory controls that are needed to effectively manage each
                 pesticide's risks.  EPA then reregisters pesticides that can be used without
                 posing unreasonable risks to human health or the environment.

                     When a pesticide is eligible for reregistration, EPA announces this and
                 explains why in a Reregistration Eligibility Decision (RED) document. This
                 fact sheet summarizes the information in the RED document for
                 reregistration Case 3073, sodium fluoroacetate, also known as compound
                 1080.
   Use Profile
     Sodium fluoroacetate is an acute toxicant predacide which is used
against coyotes which prey on sheep and goats. Registered end-use products
are injected into the rubber reservoirs of the Livestock Protection collars,
also referred to as the "toxic collar", which are strapped to the throats of
sheep or goats.  Coyotes attempting to kill collared livestock are likely to
puncture the collars and to be fatally poisoned by sodium fluoroacetate as a
result of the attack. When predation is anticipated, up to 20 collars may be
used in fenced pastures up to 100 acres in size; up to 50 collars may be used
in pastures of 101 to 640 acres; and up to 100 collars may be used in
pastures of 641 to 10,000 acres.
     Sodium fluoroacetate is a restricted use pesticide which  may be used
only by trained, certified applicators and which is only registered for use in
livestock protection collars.  Sodium fluoroacetate will retain the restricted

-------
Regulatory
     History
use classification imposed by the Agency in  1978 due to its high acute
toxicity and the need for highly specialized applicator training. The Agency
also has reviewed concerns about the exposure of threatened and endangered
animal species with the United States Fish and Wildlife Service (USFWS).
The March  1993 USFWS  final biological opinion on the effects of sodium
fluoroacetate on threatened and endangered species addressed the livestock
protection collar and included jeopardy determinations to the gray wolf and
grizzly bear. Specific areas were identified where the collar could not be
used and such restrictions  have been incorporated on the livestock protection
collar labels. No additional use restrictions to further protect threatened  and
endangered  species are being imposed at this time.

     Development and  use of sodium fluoroacetate as a predacide and
rodenticide in the U.S. began in the 1940s prior to the 1947 enactment of
the Federal Insecticide,  Fungicide, and Rodenticide Act by which
requirements for federal registration of pesticide products were instituted.
In 1964 and again in 1971, the use of poisons to control predatory mammals
were reviewed by selected committees.  In 1972 EPA cancelled all
registered predator control uses of sodium fluoroacetate, sodium cyanide,
and strychnine.
                      In 1977, the U.S. Department of the Interior (USDI) applied for an
                Experimental Use Permit (EUP) to investigate the potential risks and
                benefits associated with the use of sodium fluoroacetate in "toxic collars"
                which would be placed on the necks of sheep and goats. The toxic collar
                containing sodium fluoroacetate solution would be positioned around the
                animals' throat regions where they would be likely to be ruptured by the
                teeth of coyotes that attempted to kill the livestock with species-typical
                throat bites.

                      In 1981, EPA was petitioned by the USDI and livestock interests to
                revisit the 1972 predacide cancellation decision with  respect to sodium
                fluoroacetate. EPA held informal hearings in 1981 and formal
                administrative hearings in 1982 resulting in a final decision to permit EPA
                to consider applications for registration of sodium fluoroacetate in toxic
                collars and single-dose baits.
                      In  1985, EPA granted a registration to USDI for a toxic collar product
                which was transferred in 1986 to the Animal and Plant Health Inspection
                Service (APHIS) of the U.S. Department of Agriculture (USDA).

                      The rodenticide uses of sodium fluoroacetate were cancelled due to
                lack of supporting data. In 1989, all "special local needs" registrations

-------
Human Health
  Assessment
issued under § 24(c) of FIFRA were cancelled, and all pending applications
for Federal registration were denied by August 1990.

Toxicity

      Sodium fluoroacetate is a sodium salt of fluoroacetic acid which is a
tan colored alkaline powder with a pH of 10.3.  It melts at 197-203°C with
decomposition.  It is soluble in water, but practically insoluble in all non-
polar solvents.  Sodium fluoroacetate is stable in sunlight, at a temperature
of 54°C, and in tin coated metal containers.

      The toxicological data base on sodium fluoroacetate is adequate and
will support reregistration eligibility.  Sodium fluoroacetate has been placed
in Toxicity Category I, which indicates the highest degree of acute toxicity,
for acute oral toxicity; Toxicity Category II, moderately toxic, for acute
dermal toxicity;  Toxicity Category III, slightly toxic, for primary eye
irritant; and Toxicity Category IV, practically non-toxic, for dermal
irritation.  The requirements for acute inhalation toxicity and dermal
sensitization studies were waived due to the severe acute toxicity of the
compound.

      Sodium fluoroacetate caused dose-related findings in histopathology
and decreased size and weight of testes and epididymides in  males in a
subchronic dietary study in rats. In a subchronic study of sodium
fluoroacetate in drinking water of rats, no effects were seen in the kidney or
liver,  but testicular atrophy and nonreversible tubular degeneration were
found at the mid-and high-doses. Testicular atrophy with reversible tubular
degeneration was found at the low dose.  The metabolism of sodium
fluoroacetate is understood in the mammalian body. It can be absorbed
through the gastrointestinal tract, respiratory tract, or open wounds, but
only slowly through intact skin.

Human Risk Assessment
                          Because of the specific nature of this registered use, EPA's
                    primary concern is for the potential risk of acute toxicity.  Under the
                    current limited use pattern, no sodium fluoroacetate exposure to the general
                    population is expected.  Risk of acute toxicity to applicators is mitigated by
                    the pesticide's use restrictions and its classification as a restricted use
                    pesticide.

-------
  Environmental
    Assessment
Environmental Fate

      The Agency has reviewed published literature which suggests that
leaching and metabolism are the major routes of dissipation.  However,
undegraded fluoroacetate is considered mobile and consequently has a high
potential to move downward in the soil and reach ground water. While
sodium fluoroacetate has the potential to reach groundwater, the Agency's
Pesticides in Ground Water Database reports no detections for the period
1971 to 1991.

Ecological Effects
                            The Agency has adequate data to assess the hazard of sodium
                      fluoroacetate to nontarget organisms.  Sodium fluoroacetate is very highly
                      toxic to the mallard duck, chukar, ring-necked pheasant, widgeon, golden
                      eagle, black vulture and the black-billed magpie on an acute oral basis.
                      Substantial chronic exposure to birds is not expected with the use of the
                      sodium fluoroacetate livestock protection collar. Because the livestock
                      protection collar is specifically designed to kill a wild mammal (coyote),
                      wild mammal toxicity testing was required for sodium fluoroacetate.
                      Sodium fluoroacetate can be classified as very highly toxic to coyotes,
                      cotton rat, deer mouse, raccoon, opossum and skunk on an acute oral basis.
                      It is slightly toxic to rainbow trout and practically non-toxic to bluegill
                      sunfish.  Sodium  fluoroacetate is practically non-toxic to Daphnia magna, a
                      freshwater invertebrate.   The terrestrial non-food use of sodium
                      fluoroacetate will not result in substantial exposure to marine and estuarine
                      organisms,  therefore, these  data were not required.

                           Certain nontarget species of birds and mammals, including threatened
                      and endangered species, may be exposed to sodium fluoroacetate used in
                      livestock protection collars.  Based on a variety of studies that have been
                      reviewed by the Agency, the principal  source of risk is exposure of
                      scavengers feeding on the head and neck area of dead livestock bearing
                      sodium  fluoroacetate livestock protection  collars.  Factors that reduce the
                      risk associated with use of these collars include rapid decomposition of
                      carcasses, selective feeding  of scavengers  from wounds on the carcass rather
                      than contaminated skin surface of the head or neck, and the emetic property
                      of the chemical.  The concerns for risk to wildlife can be addressed by
                      hazard statements, special use restrictions, and endangered species
                      protection statements that are required to be placed on the product label.

Additional  Data        The generic database  supporting the reregistration of sodium
        Required   fluoroacetate for use in livestock protection collars  has been determined to

-------
                         be substantially complete.  No new generic data are being required at this
                         time.

                              The Agency also is requiring product-specific data including product
                         chemistry and acute toxicity studies, revised Confidential Statements of
                         Formula (CSFs), and revised labeling for reregistration.
  Product Labeling
Changes Required
     The labels of all registered pesticide products containing sodium
fluoroacetate must comply with EPA's current pesticide labeling
requirements as specified  in 40 CFR § 156.10 and other applicable notices.
The statements must also appear on the labels of sodium fluoroacetate end
use products consistent with the USDA/APHIS product's 18 use restrictions.
(See "Use Restrictions" in the RED document for the 18 use restrictions).
In addition, the states may add use restrictions consistent with EPA's
regulatory position and legal decisions regarding predacidal uses of sodium
fluoroacetate, but no requirements may be dropped or mitigated.  Any
changes to the use restrictions must be requested through the amendment
process and must be accepted in  advance by E.P.A.
         Regulatory
         Conclusion
            For More
         Information
     The use of registered products containing sodium fluoroacetate will
not pose unreasonable risks or adverse effects to humans or the
environment, provided that these products are used in accordance with the
restrictions on product labeling.  Therefore, the current use of these
products is eligible for reregistration.  Sodium fluoroacetate products will be
reregistered once the required product-specific data, Confidential Statements
of Formula and  revised labeling are received and accepted by EPA.

     EPA is requesting public comments on the Reregistration Eligibility
Decision  (RED) document for Sodium Fluoroacetate during a 60-day time
period, as announced in a Notice of Availability published in the Federal
Register   To obtain a copy of the RED document or to submit written
comments, please contact the Pesticide Docket, Public Response and
Program  Resources Branch, Field Operations Division (7506C), Office of
Pesticide  Programs (OPP), US EPA,  Washington,  DC 20460, telephone
703-305-5805.
                              Electronic copies of the RED and this fact sheet can be downloaded
                         from the Pesticide Special Review and Reregistration Information System at
                         703-308-7224. They also are available on the Internet on EPA's gopher
                         server, GOPHER.EPA.GOV, or using ftp on FTP.EPA.GOV, or using
                         WWW (World Wide Web) on WWW.EPA.GOV.
                              Printed copies of the RED and fact sheet can be obtained from EPA's
                         National Center for Environmental Publications and Information

-------
(EPA/NCEPI), PO Box 42419, Cincinnati, OH  45242-0419, telephone
513-489-8190, fax 513-489-8695.

     Following the comment period, the Sodium Fluoroacetate RED
document also will be available from the National Technical Information
Service (NTIS), 5285 Port Royal Road, Springfield, VA 22161, telephone
703-487-4650.

     For more information about EPA's pesticide reregistration program,
the Sodium Fluoroacetate RED, or reregistration of individual products
containing Sodium  Fluoroacetate,  please contact the Special Review and
Reregistration Division (7508W),  OPP, US EPA, Washington, DC 20460,
telephone 703-308-8000.

     For information about the health effects of pesticides, or for assistance
in recognizing and managing pesticide poisoning symptoms, please contact
the National Pesticides Telecommunications Network (NPTN).  Call toll-
free 1-800-858-7378, between 8:00 am and 8:00 pm Eastern Standard
Time, Monday through Friday.

-------
REREGISTRATION ELIGIBILITY DECISION

       SODIUM FLUOROACETATE

                 LISTC

                CASE 3073
          ENVIRONMENTAL PROTECTION AGENCY
            OFFICE OF PESTICIDE PROGRAMS
        SPECIAL REVIEW AND REREGISTRATION DIVISION

-------
                          TABLE OF CONTENTS
SODIUM FLUOROACETATE REREGISTRATION ELIGIBILITY DECISION TEAM
        	i

EXECUTIVE SUMMARY	 iv

I.     INTRODUCTION	1

H.    CASE OVERVIEW	2
      A.    Chemical Overview  	2
      B.    Use Profile	 ......... 2
      C.    Estimated Usage of Pesticide  	3
      D.    Data Requirements	4
      E.    Regulatory History	4

m.   SCIENCE ASSESSMENT	9
      A.    Physical Chemistry Assessment	9
      B.    Human Health Assessment	9
            1.     Toxicology Assessment	9
                  a.     Acute Toxicity  	9
                  b.     Subchronic Toxicity	10
                  c.     Metabolism  	10
                  d.     Reference Dose	11
            2.     Exposure Assessment	11
                  a.     Dietary and Occupational/Residential Exposure	11
            3.     Risk Characterization	11
                  a.     Toxicological Endpoints	;	11
                  b.     Occupational and Residential  	11
      C.    Environmental Assessment	11
            1.     Ecological Toxicity Data  	11
                  a.     Toxicity to Terrestrial Animals  	12
                  b.     Toxicity to Aquatic Animals  	14
                  c.     Toxicity to Plants  	16
            2.     Environmental Fate  	16
                  a.     Environmental Fate Assessment	16
                  b.     Environmental Fate and  Transport  	17
                  c.     Water Resources	18
            3.     Exposure and Risk Characterization  	18
                  a.     Ecological Exposure and  Risk Characterization  	18

IV.    RISK MANAGEMENT AND REREGISTRATION DECISION	29
      A.    Determination of Eligibility	29

-------
            1.    Eligibility Decision  	30
            2.    Eligible and Ineligible Uses  	30
      B.    Regulatory Position  	30
            1.    Restricted Use Classification	30
            2.    Endangered Species Statement  	30

V.    ACTIONS REQUIRED OF REGISTRANTS	31
      A.    Manufacturing-Use Products	31
            1.    Additional Generic Data Requirements	31
            2.    Labeling Requirements for Manufacturing-Use Products	31
      B.    End-Use Products  	31
            1.    Additional Product-Specific Data Requirements	31
            2.    Labeling Requirements for End-Use Products	32
      C.    Existing Stocks  	38

VI.   APPENDICES  	39
      APPENDIX  A.    Table of Use Patterns Subject to Registration  	40
      APPENDIX  B.    Table of the Generic Data Requirements and Studies Used to
            Make the Reregistration Decision	47
      APPENDIX  C.    Citations Considered to be Part of the Data Base Supporting the
            Reregistration  of Sodium Fluoroacetate	50
      APPENDIX  D.    Product Specific Data Call-in 	56
            Attachment 1.    Chemical Status Sheets	67
            Attachment 2.    Product Specific Data Call-In Response Forms (Form A
                  inserts)  Plus Instructions  	68
            Attachment 3.    Product Specific Requirement Status and Registrant's
                  Response Forms (Form B inserts) and Instructions	72
            Attachment 4.    EPA Batching of End-Use Products for Meeting Data
                  Requirements for Reregistration	75
            Attachment 5.    List  of All Registrants Sent This Data  Call-In  (insert)
                  Notice	77
            Attachment 6.    Cost Share, Data Compensation Forms, Confidential
                  Statement of Formula Form and Instructions  	79
      APPENDIX  E.    List of Available Related Documents	86

-------

-------
SODIUM FLUOROACETATE REREGISTRATION ELIGIBILITY DECISION TEAM

Office of Pesticide Programs:

Biological and Economic Analysis Division
Alan Halverson
Gabe Patrick

Environmental Fate and Effects Division

David Farrar
Richard Felthousen
Gail Love

Health Effects Division

Charles Frick
Pat McLaughlin
Winston Dang

Registration Division

Bipin Gandhi
Mark Perry
Bill Jacobs
Dan Peacock

Special Review and Reregistration Division

Leonard Ryan
Kathleen Depukat

Policy and Special Projects Staff

Jean Frane

Office of Compliance:

Mickey Post
Economic Analysis Branch
Biological Analysis Branch
Science Analysis and Coordination Staff
Ecological Effects Branch
Environmental Fate and Groundwater Branch
Chemical Coordination Branch
Toxicology Branch
Occupational and Residential Exposure Branch
Registration Support Branch
Registration Support Branch
Insecticide-Rodenticide Branch
Insecticide-Rodenticide Branch
Accelerated Reregistration Branch
Accelerated Reregistration Branch

-------
             GLOSSARY OF TERMS AND ABBREVIATIONS
ADI
AE
a.i.
ARC
CAS
CI
CNS
CSF
DFR
ORES
DWEL
EEC

EP
EPA
FDA
FIFRA
FFDCA
FOB
GLC
GM
GRAS
HA

HOT
LEL
LOG
LOD
LOEL
MATC
MCLG
mg/L
MOE
MP
MPI
MRID
N/A
NOEC
NPDES
 Acceptable Daily Intake. A now defunct term for reference dose (RfD).
Acid Equivalent
Active Ingredient
Anticipated Residue Contribution
Chemical Abstracts Service
Cation
Central Nervous System
Confidential Statement of Formula
Dislodgeable Foliar Residue
Dietary Risk Evaluation System
Drinking Water Equivalent Level (DWEL) The DWEL represents a medium specific (i.e. drinking
water) lifetime exposure at which adverse, non carcinogenic health effects are not anticipated to
occur.
Estimated Environmental Concentration.  The estimated pesticide concentration in an environment,
such as a terrestrial ecosystem.
End-Use Product
U.S. Environmental Protection Agency
Food and Drug Administration
Federal Insecticide, Fungicide, and Rodenticide Act
Federal Food, Drug, and Cosmetic Act
Functional Observation Battery
Gas Liquid Chromatography
Geometric Mean
Generally Recognized as Safe as Designated by FDA
Health Advisory (HA) The HA values are used as informal guidance to municipalities and other
organizations when emergency spills or contamination situations occur.
Highest Dose Tested
Median Lethal Concentration.   A statistically derived concentration of a substance that can be
expected to cause death in 50% of test animals. It is usually expressed as the weight of substance
per weight or volume of water, air or feed, e.g., mg/1, mg/kg or ppm.
Median Lethal Dose. A statistically derived single dose that can be expected to cause death in 50%
of the test animals when administered by the route indicated (oral, dermal, inhalation).  It is
expressed as a weight of substance per unit weight of animal, e.g., mg/kg.
Lethal Dose-low. Lowest Dose at which lethality occurs
Lowest Effect Level
Level of Concern
Limit of Detection
Lowest Observed; Effect Level
Maximum Acceptable Toxicant Concentration
Maximum Contaminant Level Goal (MCLG)  The  MCLG is used by the Agency to regulate
contaminants in drinking water under the Safe Drinking Water Act.
Micrograms Per Gram
Milligrams Per Liter
Margin of Exposure
Manufacturing-Use Product
Maximum Permissible Intake
Master Record Identification (number).  EPA's system of recording and tracking studies submitted.
Not Applicable
No effect concentration
National Pollutant Discharge Elimination System
                                                 11

-------
            GLOSSARY OF TERMS AND ABBREVIATIONS

NOEL         No Observed Effect Level
NOAEL        No Observed Adverse Effect Level
OP            Organophosphate
OPP           Office of Pesticide Programs
PADI          Provisional Acceptable Daily Intake
PAG           Pesticide Assessment Guideline
PAM           Pesticide Analytical Method
PHED         Pesticide Handler's Exposure Data
ppb            Parts Per Billion
PPE           Personal Protective Equipment
ppm           Parts Per Million
PRN           Pesticide Registration  Notice
Q'I            The Carcinogenic Potential of a Compound, Quantified by the EPA's Cancer Risk Model
RBC           Red Blood Cell
RED           Reregistration Eligibility Decision
REI            Restricted Entry Interval
RfD            Reference Dose
RS            Registration Standard
SLN           Special Local Need (Registrations Under Section 24 (c) of FIFRA)
TC            Toxic Concentration. The concentration at which a substance produces a toxic effect.
TD            Toxic Dose. The dose at which a substance produces a toxic effect.
TEP           Typical End-Use Product
TGAI          Technical Grade Active Ingredient
TLC           Thin Layer Chromatography
TMRC         Theoretical Maximum Residue Contribution
torr            A unit of pressure needed to support a column of mercury 1  mm high under standard conditions.
FAO/WHO     Food and Agriculture  Organization/World Health Organization
WP            Wettable Powder
WPS           Worker Protection Standard
                                               111

-------
EXECUTIVE SUMMARY

       The Environmental Protection Agency has completed an assessment of the potential human
health and environmental risks associated with the pesticidal use of sodium fluoroacetate in the
United States. Based on its review of the targe database, the  Agency has determined that the
currently registered uses will not cause unreasonable risk to humans or the environment and that
these uses are therefore is eligible for reregistration.

       Sodium fluoroacetate (Compound 1080) is an acute toxicant  predacide against coyotes
which prey on sheep and goats. Currently registered end-use products are 1 % solutions which are
injected into the rubber reservoirs of Livestock Protection Collars.  These collars are strapped to
the throats of sheep or goats. Coyotes attempting to  kill collared livestock are likely to puncture
the collars and to be fatally poisoned by sodium fluoroacetate as a result.

       Sodium fluoroacetate is highly toxic to warm blooded animals, including humans, when
taken internally.  Additionally, sodium  fluoroacetate may pose a high acute risk to non-target
birds and mammals that may scavenge the carcasses of predators that are killed from biting the
collared livestock. State-limited registrations for sodium fluoroacetate collars have been issued
in Texas, New Mexico, Wyoming,  Montana, and South Dakota.  The use of these products are
further limited to only those states which have an EPA-approved  certification and training
program, which currently includes only Texas, New Mexico, Wyoming,  and Montana. The use
is further restricted within these four  states to specific counties when there is potential for adverse
effects to endangered species.

       Before reregistering  the products containing sodium fluoroacetate, the Agency is requiring
that product specific data, revised Confidential Statements of Formula (CSF) and revised labeling
be submitted  within eight months of the  issuance of this document. These data include product
chemistry for each registration. After reviewing these data and any  revised labels and finding
them acceptable in accordance with Section 3(c)(5) of FIFRA, the Agency will reregister  a
product.
                                           IV

-------
I.     INTRODUCTION

       In 1988, the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) was amended
to accelerate the reregistration of products with active ingredients registered prior to November
1, 1984. The amended Act provides a schedule for the reregistration process to be completed in
nine years. There are five phases to the reregistration process. The first four phases of the process
focus on identification of data requirements to support the reregistration of an active  ingredient
and the generation and submission of data to fulfill the requirements.  The fifth phase is a review
by the U.S. Environmental Protection Agency (referred to as "the Agency") of all data submitted
to support reregistration.

       FIFRA Section 4(g)(2)(A) states that in Phase  5 "the Administrator shall  determine
whether pesticides containing such active ingredient are eligible for reregistration" before calling
in data on products and either reregistering products or taking "other appropriate regulatory
action." Thus, reregistration involves a thorough review of the scientific data base underlying a
pesticide's registration.  The purpose of the Agency's review is to reassess the potential hazards
arising from the currently registered uses of the pesticide; to determine the need for  additional
data on health and environmental effects; and to determine whether the pesticide meets the "no
unreasonable adverse effects" criterion of FIFRA.

       This document presents the Agency's decision regarding the reregistration eligibility of
the registered uses of sodium fluoroacetate. The document consists of six sections. Section I is the
introduction. Section II describes sodium fluoroacetate, its uses,  data requirements and regulatory
history. Section III discusses the human health and environmental assessment based on the data
available to the Agency.  Section IV presents the reregistration decision for  sodium fluoroacetate.
Section V discusses  the reregistration requirements for sodium fluoroacetate Finally, Section VI
is the Appendices  which support this Reregistration Eligibility Decision. Additional details
concerning the Agency's review of applicable data are available on request.

-------
H.    CASE OVERVIEW

      A.     Chemical Overview

             The following  active  ingredient  is covered by this Reregistration Eligibility
      Decision:

      •      Common Name:           Sodium Fluoroacetate


      •      Chemical Name:           Sodium Monofluoroacetate


      •      Chemical Family:         Fluoroacetic Acid


             CAS Registry Number:    62-74-8


             OPP Chemical Code:      075003


      •      Empirical Formula:        F-CH2-C-O2-Na


      •      Trade and Other Names:   Compound 1080


      •      Basic Manufacturer:       U. S. Department of Agriculture-registrant
                                      Tull Chemical Company, Oxford. AL.-manufacturer

      B.     Use Profile

             Presented below is information on the currently registered uses with an overview
      of use sites and application methods. A detailed table of the registered uses of sodium
      fluoroacetate is in Ap>pendix A.

             For Sodium Fluoroacetate:

             Type of Pesticide:         Predacide

             Mode of action:           Stomach poison.

-------
       Use Sites:
Sheep, lambs, kids, goats, dairy goats (lactating or
unspecified), goats (wool/angora animal)
       Target Pests:
Product kills coyotes preying on sheep or goats.
       Formulation Types

       Registered:
       Method and Rates of
       Application:
Formulation Intermediate - 90% a.i.

Collar: 1% a.i. available. All Collars contain 1.1 oz
of  formulated   material   which  is  equal   to
approximately .00067 Ibs a.i./collar.
When predation is anticipated, collars (one collar per
collared  animal) are strapped in place with  the
rubber toxicant reservoirs positioned in the throat
regions of sheep or goats in target flocks or herds.
The sodium fluoroacetate solution is released if a
collar reservoir is punctured by an attacking coyote
or by another agent.

Up to 20 collars may be used in fenced pastures up
to 100 acres in size.  Up to 50 collars may be used
in pastures of 101 to 640 acres. Up to  100 collars
may be used in pastures of 641  to 10,000 acres.
       Use Practice Limitations:
For a complete listing of product limitations,  see
Section V,  Labeling  Requirements  for  End-use
Products.
C.     Estimated Usage of Pesticide

       This section  summarizes  the best estimates available for the pesticide uses  of
sodium fluoroacetate.   These estimates are  derived  from a variety of published and
proprietary sources available to the Agency. The data, reported on an aggregate and site
basis, reflect annual fluctuations  in use patterns as well as the variability in using data
from various information sources. Table 1, below, summarizes the amounts of sodium
fluoroacetate used by site.

-------
Table 1.  Estimates of Typical Usage of Sodium Fluoroacetate
Site
Steep - US
MT only
NM only
SD only
TX only
WY only
Goats* US
NM only
TX only
Total - US
Head Available
(000)
$080- 10850
520 - 580
460-510
540 - 590
1710 - 1940
830 - 850
2250 * 2530
80-90
1650 - 1960
11330- 13400
Head Treated
(000)
0>6~0,7
-
.
.
.
-
0.2
-
-
0.8-0.9
Site Treated
(%)

-------
 small tufts of leaves and flowers from long and extensively branched underground stems.
 Africans have used extracts of gifblaar (which means "toxic leaf") and related plants as
 arrow poisons.

       The active substance in gifblaar was extracted as its potassium salt, potassium
 fluoroacetate, in 1943 or 1944 (Marais, 1944 cited by Pattison, 1959).  By that time,
 research already had  been undertaken on  synthesized fluoroacetic  acid  and related
 compounds.

       Synthesis of fluoroacetic acid  was reported in 1896 by the  Belgian researcher
 Swarts (cited by  Pattison, 1959).  Fluoroacetic acid was patented in Germany in  1930 as
 a mothproofing agent.  Subsequently, Germans researched a number of related compounds
 as potential chemical warfare agents and systemic insecticides. In the mid-to-late 1930s,
 Polish military researchers discovered that fluoroacetate compounds are extremely toxic
 materials. Much of the research conducted in Nazi-occupied countries prior to the end of
 World War II was either lost or very late in being reported publicly.  The escape of a
 Polish scientist to England brought elements of the knowledge gained in Poland to  the
 allied side.

       Further  research took place in England  and in the U.S.   English  scientists
 ultimately concluded that "compounds that form fluoroacetic acid by hydrolysis and/or
 oxidation are toxic." (Pattison, 1959, p. 19)

       In the U.S., research on compounds related to fluoroacetic  acid led to several
 developments, including the development  of sodium fluoroacetate as a rodenticide and
 mammalian predacide and fluoroacetamide as a rodenticide.  The names  1080 and  1081
 for sodium fluoroacetate and fluoroacetamide,  respectively,  came  from  the  invoice
 numbers that these materials were assigned in U.S. Government laboratories (Peacock
 1964).

       Extensive research on this family of chemicals after World War II led to a  general
 understanding of the mode of toxic action and the development of analytical methods
 which, if not extremely sensitive by present  standards, were at least able to detect the use
 of compounds related to fluoroacetic acid in certain homicides (Pattison, 1959).  However,
 the problem of poor recovery of sodium fluoroacetate in or on animal tissues remained
 until the mid 1980s (Kimball and Mishelanie, 1993).

 U.S. Regulatory History of Sodium Fluoroacetate

       Development and use of sodium fluoroacetate as a predacide and rodenticide in the
 U.S.  began in the 1940s (e.g., Robinson, 1948), prior to the  1947 enactment of the
 Federal Insecticide, Fungicide and Rodenticide Act (1947) by which requirements for
Federal registration of pesticide products were instituted.  Products  containing  sodium
fluoroacetate were among those registered shortly after the registration requirement went

-------
into effect.  Pattison (1959) reports that the Monsanto Corporation produced about 5 tons
of sodium fluoroacetate in 1948.  In 1955, Monsanto's 90% sodium fluoroacetate product
was  transferred to lull  Chemical Company of Oxford, AL.  By the early 1970s, lull
Chemical Company was the only firm legally producing  sodium fluoroacetate for pest
control purposes in the U.S. lull's registered product at the time, EPA Registration No.
5217-1, was a 90% sodium fluoroacetate concentrate which was labeled for mixing baits
that could be applied to control a variety of rodents and predatory mammals.

       In 1964 and again in 1971, the use of poisons to control predatory mammals were
reviewed by select committees (Leopold, et al 1964; Cain, et al, 1972).  Following the
issuance of the "Cain Report", President Nixon issued Executive  Order 11643, which
banned the use of poisons to control predators on  Federal lands.  Shortly thereafter, EPA
issued  PR Notice 72-2  which  canceled  all registered predator control uses of sodium
fluoroacetate, sodium cyanide, and  strychnine (Ruckelshaus, 1972).  Subsequent  to the
cancellation of predacidal uses of sodium fluoroacetate, several parties sought to have such
uses  restored.

       There was a period of illegal  use of sodium fluoroacetate  as a predacide in
Wyoming from 1975 to 1977 (Thomas,  1983, p. 22; see also Nissen, 1982, p. 79; and
Johnson, 1978).

       In 1977, the U.S. Department of the Interior (USDI) applied for an Experimental
Use Permit (EUP) to investigate the potential risks and benefits associated with the use of
sodium fluoroacetate in "toxic collars" which would be placed on the necks of sheep and
goats.  Rubber pouches containing sodium fluoroacetate  solution  would be positioned
around the animals' throat regions where they would be likely to be ruptured by the teeth
of coyotes that attempted to kill the  livestock with species-typical throat bites.

       In 1981, EPA was petitioned by the USDI  and livestock interests to revisit the 1972
predacide cancellation decision with respect to sodium fluoroacetate. EPA responded by
holding informal  hearings on the issue  in  1981  and formal, Subpart D  administrative
hearings in  1982.   The  Subpart D  hearings considered reinstatement  of sodium
fluoroacetate in injected-carcass bait stations and three additional types of applications:
toxic collars, small  "single-dose baits" intended to provide enough toxicant to reliably kill
one coyote, and "smear  posts." The initial and  final decisions (Nissen,  1982; Thomas,
1983) permitted EPA to consider applications for registration of sodium fluoroacetate in
toxic collars and single-dose baits and rejected the carcass baits and smear posts.

       On July  18, 1985, EPA granted a registration to USDI for a toxic collar product
(EPA Registration Number 6704-85).   By then,  the product was called the "Livestock
Protection Collar."  In  1986, this product was transferred to the Animal and Plant Health
Inspection  Service (APHIS) of the  U.S. Department of Agriculture  (USDA).  Its new
Registration No. became  56228-22.  Since 1987, five State-limited registrations have been
issued for Livestock Protection Collars.  These products permit use of collars in Montana,

-------
 New Mexico,  South Dakota, Texas, and Wyoming. However, there  is no approved
 training and certification program in South Dakota. A concentrate product registered to
 APHIS (56228-26) that is limited to use in the manufacture of Livestock Protection Collars
 and the six registered livestock collar products mentioned above are the only registered
 pesticide products in the U.S. which legally contain sodium fluoroacetate.

       In the mid 1980s, USDI and later APHIS obtained EUPs which  authorized field
 trials  with sodium fluoroacetate single-dose baits made of tallow.  These baits  each
 contained 5 mg of active ingredient.  However, sodium  fluoroacetate was never registered
 for this use pattern.

       The  rodenticidal uses of sodium  fluoroacetate were  not directly affected by
 Executive Order 11643 or by PR Notice 72-2.  However, the U.S. Department of the
 Interior withdrew its sodium fluoroacetate rodenticide products  following the issuance of
 Executive Order 11643.  At the time, lull's 5217-1 product and dozens of intrastate
 registrations for rodenticidal uses of sodium fluoroacetate remained valid.  In 1978, EPA
 classified all legal uses of sodium fluoroacetate as  "Restricted" due to "Acute oral toxicity
 hazard to nontarget organisms, use and accident history." (Costle,  1978)

       In the mid 1970s, EPA placed the non-predacidal uses of sodium  fluoroacetate into
 its RPAR ("Rebuttable Presumption Against Registration") process, the forerunner to what
 now is called "Special Review."  On December  1, 1976, EPA's "Position Document 1"
 (PD1) was published (41FR52792, 1976). EPA announced a preliminary decision in the
 RPAR in a second document, the PD 2/3, on November 4, 1983 (Barbehenn, et al, 1983).
 After consideration of responses to the PD2/3, EPA issued its final decisionTiTtne form
 of a PD4 document in July of 1985 (Anonymous, 1985).  The  PD 4 called for retention
 of all rodenticidal uses of sodium fluoroacetate that were permitted at that time, but also
 imposed significant requirements to modify labels and to supply missing research data.
 The PD4 represented a significant change in EPA's regulatory position from that taken in
 the PD 2/3 document, which had recommended cancellation or denial of many uses and
 modification of all others except those for control of commensal rodents  "in and around
 buildings and ships" (Barbehenn, et al,  1983).

       The data call-in issued with the PD4 sought information on the chemistry, residue
chemistry, environmental fate,  toxicology, and ecological effects of sodium fluoroacetate.
The PD4 also dictated that 0.02% was the highest active ingredient strength that could be
used for prairie dog  control, where  such use was permitted,  and for ground squirrel
control within the range of the California condor.  EPA gave registrants whose products
were used in such areas the option of developing efficacy data "to establish the lowest
effective concentration" if the 0.02% level did not appear to be effective (Anonymous,
 1985).  The Agency reserved  the right to modify the decisions reached in the PD4.

       Tull's product 5217-1 was canceled "by operation of law on February 18, 1986"
(Yost,  1989) because the company did not respond to a November 22,  1985, "Notice of

-------
Intent to Cancel" (Campt, 1985) requiring that an application for amended registration was
submitted within 90 clays of the letter.  Later, other parties indicated that they would
provide the data that Tull would not commit to obtain.  On November 13, 1986, lull was
granted a registration (5217-2) for a 90% sodium fluoroacetate product that could be used
only as a source of active ingredient for  registered sodium fluoroacetate products.  Along
with this registration, EPA issued a schedule for supplying missing data pertaining to
lull's new product.

       After two deadlines for submitting data for lull's new product (5217-2) passed,
EPA refrained from taking immediate cancellation action.  Instead, EPA met with parties
(e.g., end-use registrants, user groups) concerned with the potential loss of a source of
sodium fluoroacetate for controlling  rodents.  After the various meetings had concluded,
EPA  issued revised data call-ins in December 1987 pertaining to 5217-2 and to  the
rodenticidal uses  of  sodium fluoroacetate  (Tinsworth,  1987a,b).   Due to  lack  of
appropriate responses toward supplying the data required by the 1985 and 1987 data call-
ins (Campt,  1988), EPA proceeded toward canceling lull's manufacturing use concentrate
(5217-2).  The product was canceled on February 21,  1989 (Yost, 1989). Subsequently,
all "special local needs" registrations issued under §24(c) of FIFRA were canceled, and
all pending applications for Federal registration of intrastate products containing sodium
fluoroacetate were denied.  These actions were completed by August 9, 1990 (Campt,
1990).

Regulatory Status of Sodium Fluoroacetate

       The  currently registered uses  of sodium fluoroacetate  are strictly limited  to
livestock protection collars as a predacide in those states which have registrations and EPA
approved certification and training programs. Since all other predacidal uses were canceled
by the Administrator in 1972, as described  above in the regulatory history, additional
predacidal uses cannot be granted without observation of the procedures  for reconsidering
cancellation  decisions set forth in 40 CFR Part 164,  Subpart D.

       Under the provisions of Subpart  D,  an  application for a new  predicidal use  of
sodium fluoroacetate would require the submission by an applicant of substantial new
evidence which might have affected the  cancellation decision and could not have been
made available to the Administrator  during the prior proceeding.  In addition, Subpart D
requires that the Administrator conduct a hearing before granting reconsideration of the
1972 cancellation decision.

U.S. Regulatory History of Fluoroacetamide

       Fluoroacetamide (Compound 1081) was first registered as a pesticide in the U.S.
in 1972.  In  1976, EPA began an RPAR for this compound because of potential hazards
to humans and nontarget animals.  In  1978, all uses of fluoroacetamide were classified as
"Restricted" because of "acute oral toxicity" (Costle, 1978) and the absence of a true


                                     8

-------
 antidote.  In  1979, label changes  were adopted to address the Agency's most critical
 concerns by limiting use of the sole registered product to sewers.  As a result, the RPAR
 process with respect to this chemical was concluded (PD2, Feb. 28, 1980 - 45FR  13189).
 Fluoroacetamide ultimately was canceled in 1989 after the registrant of the only  product
 failed to pay the registration maintenance fee.

 SCIENCE ASSESSMENT

 A.    Physical Chemistry Assessment

       Sodium fluoroacetate is a sodium salt of fluoroacetic acid which is a tan  colored
 alkaline powder with  a pH of 10.3.  This is  probably  due to the sodium hydroxide
 impurity. It melts at 197-203°C with decomposition. It is soluble in water but practically
 insoluble in all non-polar solvents.   Sodium  fluoroacetate is stable in  sunlight, at  a
 temperature of 54°C, and in tin coated metal containers.

 B.     Human Health Assessment

       1.     Toxicology Assessment

              The  toxicological data base on sodium fluoroacetate is adequate and will
       support reregistration eligibility.

              a.     Acute Toxicity

Table 2. Acute Mammalian Toxicity
TEST
Oral LD50--rat
Dermal LD50«rabbit
Eye irritation-rabbit
Dermal irritation—rabbit
HBSULTS
LD50 0.22 mg/kg
LD50 277.1 mg/kg M;
324.2 mg/kg F
slight irritation
not irritating
CATEGORY
I
II
III
IV
                    An  acute  oral  toxicity  study with  rats  used  90.0%  sodium
             fluoroacetate.  The LD50 was 0.22 mg/kg, which is toxicity category I
             (MRID 40016971).  An acute oral toxicity study with coyotes used doses
             of sodium fluoroacetate diluted with water.   The LD50 was  0.12 mg/kg
             sodium fluoroacetate, which is  toxicity  category  I (MRID  00065627).
             Literature reports  have indicated oral LD50s of 0.10 mg/kg for rats, 0.50
             mg/kg for mice, 0.066 mg/kg for dogs, and 0.34 mg/kg for rabbits.' The
             human oral LD,0 has been reported as 0.714 mg/kg, and the potentially
             toxic dose for humans has been stated as  0.5-2.0 me/kg (Sax and Lewis
             1989).

-------
       An acute dermal toxicity study with rabbits used technical sodium
fluoroacetate. The LD50 was 277.1 mg/kg for males  and 324.2 mg/kg for
females.    The animals  showed lethargy,  diarrhea,  and  convulsions
preceding death,  along with extensive hemorrhage of the  thymus and
congestion of the lungs. This is toxicity category II (MRID 152129).

       A primary eye  irritation  study used a 1.0% aqueous solution of
sodium fluoroacetate with rabbits.  There was slight irritation and slight
chemosis, which is toxicity category III  (MRID 40402603).  A primary
dermal irritation  study also used a 1.0%  aqueous solution  on  rabbits.
There was only transient slight edema on one rabbit and the compound was
considered  not irritating (MRID 40402604).

       Requirements for acute inhalation toxicity and dermal  sensitization
studies were waived due to the severe acute toxicity  of the compound and
the restriction of its use in a livestock protection collar.

b.     Subchronic Toxicity

       Technical sodium fluoroacetate was administered by gavage for 13
weeks to Crl:CD(SD)Br rats.  The doses were 0, 0.05,  0.20,  or 0.50
mg/kg/day.  The NOEL was 0.05 mg/kg/day.  The LOEL was 0.20
mg/kg/day,   based   on   dose-related   findings   in   histopathology
(hypospermatogenesis,  fusion bodies, and immature or abnormal sperm)
and  decreased  size and  weight of testes  and  epididymides in  males.
Females had dose-related increases in absolute and relative heart weights
at the mid and high doses (Wolfe, 1988).

       In a study with male Sprague Dawley rats, the animals were dosed
with 0, 0.07, 0.19, or 0.71  mg/kg/day of sodium  fluoroacetate in their
drinking water for seven days.  This was  followed by 21  days without the
test compound.  A group of rats from each dose level was killed each day
of treatment and on days 3, 7, 14, and 21 after dosing. The testes, kidneys
and liver were examined. Testicular atrophy and nonreversible tubular
degeneration were found at the mid and high  dose. Testicular atrophy with
reversible tubular degeneration was found at the low dose. No effects on
liver or  kidney were  seen.   The  lowest  dose was the LOEL (MRID
40016990).

c.     Metabolism

       Fluoroacetate in  the mammalian body is converted to fluorocitrate.
This compound inhibits  the enzyme aconitase, thus blocking the citric acid
cycle.  This  leads to accumulation of citric  acid,  which  may  cause
                       10

-------
               convulsions and death from cardiac failure or respiratory arrest (Gribble,


                      Sodium fluoroacetate can be absorbed through the gastrointestinal
               tract, respiratory tract, or open wounds, but only slowly through intact skin
               (Sax and Lewis,  1989).

               d.      Reference Dose

                      The Rft) was determined to be 0.00002 mg/kg/day. This was based
               on  the  13-week subchronic oral rat study, in which the NOEL was 0.05
               mg/kg/day.   An  uncertainty factor of 3000  was  used to account for
               mterspecies extrapolation, intraspecies differences, and lack of additional
               studies  (Ghali, 1994).

        2.      Exposure Assessment

               a.     Dietary and Occupational/Residential Exposure

                     Under  the current permitted use  pattern there will be no sodium
               fluoroacetate  exposure to the general  population.  Based on the use
               information,  there are no  applicator/mixer/loader or post-application
              exposure concerns other than following the label restriction  for use by
              certified personnel only.

       3.     Risk Characterization

              a.    lexicological Endpoints

                    Because of the specific nature of this registered use, the primary
              concern  is for the potential risk of acute toxicity.

              b.    Occupational and Residential

                    There  are  no uses  of sodium  fluoroacetate  in  residential
              environments.  Based  on  the  use information, potential  risk for acute
              toxicity to workers exposed to sodium fluoroacetate is not expected.

C.     Environmental Assessment

       1.      Ecological Toxicity Data

              The Agency has adequate data to assess the hazard of sodium fluoroacetate
       to nontarget organisms.


                                    11

-------
a.     Toxicity to Terrestrial Animals

       In  order to establish the acute and subacute toxicity of sodium
fluoroacetate to birds, the following tests were required using the technical
grade material: one avian single-dose oral LD50 study on one species; the
bobwhite quail (Colinus virginianus) or preferably the mallard duck (Anas
platyrhyncos); two  subacute  dietary LC50 studies  on one  species  of
waterfowl (preferably the mallard duck) and one species of upland game
bird (preferably the bobwhite quail or the ring-necked pheasant (Phasianus
colchicus).

       (1)    Birds, Acute and Subacute

       Acute oral toxicity

             The acute oral LD50 value for the technical grade of sodium
       fluoroacetate for avian species has been reported in the literature.
       Hudson et al.  (1984) reported the acute oral  LD50 values  for the
       ring-necked pheasant, mallard duck and chukar (Alectoris graeca)
       to be 6.4 (95% C.I. = 3.85-10.8),  9.1 (95% C.I. = 5.6-14ToTand
       3.51  (95%  C.I. =  2.58-4.78) mg/kg, respectively.  Ward and
       Spencer (1947) determined the acute lethal doses for numerous
       avian species and reported LD50 values as low as 3.0, 5.0,  and  15
       mg/kg for the widgeon  (Mareca americana), golden eagle (Aquila
       chrysaetos), and black  vulture (Cartharista urubu),  respectively.
       Atzert (1971) reported the LD50 for the black-billed  magpie (Pica
       pica) to be 1 mg/kg. In addition, the USDA conducted a series of
       acute oral LD^ tests on the magpie to  get toxicity data for a species
       that is likely to scavenge the carcasses of coyotes and/or livestock
       (Burns and Connolly, 1992).  Results of these studies showed that
       the acute oral LD50 for the magpie ranged from 1.78 mg/kg to 2.3
       mg/kg, depending on temperature and season.

             These data indicate that sodium fluoroacetate is very highly
       toxic  to avian  species  on an acute oral  basis.  The guideline
       requirements for this test have been satisfied.  Table 3, below is a
       data summary  for the acute toxicity of sodium fluoroacetate to avian
       species.
                       12

-------
 Table 3.
     Mallard duck

      Chukar
AVIAN ACUTE ORAL TQXICITY DATA

              mg/kg
             9.1

             3.5
 Ring-necked Pheasant

     Widgeon
    Golden eagle
    Black vulture
    • •• "•
 Black-billed Magpie
             5.0
Table 4.
       Species
          —•-•
     Bobwhite quail

     Mallard duck
 highly toxic
-•
 highly toxic
                                        highly toxic
                                        ——————^——
                                        highly toxic
                                                               highly toxic
                                        highly toxic
                                       •
                                        highly toxic
                      Subacute dietary toxicitv

                            Campbell et al.  (1994) reported that the avian dietary LC50
                      values of sodium fluoroacetate for the mallard duck and bobwhite
                      quail were 231 (95% C.I. = 150-338) and 486 (95% C I =339-696)
                      ppm, respectively (MRID #s 43210602; 43210601). Based on these
                      data, sodium fluoroacetate can be classified as highly toxic to avian
                      species on a dietary basis. The guideline requirements for a dietary
                      study have been satisfied.  Table  4 is  a  data  summary for the
                     dietary toxicity of sodium  fluoroacetate to avian species.
                  ATOH SU&AdFTE DIETARY TOXICITY DATA
              LC3D

                486

                231
  Conclusion
 •••
 highly toxic
 •••
 highly toxic
                     (2)     Birds, Chronic

                            Substantial chronic exposure to birds is not expected with
                     use of the sodium fluoroacetate livestock protection collar.

                     (3)    Mammals

                           Wild  mammal  testing may  be required  for  a pesticide
                    depending on the results of the lower tier studies such as acute and
                    subacute  testing and on the intended  use  pattern and pertinent
                    environmental fate characteristics.  Because the livestock protection
                                     13

-------
Table 5.
                     collar is specifically designed to kill a wild mammal (coyote), wild
                     mammal toxicity testing has been required for sodium fluoroacetate.

                           Ward and Spencer (1947) determined the acute lethal doses
                     of sodium  fluoroacetate for numerous mammalian  species and
                     reported LD50 values as low as 0.1 mg/kg for both the cotton rat
                     (Sigmodon hispidus) and coyote (Canis latrans).  They also reported
                     that the LD50 for the deer mouse (Peromyces sp.) was 4.0 mg/kg.
                     Beasom  (1982) reported that the  LD50 values for the opossum
                     (Didelphis virginiana) and  raccoon (Procyon lotor) were 41.6 and
                     1.1 mg/kg, respectively. Atzert (1971) reported that the LD50s of
                     sodium fluoroacetate to the  striped skunk (Mephitus mephitus) and
                     opossum are 1 and 60 mg/kg, respectively. These data indicate that
                     sodium fluoroacetate  can  be classified as very highly toxic  to
                     mammals on an acute oral basis.  The guideline requirement for the
                     wild mammal toxicity test has been satisfied.  Table  5 is a summary
                     for the acute toxicity of sodium fluoroacetate to mammals.
MAMMALIAN ACUTE TOXICITY DATA
Species
Coyote
Cotton rat
Deer mouse
Raccoon
Opossum
Skunk
LDjo mg/kg
0.1
0.1
4.0
1.1
41.6
1.0
Conclusions
highly toxic
highly toxic
highly toxic
highly toxic
highly toxic
highly toxic
                     (4)    Insects

                           Data are not required on toxicity to insects, on the basis of
                     negligible  exposure  associated  with the  sodium  fluoroacetate
                     livestock protection collar.

                     Toxicity to Aquatic Animals

                     (1)    Freshwater Fish

                           In order to establish the toxicity of a pesticide to freshwater
                     fish, the minimum data required on the technical grade of the active
                     ingredient  are two freshwater fish  toxicity studies.  One  study
                                     14

-------
 Table 6.
Table 7.
                       should use a coldwater species (preferably the rainbow trout), and
                       the other should use a warmwater species (preferably the bluegill
                       sunfish).                                                  6

                             Collins (1993) reported that the 96-hour LC50  values of
                       technical   grade  sodium  fluoroacetate  to  the  rainbow  trout
                       (Qncorhynchus mykiss) and bluegill sunfish (Lepomis macrochirus)
                       were 54 mg a.i./l and > 970 mg a.i./l, respectively.   When no
                       substantial mortality occurs at the highest dose evaluated the LC
                       is reported as greater than that dose.  Based on these data,  sodium
                       fluoroacetate can be classified as slightly toxic to coldwater fish
                      species and practically non-toxic to warm water fish species  The
                      guideline requirements for freshwater fish toxicity tests have been
                      satisfied (MRID# 42961601, 42961602).  Table 6 is a summary for
                      the toxicity of sodium fluoroacetate to freshwater fish.
                    FRESHWATER FISH ACUTE TOXICITY DATA
                     (2)    Freshwater Invertebrates

                            The  minimum testing required to assess the  toxicity of a
                     pesticide  to freshwater invertebrates  is  a freshwater  aquatic
                     invertebrate toxicity test, preferably using the first instar Daphnia
                     magna or early instar amphipods, stoneflies, mayflies, or  midges
                     (Chironomus sp.).

                            Collins (1993) conducted an  acute  static toxicity  test  on
                     daphmds  and determined  that  the  48-hour  EC50  of sodium
                     fluoroacetate was 350 mg a.i./l  (MRID# 42961603).  Based  on
                     these data, sodium fluoroacetate can be classified as practically non-
                     toxic to freshwater invertebrates.  The guideline requirement  for the
                     freshwater toxicity  test has been satisfied.  Table 7 is a summary
                     for the toxicity of sodium  fluoroacetate to freshwater invertebrates.
               FRESHWATER It^VERTBBRATE TO^IOTY DATA
                         48-hour EC50 (mg a.i./l)
                                 350
   Conclusions
   1	 •	  	
practically non-toxic
Daphnia magna
                                    15

-------
              (3)     Estuarine and Marine Animals

                     Acute toxicity testing with estuarine and marine organisms
              is  required  when  an  end-use  product is intended  for  direct
              application to the marine or estuarine environment or is expected to
              reach that environment in significant concentrations.  The terrestrial
              non-food use of sodium fluoroacetate will not result in substantial
              exposure to  the estuarine environment.  Therefore, these data  are
              not required.

       c.      Toxicity to Plants

              Toxicity data are not required for terrestrial, semiaquatic, or aquatic
       plants for sodium fluoroacetate because the chemical is  not a herbicide, is
       not applied aerially,  and there is no other apparent basis for a phytotoxicity
       concern.

2.     Environmental Fate

       The Agency has reviewed all  literature submitted on environmental fate
properties, including studies not required for the livestock protection collar use.
No acceptable guideline studies for hydrolysis or other fate properties have been
submitted. Four published articles on environmental fate were submitted by the
Texas Department of Agriculture in support of an emergency exemption, and 13
published or  unpublished articles were  submitted in  1986  by the State of
California.   These articles were found to be  lacking significant  data  and of
uncertain value, and therefore not, acceptable as guideline studies. If any new uses
of sodium fluoroacetate are proposed, acceptable environmental fate studies may
be required.

       a.      Environmental Fate Assessment

              The fate properties of the chemical are characterized to the extent
       possible, recognizing the limitations of the available data. The conclusions
       are very tentative relative to an evaluation that could be made if guideline
       studies were available.

              The limited data available suggest that leaching and metabolism  are
       the major routes  of dissipation.  However, undegraded fluoroacetate is
       considered mobile and consequently has a high potential to move downward
       in  the soil and reach ground water.
                              16

-------
        Sodium fluoroacetate appears to degrade primarily by biologically
 mediated processes.  Sodium fluoroacetate appears first to ionize to sodium
 and fluoroacetate with  the  fluoroacetate  portion further degrading by
 biologically   mediated   processes.     Microorganisms   capable  of
 denalogenatmg  compounds are reported to  metabolize fluoroacetate to
 fluoride and glycolate faster than other microorganisms. Unvalidated data
 suggest that sodium fluoroacetate does not degrade substantially in 27 davs
 in sterile soil.                                                     7

       Because there are  no leaching adsorption-desorption data, mobility
can only be assessed on the basis of solubility in water.  Based on solubility
in water, undegraded fluoroacetate may tend  to leach   However the
potential for leaching may be reduced in some soils by adsorption to
organic matter and clay particles and absorption by plants.

b.     Environmental Fate and Transport

       (1)    Degradation

       Hydrolysis (161-1)

              Three published articles have been submitted to the Agency
       to support the hydrolysis data  requirement.  These articles were
       found to  be lacking significant data and  of uncertain value  and
       therefore, not  acceptable  to  fulfill  the  hydrolysis  guideline
       requirement.   However,  the  Agency is not  requiring a  new
       hydrolysis  study  because  of  the  limited  amount  of sodium
       fluoroacetate  that is used annually in  the  livestock protection
      collars, as  noted  Section II.C. (MRID 00061751  40016958
      40016959)                                       '          '

             Based on one of these  published  articles the stability of
      sodium monofluoroacetate in  water and saline was determined for
      a period of approximately 6 months. An immediate loss of fluorine
      was detected in both the water and saline solutions. A  progressive
      loss of fluorine was reported in the water solutions. However, the
      saline solutions indicated no significant decreases in fluorine content
      after the  initial loss.   The  chemical  reaction  was  not further
      addressed in the first of the articles by Goldman (MRID  00061751)
      However,  other articles indicate the following reaction:

                   XCH2COO- + OH = HOCH2COO- + X-
                     (where X = F, Cl, or I)
                     17

-------
       c.      Water Resources

              (1)    Ground Water

                    For terrestrial uses,  the published  or unpublished data
              indicate  that small quantities of sodium fluoroacetate have the
              potential to reach groundwater. The Agency's Pesticides in Ground
              Water Database reports no detections for the period 1971 to 1991.

3.     Exposure and Risk Characterization

       a.      Ecological Exposure and Risk Characterization

              (1)    Exposure and Risk to Nontarget Terrestrial Animals

                    Certain nontarget species of birds and mammals including
              endangered and non-endangered species may be exposed by the
              following mechanisms:

              Primary hazard

              •      Contaminated sheep or goat carcasses with either broken
                    (punctured) or unbroken collars.

              •      Toxicant spilled on the ground or vegetation when a collar
                    is punctured.


              Secondary hazard

              •      Carcasses  of  coyotes killed by the sodium fluoroacetate
                    livestock protection collars and not removed.

              •      Vomitus of poisoned  coyotes.  (The chemical has emetic
                    properties)

                    Based on a  variety of studies that have been reviewed by the
              Agency, the principal source of risk  is exposure of scavengers
              feeding on the head and neck area of dead livestock bearing the
              sodium fluoroacetate livestock protection collars. The other sources
              of exposure identified above are not likely to result in unacceptable
              risk.  Factors that reduce the risk associated with use of the  sodium
              fluoroacetate   livestock   protection   collars   include   rapid
              decomposition  of  carcasses, selective feeding of scavengers from

                             18

-------
  wounds on the carcass rather than contaminated skin surface of the
  head  or  neck,  and the emetic property  of the  chemical   The
  concerns for risk  to wildlife can be addressed with applicators
  following environmental hazard statements, special use restrictions
  and endangered species protection statements that are required to be
  placed on the label.

        The following is a review of information that applies to the
  risks to both birds and mammals, which may be exposed by similar
  mechanisms.

  Risk  from  exposure  to  livestock carcasses bearing  livestock
  protection collars.              ~                   	

        The information available suggests  that the greatest risk to
  nontarget species is from exposure to the  neck areas of livestock
 carcasses  bearing  the  sodium fluoroacetate livestock protection
 collars.

        Knowlton and  Ebbert  (1991)  used  radiolabeled sodium
 fluoroacetate as a physiological marker to determine the amount of
 toxicant likely to be consumed by a coyote and the amount likely to
 occur on the necks of collared goats (Capra sp.) when the coyotes
 attacked the goats and punctured the collars that contained  30 ml of
 the toxicant.   The volume of fluid dispensed from the collar was
 19.2 ml on average (range 11.9 to 27.8 ml); the average volume
 ingested by the coyote  was 1.0 ml (0.1 to  2.9  ml).  The average
 amount of toxicant contaminating the neck  of the goat was 75 mg
 (39 to  118 mg). The average amount of toxicant  not recovered was
 113 mg (0 to 234 mg).   Once punctured, the pouches discharged
 over 85% of their contents within a short time period.  Relatively
 little of the toxicant was actually ingested by the coyotes with 6 of
 15 coyotes ingesting less than 5 mg when killing the goat.

       Savarie etal. 1990 also studied contamination of the necks
 of collared lambs (Ovis sp.) killed by coyotes.  They found that 12
 contaminated  sheepskins contained an  average  of 96  mg sodium
 fluoroacetate with a range of 23 to 200 mg.

       Comparison of the  two  studies just cited (Knowlton and
 Ebbert,  1991;  Savarie etal. 1990) suggests that the amount of
toxicant on the necks of collared livestock is similar for goats and
sheep.  The average amount of sodium fluoroacetate released from
the collar was  130 mg in the goat study  (Knowlton and Ebert) and
                19

-------
 135 mg for the sheep study (Savarie et al.).   The amount not
 recovered was 5.6 mg for  the goat study and 6.1 mg in the sheep
 study.

       In the Knowlton and Ebbert study, the average  amount of
 fluid contaminating the neck of the goat was 7.5 ml (3.9 to 11.8
 ml), or about 75 mg toxicant. That level clearly exceeds toxicity
 values for numerous birds and mammals that could scavenge the
 carcass, which suggests that the  primary hazard to the scavengers
 is quite high. However, field studies reviewed subsequently suggest
 that mortality to scavengers feeding on  the carcasses  is actually
 minor.  For example,  it has been observed that vultures, magpies,
 ravens  (Corvus  corax),  red-tailed  hawks  (Buteo jamaicensis),
 caracaras (Polyborus cheriway), coyotes, and skunks all  scavenged
 the carcasses of collared  livestock  killed by coyotes, but  none
 appeared to have been poisoned  (USDA/APHIS, 1991;  Connolly,
 1980; Littauer, 1983).

       Several factors may account for the apparent discrepancy
 between  the field results  and  the implications of  residue
 measurements.  First, the typical behavior of scavengers is to feed
 at  wounds  or openings in the carcass or where the skin has been
 torn away from the carcass, rather than on the contaminated neck
 area.  This tendency may greatly  reduce the likelihood of exposure
 to avian species such as the bald eagle (Haliaeetus leucocephalus)
 (USFWS, 1984,  1985).  Connolly  (1980) simulated exposure to
 non-target animals with  a series of tests exposing magpies and
 domestic  dogs (Canis  familiaris) to collared livestock killed by
 coyotes.   Both dogs and magpies fed heavily on the carcass but
 neither were poisoned.  Connolly further observed that both the
 species tended to feed on parts where the coyote had previously fed
 rather than  on the  neck  area where the highest  contamination is
 likely.  They concluded that typical feeding behavior of scavengers
 confers a degree of protection  against accidental  poisoning by
 livestock collars.

       Secondly, toxicity data suggest that birds likely to  scavenge,
 particularly raptors, tend to be less sensitive to  sodium fluoroacetate
 than mammals, especially canids (Haegele etal., 1984;  Ward and
 Spencer, 1947 and Atzert,  1971). Also, emesis has been observed
 as an early symptom of sodium fluoroacetate poisoning (Ward and
 Spencer, 1947) and may cause certain raptors to discontinue feeding
before lethal amounts  are absorbed (Dana,  1971).  The emetic
property of sodium fluoroacetate is likely to reduce exposure to
                20

-------
  raptors scavenging on livestock,  and probably will also make the
  raptors less likely to continue feeding on them.

        Another factor that can greatly influence the primary hazard,
  especially in warm weather, is that livestock carcasses decompose
  rapidly under field conditions, rendering them unpalatable to many
  avian and mammalian species (Burns et al.,  1984 and Connollv
  1980).                                                     •y'

  Risk from lost or spilled toxicant

        Knowlton and Ebbert (1991) found that the average volume
 of fluid not recovered was 11.3 (0-23.4) ml or approximately 113
 mg sodium fluoroacetate, which is nearly 33% of the total amount
 in the 30 ml collar.  It  is believed that most  of the  fluid not
 recovered is  spilled on the  ground. The available fate information
 consists largely of studies that  were not found  to be acceptable.
 Nevertheless the available information on fate properties  suggests
 that sodium  fluoroacetate tends  to be absorbed rapidly to organic
 material and  tends to degrade rapidly in soil. The Agency believes
 that there is no substantial hazard to non-target organisms from the
 sodium fluoroacetate that  spills on the ground as a result of the
 collar being  punctured by an attacking coyote.

 Risk from consumption of tissue, stomach contents, or vomitus of
 coyotes killed by  the sodium fluoroacetate livestock protection
 collars

        Connolly (1980) evaluated sodium fluoroacetate residues in
 muscle of captive coyotes  that received known oral doses. At a
 known oral  dose  of 5.0  mg the concentration in muscle  was
 determined to be  0.10 ppm while the  10 mg dose  resulted  in a
 concentration of 0.19 ppm.  Based on this relationship a coyote that
 ingests an average  of 1 ml fluid (10 mg toxicant) will have muscle
 tissue  residues of 0.19 ppm sodium  fluoroacetate.  The highest
 sodium fluoroacetate residue level found in muscle tissue was 0 93
 ppm.

       Residues in coyotes that have killed sheep wearing the 30 ml
collar have been determined by  Burns et al. (1984).  Those authors
report average concentrations of 0.15 ppm in muscle, 0.5 ppm in
stomach contents,  and 0.35 ppm in vomitus.  The highest residue
found occurred in the stomach  contents and was 2.3 ppm.
                21

-------
                           Knowlton and Ebbert (1991) analyzed muscle tissue from 10
                    coyotes that were killed as a result of puncturing collars. Residues
                    were detected in the muscle of all the coyotes.  The concentration
                    in muscle tissue was 0.089 ppm (range of 0.05  to 0.280 ppm); the
                    mean±SE sodium fluoroacetate lost from 12 collars was 92 ±56 mg
                    (range 3 to 183 mg).

                           Table  9 below gives  estimates of the  amount of muscle
                    tissue, stomach contents, or vomitus, from coyotes killed with the
                    30 ml  sodium fluoroacetate livestock protection collar that would
                    have to be consumed in order for a scavenger to ingest an LD50
                    (Burns et al.,  1984).  These data suggest  that secondary hazard to
                    to animals that may feed on a contaminated coyote carcass is
                    ordinarily not substantial  (Burns et al.,  1984;  Connolly, 1980;
                    Knowlton and Ebbert, 1991). However, it is likely that carcasses
                    will occasionally contain enough  sodium fluoroacetate to kill a
                    scavenger. The results below represent average exposures. The data
                    suggest substantial variation  from one carcass to the next.  This
                    qualification has to be considered when interpreting  statements in
                    the following  assessments related to  muscle tissue,  vomitus, and
                    stomach contents.
Table 9.
Approximate aroouafc of timu? from coyotes JdJled %i& tb* 30 ml sodium &ioioa
-------
  weights, respectively, to obtain an LD50 dose from muscle tissue
  Even a coyote, the most sensitive species tested, would have to eat
  approximately 67% of its body weight to get an LD50 dose.

  Stomach Contents

         Black vulture, golden eagle, and black-billed magpie would
  have  to consume  30x,   10x  and  2x  their  body  weight
  respectively,  to  obtain an  LD50 dose  from  stomach contents'
  Because of the higher concentrations in stomach contents, species
  that feed primarily on the viscera may be at greater risk than those
  that feed primarily on muscle.

  Vomitus

        Clinical observations suggest that sodium fluoroacetate is
 emetic especially to canids which have ingested more than an LD,n
  [Ward  and  Spencer,  1947 and Texas A&M University  System
 (TAMUS), 19831. Observations of coyote behavior made during
 the TAMUS study also found that some  coyotes would cache  the
 vomitus, which may further reduce exposure to animals that would
 otherwise eat it.  Connolly (1980) reported that concentrations in
 vomitus of four poisoned coyotes ranged from below the detection
 limit (0.1 ppm) to 0.72 ppm. The average  concentration in vomitus
 from five coyotes that attacked sheep wearing the 30 ml collar has
 been reported to be 0.35 ppm (USDA/APHIS, Unpublished Report
 1986).   These  levels may be toxic to certain species that are very
 sensitive to sodium fluoroacetate; however, the Agency considers
 it unlikely that sufficiently large amounts of vomitus  would  be
 available or found by non-target animals under field conditions to
 exceed the Agency's risk criteria. For example, the coyote would
 have to  consume about 29%  of its body  weight to obtain a LD
 equivalent from vomitus. The skunk would have to consume 280%
 of its body weight.

       Burns et al. (1986) also studied residues in coyotes killed
 with single drop baits (SDBs) treated at 5 mg/bait.  They found
 average concentrations of 0.29 ppm for muscle, 0.30 ppm for small
 intestine, and 0.31 ppm for stomach.  They concluded that these
 values were  consistent  with  those found in  the 30 ml sodium
 fluoroacetate livestock  protection  collars  study  conducted  by
 Connolly (1980).  They  also conducted a series of feeding tests  to
determine if there was any potential for secondary hazard to non-
target animals that fed on coyotes poisoned by the SDBs.  All  of the
               23

-------
removed tissue except the gastrointestinal tract was fed to 3 dogs
(Canis familiaris), 3 coyotes, 4 striped skunks and 15 magpies for
periods  ranging from 14  to  35 days.   The total amount of
contaminated tissue consumed, and expressed as percent of body
weight averaged 67% for dogs, 152% for coyotes, 117%  for skunks
and 371 % for the magpies.   None of the test species exhibited any
signs of sodium fluoroacetate poisoning or  had any  detectable
sodium fluoroacetate residues in there tissues. Again, these data
indicate that even if non-target species feed on carcasses of coyotes
killed  by the collar, it is  highly unlikely  that they will  ingest
sufficient quantities of contaminated tissue to result in a secondary
hazard.

       Finally, the U.S. Fish and Wildlife Service was required to
evaluate  secondary hazard to non-target organisms resulting from
use of the 30 ml sodium fluoroacetate livestock protection collars.
To simulate  secondary poisoning, coyotes were administered doses
of 4 mg, 100 mg, and 400 mg of sodium  fluoroacetate.  Upon
death, all the coyotes were skinned and eviscerated and all muscle
tissue was removed from the skeletons.  All the tissue  except  the
gastrointestinal tract was ground up and fed  to stripped skunks,
raccoons  and opossums.   The results  indicated that only  the
carcasses of animals that had  received more than 200 mg of sodium
fluoroacetate would be expected to place scavengers at risk and that
the only species of scavengers that would be expected to be at risk
would  be those with  relatively low tolerance for the chemical
(TAMUS,  1983).    The dosages that caused observable effects
greatly exceeded those administered to the coyote by the sodium
fluoroacetate livestock protection collars, indicating that mortality
to non-target animals is unlikely from operational use of the collar.

Total Collar Use

       In addition  to the residue information, it is  important to
consider how many collars will typically be used in coyote control
operations.  Based  on the  results  of  field  studies conducted in
various states, it appears that the numbers of collars  used and  the
amounts of  sodium fluoroacetate actually lost to the  environment
are both  quite low.  For example,  in the study conducted in New
Mexico only 23 of 330 of the collars  (or 7%) were ever punctured.
Of those 23 collars only 5  (or 22%) were punctured by coyotes
(Littauer, 1991). The remaining 18  collars were punctured  from
vegetation or unknown causes.
                24

-------
        During three years of monitoring in Wyoming, Montana,
  Texas, and New Mexico only 294 out of 2257 collars (13%) were
  punctured and had their contents released.  Assuming that each
  collar was completely emptied, the amount of sodium fluoroacetate
  released to the environment would be 88.2 grams, or an average of
  29.4 grams/year over the four state area where the collars were
  used.  What is even more significant is that only 108 of the 294
  collars punctured, or 36.7%, were punctured by coyotes. The total
  amount of sodium fluoroacetate released from collars punctured by
  coyote attacks (assuming that each collar was emptied) was 32.4
  grams or an average of only 10.8 grams/year over the four state
  area.  Nearly as many collars (80 collars or 4%) were punctured
  from vegetation and unknown causes as from coyote attacks.

 Field Studies

       From 1978 to 1980, the U.S. Fish and Wildlife  Service
 conducted field research in various states  to assess primary and
 secondary  hazards  from  the  use  of the sodium fluoroacetate
 livestock protection collars (Connolly,  1980). It was found  that the
 primary scavenger of collared goats that were killed by coyotes in
 Texas were turkey vultures (Cartharista aura) and black vultures,
 while red-tailed hawks, caracaras and ravens infrequently scavenged
 kills. No  scavenging by mammals was observed.  In Montana and
 Idaho,  black-billed  magpie  was  the species  observed most
 frequently as a scavenger of sheep killed by coyote.  Scavenging by
 ravens was  observed infrequently.    In addition the following
 summary  is given for primarly poisoning:

       "In summary, coyote-killed collared livestock were known
 to have been scavenged by turkey vultures, black vultures, magpies,
 ravens, red-tailed hawks, caracaras,  a skunk and a coyote during
 the present studies. No scavenger was known or believed to have
 been poisoned.  Scavengers ignored the collars and fed instead upon
 the viscera and muscle that has been exposed by the killer coyote."

       Field observations  of secondary poisoning studies, conducted
 in Texas and Montana showed that turkey vultures were the only
 scavengers of dead coyotes although  numerous other  scavengers
 such as golden eagles, ravens, magpies, skunks and other potential
 scavengers were abundant in the area.

       From  1981 to 1983, the New Mexico Department of
Agriculture conducted an experimental field program evaluating the
                25

-------
efficacy and safety of the toxic collar.  A total of 330 collars were
used over approximately 1,000 days.  Twelve collared lambs were
attacked, but  only 5 collars were actually punctured by predators.
A total of 18  collars were accidentally punctured while 21 collars
were lost.  Three predators were found dead, two coyote and one
bobcat (Lynx  rufus).  The only non-target animal believed to have
been poisoned during the study was a skunk.  The results of this
study suggest that exposure of non-target species by feeding on the
coyote carcass or the neck area of the collared livestock  was  low
and did not result in any significant adverse effects (Littauer, 1983).

      As part of the registration requirements, the USDA/APHIS
was required to submit information on hazard to non-target species
resulting from the use of the 30 ml sodium fluoroacetate  livestock
protection  collars, collected as a result of use of the device in
Montana,   Wyoming,  New Mexico,  South  Dakota and Texas
(USDA/APHIS, 1991). The major findings from the actual use of
the collar during  1988,  1989 and 1990 as well as a report on the
field and laboratory research conducted from  1978 to 1980 are as
follows:

•     The contents of a small portion (13%) of the collars placed
      on livestock were actually released into the environment.
      The total amount of sodium fluoroacetate involved in the
      release, assuming that each collar was completely  emptied,
      was 88.2 grams.  This is an average  of 29.4 grams/year
      over the four state area where the collars were used.  (No
      collars were used in South Dakota.)

•     There were  no  reports  of deaths of  non-target animals
      associated with  the use of the sodium fluoroacetate  livestock
      protection collars during this period.

•     Only  limited  scavenging occurred on coyote carcasses.
      Scavenging was  reported by caracara and two species of
      vulture.

•     Livestock carcasses  were  scavenged by vultures,  magpies,
      ravens, red-tailed hawks, caracaras, skunks and coyotes, but
      none of these non-target species were known to have been
      poisoned as a result.

»     Scavenger species tended to feed mainly on viscera  and
      muscle of hind quarters.
                26

-------
  •      Of the  13%  of the collars that had their contents released
        during  the time period (or 294 collars),  only 5% (108
        collars) were punctured by coyotes.

        (a)    Birds

               The chemical is  very highly  toxic  to birds on an
        acute oral basis.  Certain bird species may be exposed,
        primarily as a result of scavenging the carcasses of livestock
        bearing  the  sodium  fluoroacetate  livestock  protection
        collars.  The risks are discussed in detail above, generically
        for nontarget avian  scavengers and nontarget mammalian
        scavengers.  The concerns  for risk to wildlife  can  be
        addressed with the environmental hazard statements, special
        use  restrictions,  and  endangered   species  protection
        statements, that are required to be placed on the label.

        (b)   Mammals

              The chemical  is very highly toxic to mammals on an
        acute oral basis.  Certain species may be exposed, primarily
        as  a result of scavenging the carcasses of livestock bearing
        the sodium fluoroacetate livestock protection collars.  The
        risks are discussed in detail above,  generically for nontarget
        avian  scavengers and  nontarget  mammalian  scavengers.
        The concerns for risk to wildlife can be addressed  with
        environmental hazard statements, special use  restrictions,
        and endangered species  protection  statements,  that are
        required to be placed on the label.

        (c)     Insects

              Substantial exposure  of  nontarget  insects  is not
        anticipated  from  the use  of the  sodium  fluoroacetate
        livestock protection collars.

(2)    Exposure and Risk to Nontarget Aquatic Animals

       Based on low  toxicity to aquatic animals and low exposure
associated with use of the sodium fluoroacetate livestock protection
collars,  the  Agency finds that use of the collar is not likely to result
in unacceptable risk.  Sodium fluoroacetate is practically non-toxic
to warmwater fish species  and aquatic  invertebrates, and only
                27

-------
slightly toxic to coldwater fish species.  The Agency does not have
reports of detections in surface or ground water.
(3)    Exposure and Risk to Nontarget Plants

       Evaluation  of  exposure  and  risk  is  not required for
terrestrial,  semiaquatic,   or  aquatic  plants  because  sodium
fluoroacetate is not a herbicide and is not applied aerially, and there
is no other apparent basis  for a phytotoxicity concern.

(4)    Endangered Species

       On March 21, 1985, the Agency requested formal Section
7 consultation relative to the United States Department of Interior's
application to register compound sodium fluoroacetate livestock
protection collar.  On June 14, 1985, the U. S. Fish  and Wildlife
Service - Office of Endangered Species (USFWS-OES) responded
and concluded that the use of the sodium fluoroacetate collar with
proposed use directions and restrictions posed no jeopardy to the
bald eagle, San  Joaquin  kit fox, black-footed  ferret (Mustela
nigripes), and gray wolf (Canis lupus), but was likely to jeopardize
the continued existence of the grizzly bear (Ursus arctos horribilus),
Rocky Mountain  wolf (Canis lupus  irremotus)  and  California
condor (Gymnogys californianus) (USFWS,  1985). The USFWS-
OES  provided  specific state and  county  recommendations for
avoiding adverse effects to the non-jeopardy species  as well as
reasonable and prudent alternatives for precluding jeopardy to the
three species in jeopardy  from the use pattern.   Based on these
recommendations,  the  Agency  developed  specific endangered
species label precautions and use restrictions for the 30 ml collar.
These use restrictions have been included in a Technical Bulletin
that accompanies the labeling.

       In 1987, as a  result of informal consultation  with field
operations personnel from  the USFWS, the Agency became  aware
that  additional precautions, specifically addressing the use  of the
sodium fluoroacetate livestock protection  collars in Texas,  were
required to protect the ocelot (Felis pardalis)  and jaguarundi (Felis
yagouarundi  cacomitei) (USFWS, 1986).   The   additional use
precautions were  reviewed by the Agency and included in the
Technical Bulletin.
                28

-------
                                  In March 1993 the USFWS issued a final biological opinion
                            on the effects of 16 vertebrate control agents on threatened and
                            endangered  species.   This opinion  specifically  addressed the
                            livestock protection collar and included jeopardy determinations to
                            the  gray wolf and grizzly bear.  It did  not  conclude jeopardy
                            determinations to any other species. The USFWS identified specific
                            areas  where the collar could not be  used and  concluded  that
                            implementation of such a restriction would preclude jeopardy to
                            both the graph wolf and the grizzly and  that no incidental take
                            would occur from the use of the collar. Such restrictions have been
                            incorporated on the livestock protection collar labels.

IV.    RISK MANAGEMENT AND REREGISTRATION DECISION

       A.    Determination of Eligibility

             Section 4(g)(2)(A) of FIFRA calls for the Agency to determine, after submission
       of relevant data concerning an active ingredient, whether products containing the active
       ingredients  are  eligible  for reregistration.  The Agency has previously identified and
       required the submission of the generic (i.e. active ingredient specific) data required to
       support reregistration of products containing sodium fluoroacetate active ingredients.  The
       Agency has completed its review of these generic data,  and has determined that the data
       are sufficient to support reregistration of all products containing sodium fluoroacetate.
       Appendix B identifies the generic data requirements that the Agency reviewed as part of
       its  determination  of reregistration  eligibility of  sodium fluoroacetate,  and  lists  the
       submitted studies that the Agency found acceptable.

             The data identified in Appendix B were sufficient to allow the Agency to assess the
       registered uses of sodium  fluoroacetate and to determine that sodium fluoroacetate can be
       used without resulting in unreasonable adverse effects  to humans and the environment.
      The Agency, therefore,  finds that all products  containing sodium fluoroacetate as the
      active ingredients are eligible for reregistration. The reregistration of particular products
      is addressed in Section V of this document.

             The Agency made its reregistration eligibility determination based upon the target
      data base required for reregistration, the current guidelines for conducting acceptable
      studies to generate such data, published scientific literature, etc. and the data identified in
      Appendix B.  Although the Agency has found that all currently registered uses of sodium
      fluoroacetate are eligible for reregistration, it should be understood that the Agency may
      take appropriate regulatory action, and/or require the submission of additional data to
      support the registration of products containing sodium fluoroacetate if new information
      comes to the Agency's  attention or  if the data requirements  for registration (or the
      guidelines for generating  such data) change.
                                          29

-------
       As described in the Regulatory History and Status section of this document (Section
H.E.), and in 40 CFR Part 164, Subpart D, new predicidal uses for sodium fluoroacetate
cannot be granted without submission by the applicant of new evidence which was not
available and which could have impacted the outcome  of the decision in  1972 by the
Administrator to cancel the predicidal uses, and without a hearing involving all interested
parties.
       1.     Eligibility Decision

              Based on  the reviews of the generic data for the active ingredient sodium
       fluoroacetate, the  Agency has sufficient information on the health effects of sodium
       fluoroacetate and on its potential for causing adverse effects in fish and wildlife
       and the environment.

              The Agency has determined that sodium fluoroacetate products, labeled and
       used  as specified  in  this  Reregistration Eligibility  Decision,  will not  pose
       unreasonable risks or adverse effects to humans or the environment. Therefore, the
       Agency concludes that products containing sodium fluoroacetate registered for the
       sole remaining  use are eligible  for reregistration.

       2.     Eligible and Ineligible  Uses

              The  Agency has  determined that the  single  currently  registered use of
       sodium fluoroacetate is eligible for reregistration.

B.     Regulatory Position

       The following is a summary of the regulatory positions and rationales for sodium
fluoroacetate. Where labeling revisions  are  imposed, specific language is set forth in
Section V of this document.

       1.     Restricted Use Classification

              Sodium fluoroacetate,  which  is  only  registered  for  use  in livestock
       protection  collars,  will retain  the restricted use classification imposed by the
       Agency in 1978 due to its high  acute toxicity and the need for highly specialized
       applicator training.

       2.     Endangered  Species Statement

              The Agency has concerns about the exposure of threatened and endangered
       animal species to sodium fluoroacetate as discussed above in the science assessment
       chapter.


                                     30

-------
                    At this time no farther measures are necessary for protection of endangered
              species.  Should the use of sodium fluoroacetate change or the Agency becomes
              aware of new information that would warrant new concerns, the Agency will take
              additional action as necessary.

V.     ACTIONS REQUIRED OF REGISTRANTS

       This section specifies the data and labeling requirements and responses necessary for the
reregistration of both manufacturing-use and end-use products.

       A.    Manufacturing-Use Products

             1.     Additional Generic Data Requirements

                    The generic data base supporting the reregistration of sodium fluoroacetate
             for  the above eligible use has been reviewed and determined to be substantially
             complete.

             2.    Labeling Requirements for Manufacturing-Use Products

                   To remain in compliance with FIFRA, manufacturing use product (MP)
             labeling must be revised to comply with all current EPA regulations PR Notices
             and  applicable policies. The MP labeling must bear the following statement under
             Directions for Use:

             "For use only for reformulating into sodium fluoroacetate solutions for use only
             in Federally-registered livestock protection collars".

      B.     End-Use Products

             1.     Additional Product-Specific Data Requirements

                   Section 4(g)(2)(B) of FIFRA calls for the Agency to obtain any needed
            product-specific data regarding the  pesticide after a determination of eligibility has
            been made. The product specific data requirements are listed in Appendix G the
            Product Specific  Data Call-In Notice.

                  Registrants must review previous data submissions to ensure that they meet
            current EPA acceptance criteria (Appendix F; Attachment E) and if not, commit
            to conduct new studies.  If a registrant believes that previously submitted data meet
            current testing standards, then study MRID numbers should be cited according to
            the instructions in the Requirement  Status and Registrants Response Form provided
            for each product.
                                        31

-------
              2.     Labeling Requirements for End-Use Products

                     The use of sodium fluoroacetate in the animal protection collar is currently
              registered in five  states (Montana,  New Mexico, South  Dakota, Texas, and
              Wyoming).

                     The following list of use restrictions for sodium fluoroacetate represents the
              USDA/APHIS product.

                     The labels and labeling of all products must comply with EPA's current
              regulations and requirements as specified in 40 CFR §156.10 and other applicable
              notices.

              USE RESTRICTIONS

              1.     Use of livestock protection (LP) collars shall  conform to all applicable
                     Federal, State, and local regulations.

              2.     LP Collars shall be sold or transferred only by registrants or their agents
                     and only to certified Livestock Protection Collar applicators.  Collars may
                     be  used  only  by specifically  certified  Livestock Protection  Collar
                     applicators or by persons under their direct supervision. l

                     The certified applicator is directly responsible for assuring that all use
                     restrictions  are met.  The certified applicator will decide, in accordance
                     with label directions, when and under what circumstances collars will be
                     used. The certified applicator will either apply collars or be physically
                     present where collars are applied by a noncertified person.  However, a
                     noncertified person who has received adequate instructions  from the
                     certified applicator may  store collars, check collars  in the field, remove
                     collars,  repair  or dispose of damaged collars in accordance with use
                     restrictions,  retrieve collars laying in the field and  properly dispose of
                     contaminated material and animal carcasses.

              3.     Certification of applicators shall be performed by appropriate regulatory
                     agencies. Prior to certification, each applicator shall receive training which
                     will include, but need not be limited to:

                     (a)     Training in safe handling and attachment of LP collars.
   1 "Direct Supervision," as described in this restriction, conforms to the requirements
established under 40 CFR 171.6.

                                            32

-------
        (b)    Trainig in disposal of punctured  or leaking LP collars, and
               contaminated animal remains, vegetation, soil,  and clothing.
        (c)    Instructions for practical treatment of 1080 poisoning in humans
               and domestic animals.
        (d)    Instructions on record keeping.

 4.     Registrants  or their agents shall  keep records of all collars sold or
        transferred at  their address of record.  Records  shall  include the  name,
        address, state where Livestock Protection Collar certification was issued,'
        certification number of each recipient,  and dates and numbers of collars
        sold or transferred.

 5.     Each applicator shall keep records dealing with the use of LP Collars and
        the results of such use.  Records shall be maintained in accordance with
        appropriate State  or  Federal regulations but for  not less than two years
        following disposal or loss of collar.  Such records shall include, but need
        not be limited to:

        (a)    The number of LP collars attached on livestock.
        (b)    The pasture(s) where LP collared livestock were placed.
        (c)    The dates of each attachment, inspection, and removal
        (d)    The number  and locations of livestock found  with ruptured or
              punctured LP collars and the apparent cause of the damage.
        (e)    The number,  dates, and approximate location  of LP collars lost.
        (f)    The species,  locations, and dates of all suspected poisonings of
              humans, domestic animals or non-target wild animals resulting from
              LP collar use.

6.     Any suspected poisoning  of threatened or endangered species must be
       reported immediately (within three days) to the Environmental Protection
       Agency, as will each suspected poisoning of humans, domestic animals or
       non-target wild animals.  The  person to contact at  the Environmental
       Protection Agency is  Robert A. Forrest (PM-14), Registration Division
       (7505C), 401 M Street,  SW, Washington, DC 20460.

7.     Only the registrant or collar manufacturer is authorized to fill LP collars
       with 1080 solution.  Certified  applicators are not authorized to fill  LP
       collars. Compound 1080 solution may not be removed from collars and
       used for any other purpose.
                             33

-------
              8.     LP Collars shall only be used to take coyotes within fenced pastures2 no
                     larger  than  2,560 acres  (4 square  miles). But  where average  annual
                     precipitation does not exceed 20 inches and vegetation is sparse, consisting
                     only of short to mid-height grasses and scattered  shrubs, collars may be
                     used in pastures up to a maximum of 10,000 acres (16  square miles) in
                     size.

              In no case shall  the applicator place LP collared livestock in pastures where
              compliance with  other Use  Restrictions, such as monitoring, is impossible; in
              fenced pastures larger than 10,000 acres; or  in unfenced,  open range.

              9.     LP Collars shall  be  used only where  losses of  sheep  or  goats  due to
                     predation by coyotes are occurring or,  based upon prior experience, where
                     coyote predation can  reasonably be expected to occur.

              10.    Where LP collars are in use, each logical point of access (for example,
                     roads,  gates, and trails) shall be conspicuously posted  with a bilingual
                     (English/Spanish or  other second  language appropriate for the region)
                     warning sign not less than 8" X 10" in  size. Signs shall be inspected weekly
                     to ensure their continued presence and legibility and will be removed when
                     collars  are removed. The signs will  have a  minimum  type size  for
                     "DANGER-POISON" of 24 point (1/4 inches), with remaining text at least
                     18 point (3/16 inches).

              11.    All LP collared livestock must be checked at least once every seven days
                     and collars adjusted if needed.

                     If any LP collared animal is not accounted for in two consecutive checks,
                     an intensive search for it must be made.

                     In addition, if more than three LP collared animals are not accounted for
                     during  any one check, an intensive search for these animals  is required.

                     If more than  nine (9) LP collars are  unaccounted  for  during any 60 day
                     period, remove all collars from animals and terminate their use.  Do  not
                     resume  use  until  adequate steps have been  taken to prevent further,
                     excessive loss of collars.
     Fenced pastures include all grazing land that is enclosed by livestock fencing. This includes
wire or other man-made fences such as rock walls, and natural barriers such as escarpments,
lakes, and large rivers that will prevent the escape of livestock.
                                           34

-------
 12.    Damaged, punctured, or leaking LP collars shall be removed from the field
        for repair or proper disposal. Damaged collars shall be placed individually
        in leakproof  containers  while  awaiting  repair  or proper  disposal
        Authorized collar repairs  are limited  to  minor  repairs of straps  and
        fastenings. Leaking or punctured collars must be properly disposed.

 13.    Dispose of 1080 wastes (punctured, leaking, or otherwise unrepairable LP
        collars;  contaminated  leather clothing, animal  remains,  wool, hair
        vegetation, water, and soil) under three feet of soil, at a safe location!
        preferably on property owned or managed by the applicator and at least 1/2
        mile from human habitations and water supplies. No more  than 10 collars
        may be buried  in any one hole.  If buried in a trench, each group of 10
        collars must be at least  10 feet apart.
        Incineration  may be used  instead  of burial  for  disposal  in the field
        (preferably on  property owned or managed  by the applicator) at least 1/2
        mile from human   habitation and water supplies. Place collars and waste
        (listed above) in an incinerator or refuse hole, saturate with diesel fuel, and
        ignite. Attend  the burn until  the contaminated material  is completely
        consumed.

       Alternatively,  contact your  State  Pesticide or Environmental Control
       Agency or the Hazardous Waste representative at the nearest  EPA Regional
       Office for  guidance in disposing  of wastes  at approved hazardous waste
       disposal facilities.

       When snow or frozen ground make on-site disposal impractical,  up to one
       cubic  foot of wastes may be stored in a leak-proof container  in  a dry
       locked place for 90 days.

       Metal Container: Triple rinse contaminated and uncontaminated containers
       with water.  Puncture and dispose of contaminated container and rinsate as
       above.

       Plastic Container: Triple rinse with water. Then puncture and dispose of
       container and rinsate as above.

14.     All persons authorized to possess and use LP Collars shall store them under
       lock and key in a dry place away from food, feed, domestic animals, and
       corrosive chemicals  and in  outbuildings,  or in outdoor  storage areas
       attached to, but separate from human living quarters.
                             35

-------
  15.    Provisions for the protection of endangered species:
        The  LP Collar may not be used in the following areas due to potential
        adverse effects to endangered species (California condor).
STATE
California
     COUNTIES
           Fresno, Kern, Kings, Los Angeles, Monterey, San
           Luis Obispo,  Santa Barbara, Tulare, and Ventura
 The LP collar may not be used in the following areas without written approval
 from the nearest U.S. Fish and Wildlife Service Office (FWS, Endangered Species
 Specialists). If FWS or the user determines that the use of collars may adversely
 impact an endangered species (San Joquin kit fox, black-footed ferret, Northern
   Rocky Mountain wolf, or Grizzly bear) in the specific areas requested, collars
 may not be used in these areas. Written approval must be obtained annually.
  State
Counties or Area
NEAREST FWS
OFFICE/
PHONE
  California     Alameda, Contra Costa,
                Merced, San Joaquin,
                Santa Clara, and Satnislaus
  Idaho         Bonner, Boise (north of
                State Highway 21),
                Boundry, Clearwater,
                Custer (north of local road
                running from Sun Valley to
                Chilly and a corresponding
                line northeast from Chilly
                to Patterson), Fremont,
                Idaho, Lemhi, Shosshone,
                and Valley

  Michigan      Keweenaw (Isle Royal) and
                entire Upper Peninsula
                           Sacramento, CA
                           916-978-4866

                           Boise, ID
                           208-334-1931
                           Twin Cities, MN
                           612-725-3276
                             36

-------
  State
          Counties or Area
                                           NEAREST FWS
                                           OFFICE/
                                           PHONE
  Minnesota     Aitkin, Becker, Beltrami,    Twin Cities, MN
                Carlton, Cass, Clearwater,   612-725-3276
                Cook, Crow Wing,
                Hubbard, Itasca, Kittson,
                Koochiching, Lake, Lake
                of the Woods, Mahnomen,
                Marshall, Pennington, Pine
                Roseau, and St. Louis


  Montana       Beaverhead, Carbon,         Helena, MT
                Flathead,  Gallatin, Glacier,   406-449-5322
                Lake, Lewis and Clark,
                Lincoln, Madison,
                Missoula, Park, Pondera,
                Powell, Sanders,
                Stillwater, Sweet Grass,
                and Teton
 Washington   Pend Orielle, Okanogan,
               (National Park and Forrest
               Land), Skagit, and
               Whatcom

 Wisconsin     Douglas, Florence,
               Lincoln, Oneida, and Price
 Wyoming     Fremont, Park, and Teton
               and  Yellowstone National
               Parks
16.
                                    Boise, ID
                                    208-334-1931
                                    Twin Cities, MN
                                    612-725-3276
                                    Helena, MT
                                    406-449-5322
The number of LP collars used shall be the minimum  necessary for
effective livestock protection. For pastures of the following size classes, do
not use more collars than the number indicated.
      Size (acres)

       up to 100
       101 to 640
       641 to 10,000
                                Number of Collars

                                       20
                                       50
                                       100
                            37

-------
       17.    Each applicator will have a one-ounce bottle of syrup of ipecac (to induce
              vomiting  in  case  of accidental poisoning)  available when attaching,
              inspecting,  removing, or disposing of LP collars.

       18.    No contaminated animal will be used for food or feed.

       In addition,  for State-limited products, additional use restrictions consistent with
EPA's regulatory position  and  legal decisions regarding predacidal  uses of sodium
fluoroacetate may be added.  The organization of restrictions may be altered so as to
maintain  consistency with applicable State and Federal  laws  and regulations but no
requirements may be dropped or mitigated. Any changes to the use restrictions must be
requested  through  the  amendment  process   and must be  accepted  by the  U.S.
Environmental Protection Agency before they  may be incorporated into the labeling of
product released for shipment in the U.S.

       Unless the Agency specifically indicates otherwise, the current accepted labeling
for registered  1080  Livestock Protection Collar products remains acceptable.

       The  registrants should submit 5 copies of their  last accepted  labeling (all 3
componets thereof) with their 8-months responses. The Agency will then review  the
documents to determine whether any changes are needed.

C.     Existing Stocks

       Registrants may generally distribute and sell products bearing  old labels/labeling
for 26 months from the date of the issuance  of this Registration Eligibility  Decision
(RED). Persons other than the registrant may  generally distribute or sell such  products
for 50 months from the date of the issuance of this RED.  However, existing stocks time
frames will be established case-by-case, depending on the number of products involved,
the number of label changes, and other factors. Refer to  "Existing Stocks of Pesticide
Products;  Statement of Policy"; Federal Register, Volume 56, No. 123, June 26, 1991.

       The Agency has  determined that  registrants  may distribute and sell  sodium
fluoroacetate products bearing old labels/labeling,  i.e., labels absent the modifications
specified in this RED document, except as noted below, for 26 months from the date of
issuance of this RED. Registrants and persons other than the registrants remain obligated
to meet preexisting  Agency  imposed label  changes and existing stocks requirements
applicable to your products.
                                    38

-------
GO
W
U
                                 en

-------
                                                                                                                                                                                               o  o
                                                                                                                                                                                               a  J
                                                                  U  4J  in   4J   

C X: TH o 4_> m 4-1 in in -H -^ 0) ,

u TJ C O 4J >, -r u o CQ en c a> c/i c —- in in D a; - c in u c a a;


-------
                                                                                                                                                                                                       O  D  -H  >
       M  (/)
a  a  o  —
                                                                                               ••  Xi   o
                                                                                               _  M   o>
                                                                                               M  03   a
                                                                                               o  CD   wi
                                                                                               c    -  xi   m    -  01
                                                                                               M   O  1C  i->   0]
                                                                                               O   Q.  r-.   O  •-<  01
                                                                                              1-1   01       01   01  01
                                                                                              •M  -H  d)   0)   (0  0)
                                                                                                  M  3   O   i->  O
                                                                                                                                                                                                           o   o  cn   01
                                                                                                                                                                                                      CO   C  —   01
                                                                                                                                                                                                           w  u   c
                                                                                                                                                                                                           3  CD   (D
                                                                                                                                                                                                               Q. CO
                                                                                                                                                                                                      2   C   O)  C
•-H   J->   >,  d>  C   C
 O        d>   Ul  M   Q)   0)
 u   01   M   a  o  jj   o
                                                                                                                                                                                                              •a   c
                                                                                                                                                                                                              *  «:
                                                                         M       c  x:

-------
                                                                                                                 Ifl  4->   0)  C
ce DO  n  —
W  E-"  2: Q

  .  n  -o —
r-H  «<   (1)  0)
a —  jj  cn
a      o -M
<  0)   C  S
                                                                                                            a>   c
                                                                                                            3  --H
                                                                                                            T3  ^
                                                                                                                 CT'  C  J3 "-(
                                                                                                                     a)  j->  cn  co
                                                                                                                             cn  a)
                                                                                                                            •M  .C
                                                                                                                            3  U
                                                                                                            fO   tn  H   u
                                                                                                        (~n  u  dv   co  -rH   cn -H
                                                                                                            >,  C  CD  Hi     u
                                                                                                                cn  
-------
                                                                                                                                                                                       -  (U   C   d)  4J   U)
                                                                                                                                                                                                            O   D
                                                                                                                                                                                                            O
                                                                                                                                                                                                            en   0>
   en -o
   O  
       CD   0)  O  1-1
     OJ   ID   0)
     J-J   01  £
     iB   

IE OS rH O W O - C E Qi O -M :J3: •Q: w •e&: & to! jj & •tU' c «! o 55: U «: — Si: Q :£,: u Ui W 1 ± :B3: O $ ^ "W: O ij: O .6j: o :!>:! a, $ 2 M: 0 P *^ •>f-i< :**: §' • :rr*rr !& 'O o & 1 xj$ A JS tt 7Z <-r( O. .3 o >-( <3 ., c I r~. s § *H 25 1 £3 1 >j B -~ £ •*. 8 o o (0 •rH C ^»1 M ^H O 0 M-4 -H * 0 eji c •H 3 0 i-H i — 1 0 *4-l CP x: ij in c 2 .-i TD 0) CO D W 2 0) XI jj C/l O 2 C ^>, fC 6 M C/) (0 2 rH O o 0) XI E-< 2 c"> ^H O o C/) CD 2 O ^ X> l-i -4 (0 ^ r— ( 0 O I U DJ O LO 'JD C CO TJ C 0' O -0 en aj U CD u ^-i 0) 0) CO k-l 0) T3 10 r— — fi m ^ CO XI M (0 CO (0 1J c (0 in *. 0 a CO •i-4 X! O CO •H D J C (0 C/> O aJ C CD CO C cO C/) V 01 k-i 0) 4J c o s CO 0) ,— t CD D) < C a o o 0 U-4 .,_( U CD a j_, o , — 1 0) X! (0 0) CO — CO CD .^H 4J c a 0 u CO D O k^ CO C TD 01 CO D CD XI >, CO E v^ (0 r-4 O O C a ._ _,-~ CO -0 S 4-J T3 0) C •^-c cO t-> XI O CD i-> CO CO CD a u E (0 u - w en •-H 0) en in rfl CD j , j (0 a 3 H C C D co n 3 c (0 3 ,_> C O -i O i — i -i cO ii ^> 0 (D Q, •• a " cO n C CD C 1_> ! iJ ... .,_( > M > S CL C71 ** C - e T o ^ S 3: ~ - CO 3 o o CD en c . c cO (0 E -O


-------
in   3
(/)   JH
0)   0>

-------
                  •-<  QJ  It)
                   01  DJ      T3
                       <  73  OJ
                                         C   10  U   <0  3
                                         3   Q)   O   (/I   10
                                                                                                                                  ~  a  u)
                                                                                                                                  i—i  nj  Q,
                                                                                                                                  0)  O  £
                                         it)   u   10   a)  xi
                                         0)  CiJ   C  (0   (0
                                         >->      -rH      x:
                                         C  T!   10  73
                                         e  o   o  QJ  jc
                                         C  o)  M  Di i->
—      —       ox
     —       —  Q   (0
oj   a>  cu   0)      E
4->   01  J-l   0)
iO  -^-i  ft)  •'-i  X  (5J
as   3  ce
                                        ~fc
                                         oi   o>
                       01       —  u
                                ai  x:   0)   c
                               E  c  5:  D:  cu
T3  QJ  Q)   .
 ai  a  a  >
 a>  <  co  c
                                                                                                               2  oi   o  o   c
                                                                                                               CD   2  <   CO  O
                                                                                                                             (J   M  W   Q,
                                             E  E
                                         o  Cu  a,
                                        2  cu  a,
                                                                       CO   U
                                                                       U   OJ  •
                                                                       Q   a.
                                                                       O   en
                                                                                                                                                                          CDC      M
                                                                                                                                                                                                        i       8

-------

-------
                               GUIDE TO APPENDIX B


 Appendix B contains listings of data requirements which support the reregistration for active
 ingredients within the case SODIUM FLUOROACETATE covered by this Reregistration
 Eligibility Decision Document. It contains generic data requirements that apply to SODIUM
 FLUOROACETATE in all  products,  including data requirements for  which a  "typical
 formulation" is the test substance.

       The data table is organized in the following format:

       1.  Data Requirement (Column 1).  The data requirements are listed in the order in which
 they appear m 4U UhK Fart 158.  the reference numbers accompanying each test refer to the test
 protocols set in the  Pesticide Assessment Guidelines, which  are  available from the National
 Technical Information Service, 5285 Port Royal Road, Springfield, VA 22161 (703) 487-4650.

       2.  Use Pattern (Column 2).  This column indicates the use patterns for which the data
 requirements apply.  The following letter designations are used for the given use patterns:

                          A     Terrestrial food
                          B     Terrestrial feed
                          C     Terrestrial non-food
                          D     Aquatic food
                          E     Aquatic non-food outdoor
                          F     Aquatic non-food industrial
                          G     Aquatic non-food residential
                          H     Greenhouse food
                          I      Greenhouse non-food
                          J      Forestry
                          K     Residential
                          L     Indoor food
                          M     Indoor non-food
                          N     Indoor medical
                          O     Indoor residential

       3. Bibliographic citation (Column 3). If the Agency has acceptable data in its files, this
column lists the  identifying number of each study.  This  normally is  the  Master Record
Identification (MRID) number, but  may be  a  "GS" number if no  MRID number has been
assigned. Refer to the Bibliography appendix for a complete citation  of the study.
                                         47

-------


0>
3
o
03
o
o
E
ag
0
c»
o
e
eo
13
t-
•+ri
P5|
t^
^^^( QJ
HH
Q 1
^"3^ U
^H ,O
w I
DM 1
^ 4>
•<3 .b
I
0g
"3
s
*3
O
ox
e
• P>4
^^
t-
o
a
a
9
c»
2
'S
a



»
z
o
B
JS
^^
^^
u















K
1
^
W
CM
P








H
Z
H
g
§
p
o
w
B






























^H
B
O5
ti
ffi
U
H
U
P
a
o
PN
OH
o o
-H Tj-
\o r-
—> r^
r^ ^
>-H  ^£i ^5 ^C x^i
i-J _)>—]_) i-J i—]






CA
.2
•r « 2
M »^« .Z
&!» 1-°
M"* -§
f 1 1 1 *
o 2 1 "3 M
« .9 2 .a -a
ea H IP* *^ ij
1| 1 1> j |
fa £ U «3 U OH


S .H^M «
1 *>!i ri #»!i *^ *A
vo ve vc vo vo vc
0000
oo ^ Z^ Z^
Illl

















S S S S
•— 3 i-J i-J >— 3







•M
a
CtJ
•tad
en
a
o
•^^ ^j
•§ °
{£ -2
g ^1
g g *« o
O S O *Q


^ ^ o
7J, i i i
ve vo ve v«
ooooooo
vovot^oxvovovo
OOOOTt"— 1^^'— I
*   ON TD  CO

  .  r^  o  o
f^  ^H  >  VO

 O
                                —  ^ ^t
40
                            S  S  S

-------



a
e
'5
0
o
u
c
E
E
c
o
c
*z
a
tJ
"5
d
£
^
a>
•£
t-
c2
'c
a>
E
4,
2
tf
a>
sfi
MM
'S
"3
Dl
^C
O
o
a
C/3
CQ
13
Q


^ ^
%
O
^
h
H













z
»
tf
h
^
tu









H


I
^
8
o
§


















^
I_J





1
p^
a
,o

1
C
Primary Dermal

m
i-H
00
•r:
.>
w
£
t^


















^
J









c
,g
'•**
Dermal Sensitiza


i— i
00
#
t
ON"
s
§

















2
__J








sa
V
"O
&
90-Day Feeding -

5
oo
#





















S










&
.2
General Metabol

vH
uS
00

































w
H
£
J
?S
^
O
>
w
ON
0
^
|
o
O
^
rl
ac
^1-
»n
^o










S











C/5
1
•o
ffl

1
S
i-H
















D
•^
3
•J
d
•H
>
H
-H
g
^
-M
•^
-H
-H '
2
3
X
L>
•«
2

•H
4
D
-4
H
M
5
^
u
H
^
-^
D

4
H
X
«
H
^}
^
4
H
^
4
Q
i
H



Ox

-------
                               GUIDE TO APPENDIX C

1.     CONTENTS OF BIBLIOGRAPHY.  This bibliography contains citations of all studies
       considered relevant by EPA in arriving at the positions and conclusions stated elsewhere
       in  the  Reregistration  Eligibility  Document.    Primary  sources  for  studies  in  this
       bibliography have been the body of data submitted to EPA and its predecessor agencies
       in support of past regulatory decisions.   Selections  from other sources  including the
       published literature, in those instances where they have been considered, are included.

2.     UNITS OF ENTRY.  The unit of entry in this bibliography is called a  "study". In the
       case  of published materials,  this corresponds closely  to an article.  In the case of
       unpublished materials submitted to the  Agency,  the  Agency  has sought to  identify
       documents  at a level parallel to the published article from within the  typically larger
       volumes in which they were submitted.  The resulting  "studies" generally have a distinct
       title (or at least a single  subject), can stand alone for purposes of review and can be
       described with a conventional bibliographic citation.  The Agency has also attempted to
       unite basic documents and commentaries upon them, treating them as a single study.

3.     IDENTIFICATION OF  ENTRIES.  The entries  in this  bibliography are sorted
       numerically by Master Record Identifier, or "MRID number".  This number is unique to
       the citation, and should be used whenever a specific reference is required.  It is not related
       to the six-digit "Accession Number" which has been used to identify volumes of submitted
       studies  (see paragraph 4(d)(4) below for further explanation).  In  a few cases, entries
       added to the bibliography late in the review may be preceded by a nine character
       temporary identifier.  These entries  are listed after all MRID entries.  This temporary
       identifying number is also to be used whenever specific reference is needed.

4.     FORM OF  ENTRY.  In  addition  to the Master  Record Identifier (MRID), each entry
       consists of  a citation containing  standard elements followed, in the case of material
       submitted to EPA, by a description  of the earliest known submission.  Bibliographic
       conventions used reflect the standard of the American National Standards Institute (ANSI),
       expanded to provide for certain special needs.

       a      Author.  Whenever the author could confidently be identified, the Agency has
             chosen to show a personal author. When no individual was identified, the Agency
             has shown an identifiable laboratory or testing facility as the author.  When no
             author or laboratory could be identified, the Agency has shown the first submitter
             as the author.

       b.     Document date.  The date of the study is taken directly from the document. When
             the date is followed by a question mark, the bibliographer has deduced the date
             from the evidence contained in the  document.  When the date appears as (19??),
             the Agency was unable to determine or estimate the date of the document.

       c.     Title.  In some cases, it has been necessary for the Agency bibliographers to create
             or enhance a document title. Any such editorial insertions are contained between
             square brackets.

       d.     Trailing parentheses. For studies submitted to the Agency in the past, the trailing
             parentheses include (in addition to any self-explanatory text) the following elements
             describing the earliest known submission:

             (1)   Submission date.   The date of  the  earliest known  submission  appears
                   immediately following the word "received."

             (2)   Administrative number. The next element immediately following the word
                   "under"  is  the  registration  number, experimental  use permit  number,


                                          50

-------
       petition number, or other administrative number associated with the earliest
       known submission.

(3)     Submitter.   The third element  is the submitter.  When  authorship is
       defaulted to the submitter, this element is omitted.

(4)     Volume  Identification (Accession Numbers).   The final element in the
       trailing parentheses identifies the  EPA accession number of the volume in
       which the original submission of the study appears.  The six-digit accession
       number  follows the  symbol "CDL," which stands for "Company Data
       Library."  This accession number is in turn  followed by an  alphabetic
       suffix which shows the relative position of the study within the volume.
                            51

-------
                                BIBLIOGRAPHY


MRID                         CITATION
             Beasom, S. L., (1982). Report on-Efficacy of the 1080 toxic collarsas a predator
             damage control method  (July 1, 1982  -September  30,1982). Texas  A & M
             University, College Station, Texas.

             Burns R. J., Connolly, G. E. and Okuno, I. (1986). Secondary toxicity of coyotes
             killed by 1080 single-dose baits. Denver Wildlife Research Center, USDA/APHIS.
             Proc. 12th Vertebrate Pest Conf, San Diego,  California. p324-329.

             Burns, R.J. and G.E. Connolly 1992. Toxicity of Compound  1080 to Magpies
             and  the Relationship of Dose Rates to Residues Recovered.  USDA,  Denver
             Wildlife Research Center. Proc. 15th Vertebrate Pest Conf., Newport Beach, Ca.
             p403 (6).

             Dana, R. H. 1971. Vertebrate pest control in California. Unpublished  mimeo. rep.
             California Dept. of Agriculture. 14 pp.

             Ghali, G. 1994. RfD/Peer  Review Report  of Sodium Fluoroacetate. U.S. EPA
             memorandum.

             Gribble, G. 1973. Fluoroacetate Toxicity. J.  Chem. Educ. 50:460-2.

             Hegdal, P. L., T.A. Gatz, K. A. Fagerstone, J.F. Glahn and  G. H.Matschke.
             (1979). Hazards  to wildlife associated with 1080 baiting for California ground
             squirrels.

             Hilton,  H.  W., Q.H. Yuen,  and N.S.  Nomura.  1969.  Absorption of
             monofluoroacetate-2C ion and its translocation in sugarcane. J.Agric.  Food Chem
             17:131-134.

             Hudson, R. K., R. K. Tucker, and M. A. Haegele, 1984. Handbook of toxicity
             of pesticides to wildlife, 2nd edition. U.S. Dept. oflnterior, Fish and Wildlife
             Service, Resource Publication 153, Washington, D.C. 90 pp.

             Knowlton, F.F., and S.M. Ebbert. 1991.  Develop physiologic markersto identify
             coyotes that  kill  sheep or  goats  (Unpublished report to the EPA - QA-090)
             USDA/APHIS, Denver Wildlife Research Center, Denver, Colorado. 27 pp.

             Sax, N. I., and  Lewis,  R. J. SR,  (1989) Dangerous Properties of Industrial
             Materials, 7th Ed. Van Nostrand Reinhold,
             TAMUS (Texas A&M University System). 1983. Efficacy of the 1080 toxic collar
             as a predator damage control method. Final report tothe U.S. Fish and Wildlife
             Service for Cooperative Research Project No. 14-16-0009-81-934, September 1,
             1980-June 30, 1983.  Department  of Wildlife and  Fisheries Sciences, Texas
             Agricultural Experiment Station.  Data report submitted  to the Environmental
             Protection Agency to support modification of the Texas A&M University System,
             College Station, TX. 134pp.
                                         52

-------
                                 BIBLIOGRAPHY
 MRID
                    CITATION
              USDA/APHIS,  1986. Unpublished  Report entitled:   Residues  of sodium
              fluoroacetate (1080) in coyotes and on the necks of sheep due to the use of large
              (60 ml) compound 1080 livestock protection collars. Denver Wildlife  Research
              Center, Denver, Colorado. A data report to support the registration of the 60 ml
              collar. Laboratory and Pen Studies. September 1985-January 1986. 10 pp.

              USDA/APHIS,  1991. Correspondence  from  P.  Joseph, summarizing the
              information on the use of the Compound 1080 Livestock Protection Collar durine
              FY-1988, 1989, and 1990 in five western states.

              USFWS, 1984.  Formal Section 7 Biological Opinion regarding 1 year extension
              of experimental use permit for the 1080 toxic collar in Idaho, Montana  and Texas
              (6704-EUP-14). (FWS/OES EPA-84-3) 5 pp.

              USFWS,  1985.  Formal Section 7 Biological Opinion on the 1080  livestock
              protection collar. Region 6 (6-RO-85-001) 18 pp.

              USFWS, 1986. Letter from Allan J. Mueller, Acting Field Supervisor Division of
              Ecological Services, Houston, Texas to Roger Mulder, Regulatory Division, Texas
              Department  of Agriculture, regarding endangered species  use restrictions for
              Texas.

              Ward, J. C. and D.A. Spencer. 1947.  Notes on the  pharmacology ofsodium
              fluoroacetate-compound  1080.   Journal  of  the  American  Pharmaceutical
             Association.  36(2): 59-62.

              Wolfe, G. 1988.  Subchronic Toxicity Study in Rats with Sodium Fluoroacetate
              Study No. HLA-2399-118.  Unpublished study conducted by Hazleton.
00061746
00061750
00065627
Atzert, S.P. (1971) A Review of Sodium monofluoroacetate (Compound 1080):
Its Properties, Toxicology, and Use in Predator and Rodent Control. By U.S. Fish
and Wildlife Service, Div. of Wildlife Services.  Washington, D.C.: U.S. FWS.
(Special scientific report-wildlife no. 146; available from:  Superintendent of
Documents, U.S.  Government  Printing Office,  Washington,  D.C.  20402-
published study; CDL:229637-B)

David, W.A.L.; Gardiner, B.O.C.  (1966) Persistence of  Fluoroacetate  and
fluoroacetamide in soil.  Nature 209(5030): 1367-1368.  (Also in unpublished
submission received Apr 21, 1977 under 35978-2; submitted by Wyoming, Dept
of Agriculture, cheyenne, Wyo.; CDL: 229637-F)

Connolly, G., comp. (1980)  Use of Compound 1080 in Livestock Neck Collars to
Kill Depredating Coyotes.  (U.S. Fish and Wildlife Service, Denver  Wildlife
Research Center; unpublished study including published data;  CDL:243665-A)
                                         53

-------
                                 BIBLIOGRAPHY
MRID
CITATION
00144405    Burns, R.; Connolly, G.; Meeker, D.; et al. (1984) Efficacy and Hazards  of
             Compound 1080 in Toxic Collars: Laboratory and Pen Studies, April 1980 July
             1984.  Unpublished  compilation prepared by US  Fish  and Wildlife  Service,
             Denver Wildlife Research Center. 53 p.

00243665    USDI Fish and Wildlife. 1980. Acute Oral Toxicity Study  with Coyotes.

40016958    Goldman, P.; Milne, G. (1966) Carbon-fluorine bond cleavage. II. Studies on the
             mechanism of the defluorination of fluoroacetate. Journal of Biological Chemistry
             241(23):5557-5559.

40016959    Harrison,  B.; Bransford, A.; MaNamara, B. (1951) Deterioration of sodium
             monofluoroacetate in water and saline solutions. Federation  Proceed. Pharm. and
             Experimental Therapeutics 10:306-307.

             Kelly,  M. (1965)  Isolation of bacteria  able  to metabolize fluoroacetate  or
             fluoroacetamide. Nature 208(5012):809-810.

             Lien, B.; Cole, A.; Walker, J. (1979)  Effect of sodium fluoroacetate ("compound
             1080") on the soil microflora. Soil Biol. Biochem. 11:13-18.

             Tonomura,  K.; Futai,  F.;  Tanabe,  O.,  et  al.   (1965)  Defluorination  of
             monofluoroacetate  by bacteria. Part I.  Isolation of bacteria and their activity of
             defluorination. Agr. Biol. Chem. 29(2): 124-128.

40016966    Walker, J.; Lien, B.  (1981) Metabolism of fluoroacetate by a soil Pseudomonas
             sp. and Fusarium solani.  Soil. Biol.  Biochem. 13: 231-235.

40016967    Corr, P.; Martire, P. (1971) Leaching by rain of sodium fluoroacetate ("1080")
             from baits used for rabbit control. Austral.  J. Exp. Agric. and Animal Husb.
             ll(Jun):287-28l.

40016969    Peters, J.  (1974) Environmental Contamination, Toxicology, and Residues  of
             Compound 1080 (Sodium Fluoroacetate) in Relation to Aerial Control Programmes
             in Protection Forests: A Synopsis. Unpublished study prepared by New Zealand
             Forest Service. 6 p.

40016970    Staples, E.  (1968) The reduction of  the sodium  monofluoroacetate  ("1080")
             content of carrot baits of various thickness by weathering.  N.Z. Jour. Agric.  Res.
             ll(2):319-329.

40016971    Dieke, S.;  Richter, C. (1946) Comparative assays of rodenticides on wild norway
             rats:  I. Toxicity. Reprint No. 2708, Public Health Reports  61(19):672-679.

40016990    Sullivan, J.; Smith, F.; Carman, R. (1979) Effects of fluoroacetate on the testis
             of the rat.  Reprod.  Pert. 56:201-207.
                                          54

-------
                                BIBLIOGRAPHY
 MRID
                    CITATION
 40402603
 40402604
41514901
42961601
42961602
42961603
43210601
43210602
 Cerven, D. (1987) Primary Eye Irritation/Corrosion in Albino Rabbits: Sodium
 Monofluoroacetate Compound 1080-1% (...) Poison: Lab. Proj. ID MB 87-8886
 D.  Unpublished study prepared by MB Research Laboratories, Inc. lip.

 Cerven,  D.  (1987)  Primary  Dermal Irritation  in  Albino Rabbits:  Sodium
 Monofluoroacetate Compound 1080-1% (...) Poison: Lab. Proj. ID MB 87-8886
 C.  Unpublished study prepared by MB Research Laboratories, Inc. 10 p.

 Savarie, P.; Burns, R.; Zemlicka, D. (1990) Sodium Fluoroacetate (Compound
 1080) Contamination on the Necks of Lambs with  Livestock Protection Collars
 (LPCs) that are killed by Coyotes: Lab Project Number: QA-65.  Unpublished
 study prepared by USDA-APHIS-S&T, Denver Wildlife Research Center. 227 p.

 Collins, M. (1993) Sodium  Fluoroacetate-Acute Toxicity to Bluegill Sunfish
 (Lepomis macrochirus) Under Static Renewal Conditions: Lab Project Number
 13014.0293.6100.100: DWRC QA-294: 93-7-4847.  Unpublished study prepared
 by Springborn Labs, Inc. 65 p.

 Collins, M. (1993) Sodium  Fluoroacetate-Acute  Toxicity  to  Rainbow  Trout
 (Oncorhynchus   mykiss)  Under  Static  Conditions:  Lab   Project   Number
 13014.0293.6101.103: QA-295: 93-8-4885. Unpublished study  prepared by
 Springborn Labs, Inc. 68 p.

 Collins, M. (1993) Sodium Fluoroacetate-Acute Toxicity to Daphnids (Daphnia
 magna) Under Static  Conditions: Lab Project Number:  13014.0293.6102.110-
 DWRC QA-296: 93-7-4844. Unpublished study prepared by Springborn Labs, Inc.
 70 p.

Campbell, S.; Beavers, J.;  Grimes, J. (1994) Sodium Fluoroacetate: A Dietary
LC50 Study  with the Northern Bobwhite: Lab Project Number: 247-101B-
QA-297: 94-021.  Unpublished  study prepared by Wildlife International Ltd 27
P-

Campbell, S.; Beavers, J.;  Grimes, J. (1994) Sodium Fluoroacetate: A Dietary
LC50 Study with the Mallard: Lab Project Number: 247-102B: 94-021: QA-298
Unpublished study prepared by Wildlife International Ltd. 26 p.
                                        55

-------
                   UNITED STATES ENVIRONMENTAL PROTECTION AGENCY

                                      WASHINGTON, D.C. 20460
                                                                           OFFICE OF

                                                                      PREVENTION, PESTICIDES

                                                                      AND TOXIC SUBSTANCES
                              DATA CALL-IN NOTICE


CERTIFIED MAIL
Dear Sir or Madam:


This Notice requires you and other registrants of pesticide products containing the active
ingredient identified in Attachment 1 of this Notice, the Data Call-In Chemical Status Sheet, to
submit certain product specific data as noted herein to the U.S. Environmental Protection
Agency (EPA, the Agency).  These data are necessary to maintain the continued registration
of your product(s) containing this active ingredient.  Within 90 days after you receive this
Notice you must respond as set forth in Section III below.  Your response must state:

       1.     How you will comply with the requirements set forth in this Notice and its
             Attachments A through G; or

       2.     Why you believe you are exempt from the requirements listed in this Notice and
             in Attachment 3,  Requirements Status and Registrant's Response Form, (see
             section III-B); or

       3.     Why you believe EPA should not require your submission  of product specific
             data in the manner specified by this Notice (see section III-D).

       If you do not respond to this Notice, or if you do not satisfy EPA  that you will comply
with its requirements or should be exempt or excused from doing so, then the registration of
your product(s) subject to this Notice will be subject to suspension.  We have provided a list
of all of y9ur products subject to this Notice in Attachment 2, Data Call-in Response Form,  as
well as a list of all registrants who were sent this Notice (Attachment 6).

       The authority for this Notice is section 3(c)(2)(B) of the Federal Insecticide, Fungicide
and Rodenticide Act as amended (FIFRA), 7 U.S.C. section 136a(c)(2)(B).  Collection of this
information is authorized under the Paperwork Reduction Act by OMB Approval No. 2070-
0107 (expiration date 12-31-92).
       Tnis Notice is divided into six sections and seven Attachments.  The Notice itself
contains information and instructions applicable to all Data Call-In Notices.  The Attachments
contain specific chemical information and instructions. The six sections of the Notice are:

       Section I  -  Why You Are Receiving This Notice
       Section II  -   Data Required By This Notice


                                         56

-------
       Section III -  Compliance With Requirements Of This Notice
       Section IV -  Consequences Of Failure To Comply With This Notice
       Section V -  Registrants' Obligation To Report Possible Unreasonable
                    Adverse Effects
       Section VI -  Inquiries And Responses To This Notice

 The Attachments to this Notice are:

       1  -    Data Call-In Chemical Status Sheet
       2  -    rrociuct-speclfic Data Call-in Response Form
       3  -    Kequirements status and Registrant's Response Form
       4  -    zrA mtcning"or ana- use rroaucts tor Meeting Acute Toxicology Data
              Kequirements tor Keregistration                            ~ -
       5  -    List ot Registrants Receiving This Notice
       6  -    Cost  Share and  Data Compensation horms, and Product Specific Data Report



 SECTION I. WHY YOU ARE RECEIVING THIS NOTICE

       The Agency  has reviewed existing data for this active ingredient and Devaluated the
 data needed  to support continued registration of the subject active ingredient.  The Agency has
 concluded that the only additional data necessary are product specific data No additional
 generic data requirements are being imposed.  You have been sent this Notice because you
 have product(s) containing the subject active ingredient.

 SECTION II.  DATA REQUIRED BY THIS NOTICE

 II- A.   DATA REQUIRED

       The product specific data required by this Notice are specified in Attachment 3
 Requirements Status and Registrant's Response Form. Depending on the  results of the studies
 required in this Notice,  additional testing may be required .

 II-B.  SCHEDULE FOR SUBMISSION OF DATA

    You are required to  submit the data or otherwise satisfy the data requirements specified in
 Attachment 3, Requirements Status and Registrant's Response Form, within the time frames
 provided.                         ~ - —* -

 II-C.   TESTING PROTOCOL

    All studies required under this Notice must be conducted in accordance with test standards
 outlined in the Pesticide Assessment Guidelines for those studies for which guidelines have
 been established.
,XT™ J!?ese ^P4 Guidelines are available from the National Technical Information Service
(NTIS), Attn: Order Desk, 5285 Port Royal Road, Springfield, Va 22161 (tel: 703-487-4650).
/^r^^^        aPProved ty the Organization for Economic Cooperation and Development
(OECD) are also acceptable if the OECD-recommended test standards conform to those
specified in the Pesticide Data Requirements regulation (40 CFR § 158.70).  When using the
OhLD protocols, they should be modified as appropriate so that the data generated by the
study will satisfy the requirements of 40 CFR § 158.  Normally, the Agency will not extend
                                         57

-------
deadlines for complying with data requirements when the studies were not conducted in
accordance with acceptable standards.  The OECD protocols are available from OECD,  1750
Pennsylvania Avenue N.W., Washington, D.C. 20006.

       All new studies and proposed protocols submitted in response to this Data Call-In
Notice must be in accordance with Good Laboratory Practices [40 CFR Part 160.3(a)(6)].

II-D.   REGISTRANTS RECEIVING PREVIOUS SECTION 3(c)(2)(B) NOTICES ISSUED
       BY THE AGENCY	

     Unless otherwise noted herein, this Data Call-In does  not in any way supersede or change
the requirements of any previous Data Call-ln(s), or any other agreements entered into with
the Agency pertaining to such prior Notice.  Registrants must comply with the requirements of
all Notices to avoid issuance of a Notice of Intent to  Suspend their affected products.

SECTION III.  COMPLIANCE WITH REQUIREMENTS OF THIS NOTICE

III-A.  SCHEDULE FOR  RESPONDING TO THE  AGENCY

       The appropriate responses initially required by this Notice for product specific data
must be submitted to the Agency within 90 days after your receipt of this  Notice. Failure to
adequately respond to this  Notice within 90 days of your receipt will be a basis for issuing a
Notice of Intent to  Suspend CNOIS)  affecting your products. This and other bases for issuance
of NOIS due to failure to comply with this Notice are presented in Section IV-A and IV-B.

III-B.  OPTIONS FOR RESPONDING TO THE AGENCY

       The options for responding to this Notice for product specific data are: (a) voluntary
cancellation, (b) agree to satisfy the product specific  data requirements imposed by this notice
or (c) request a data waiver(s).

       A discussion of how to respond if you chose the Voluntary Cancellation option is
presented below. A discussion of the various options available for satisfying the product
specific data requirements  of this Notice is contained in Section III-C. A discussion of options
relating to requests for data waivers is contained in Section III-D.

       There are two forms that accompany this Notice of  which, depending upon your
response, one or both must be used in your response to the Agency.  These forms are  the
Data-Call-in Response Form, and the Requirements Status  and Registrant's Response Form,
Attachment 2 and Attachment 3. The Data Call-in Response Form must be submitted as  part
of every response to this Notice.  In addition, one copy or the Requirements Status and
Registrant's  Response Form must be submitted for each product listed on  the Data Call-In
Response horm unless the  voluntary cancellation option is selected or unless the product is
identical to another (refer to the instructions for completing the Data Call-In Response Form
in Attachment 2).  Please note that the company's authorized representative is required to sign
the first page of the Data Call-In Response Form and Requirements  Status and Registrant's
Response Form (if this form is required) and initial any subsequent pages. The forms contain
separate detailed instructions  on the response options.  Do not alter the printed material.   If
you have questions or need assistance in preparing your response, call or write the contact
person(s) identified in Attachment 1.

       1. Voluntary Cancellation - You may avoid the requirements of this Notice by
requesting voluntary cancellation of your product(s) containing the active ingredient that is the
subject of this Notice.  If you wish to voluntarily cancel your product, you must  submit a

                                          58

-------
 completed Data Call-in Response Form, indicating your election of this option.  Voluntary
 cancellation is item number 3 on the Data Call-in Response Form.  If you choose this option
 this is the only form that you are required to complete.	

        If you chose to voluntarily cancel your product, further sale and distribution of your
 product after the effective date of cancellation must be in accordance with the Existing Stocks
 provisions of this Notice which are contained in Section IV-C.

        2. Satisfying the  Product Specific Data Requirements of this Notice There are various
 options avaiiaoie to satisfy trie product specific data requirements ot this Notice  These
 options are discussed in  Section III-C of this Notice and comprise options 1 through 6 on the
 Requirements Status and Registrant's Response Form and item numbers 7a and 7b on  the Data
 Lall-In Response horm.  Deletion ot a use(s) and the low volume/minor use option are not	
 valid options tor fulfilling product specific data requirements.

        3 Request for Product Specific Data Waivers.  Waivers for product specific data are
 discussed in section lll-U or this Notice and are covered by option 7 on the Requirements
 Status and Registrant s Response Form.  If you choose one of these options, you must submit
 5oth forms as well as any otner mtormation/data pertaining to the option chosen to address the
 data requirement.

 HI-C  SATISFYING THE DATA REQUIREMENTS OF THIS NOTICE

       If yoa acknowledge on the Data Call-in Response Form that you agree to satisfy the
 product specific data requirements (i.e. you select item number 7a or 7b), then you must select
 one of the six options on the Requirements Status and Registrant's Response Form related to
 data production for each  data requirement.  Your option selection should be entered  under
 item number 9, "Registrant Response."  The six options related to data production are the first
 six options discussed under item 9 in the instructions for completing the Requirements Status
 and Registrant's Response Form. These six options are listed immediately below with	
 information in parentheses to guide registrants  to additional instructions provided in this
 Section. The options are:

       (1)     I will generate and submit data within the specified time  frame (Developing
              Data)
       (2)     I have entered  into an agreement with one or more registrants to develop data
             jointly (Cost Sharing)                                              F
       (3)     I have made offers to cost-share (Offers to Cost Share)
       (4)    I am submitting an existing study that has not been submitted previously to the
             Agency by anyone (Submitting an Existing Study)
       (5)    I am submitting or citing data to upgrade  a study classified by EPA as partially
             acceptable and upgradeable (Upgrading a Study)
       (6)    I am citing an existing study that EPA has classified as acceptable or an  existing
             study that has been submitted but not reviewed by the Agency (Citing  an
             Existing Study)

       Option 1, Developing  Data -- If you choose to develop the required data it must be in
confprmance witn Agency deadlines and with other Agency requirements as referenced herein
and in the attachments. All data generated and submitted must comply with the Good
Laboratory Practice (GLP) rule (40 CFR Part  160), be conducted according to the Pesticide
Assessment Guidelines (PAG), and be in conformance with the requirements of PR Notice 86-
5.
                                          59

-------
       The time frames in the Requirements Status and Registrant's Response Form are the
time frames that the Agency is allowing tor the submission of completed study reports.  The
noted deadlines run from the date of the receipt of this Notice by the registrant.  If the data are
not submitted by the deadline, each registrant is subject to receipt of a Notice of Intent to
Suspend the affected registration(s).

       If you cannot submit the data/reports to the Agency in the time required by this Notice
and intend to  seek additional time to meet the requirements(s), you must submit a request to
the Agency which includes:  (1) a detailed description of the expected difficulty and (2) a
proposed schedule including alternative dates for meeting such requirements on a step-by-step
basis.  You must explain any technical or laboratory difficulties and provide documentation
from the laboratory performing the testing. While EPA is considering your request, the
original deadline remains. The Agency will respond to your request in  writing.  If EPA does
not grant your request, the original deadline remains. Normally, extensions can be requested
only in cases  of extraordinary testing problems beyond the expectation or control of the
registrant.  Extensions will not be given in submitting the 90-day responses. Extensions will
not be considered if the request for extension is not made in a timely fashion; in no event shall
an extension request be considered if it is submitted at or after the lapse of the subject
deadline.

       Option 2, Agreement to Share in Cost to Develop Data  ~ Registrants may only choose
this option  tor acute toxicity data and certain efficacy data and only if EPA has indicated in the
attached data tables that your product and at least one other product are similar for purposes of
depending on the same data. If this is the case, data may be generated for just one of the
products in the group. The registration number of the product for which data will be
submitted must be noted  in the agreement to cost share by the registrant selecting this option.
If you chooseTo enter into an agreement to share in the cost of producing the required data but
will not be submitting the data yourself, you must provide the name  of the registrant who will
be submitting the data.  You must also provide EPA with documentary evidence that an
agreement has been formed. Such evidence may be your letter offering to join in an
agreement and  the other registrant's acceptance of your offer, or a written statement by  the
parties that an agreement exists. The agreement to produce the data need not specify all of the
terms of the final arrangement between the parties or the mechanism to resolve the terms.
Section 3(c)(2)(B) provides that if the parties cannot resolve the  terms of the agreement  they
may resolve their differences through binding arbitration.

       Option 3, Offer to Share in the Cost of Data Development ~ This option only applies
to acute toxicity and certain etticacy data as described in option  2 above.  If you have made an
offer to pay in  an attempt to enter into an agreement or amend an existing agreement to meet
the requirements of this Notice and have been unsuccessful, you may request EPA (by
selecting this option)  to exercise its discretion not to suspend your registration(s), although you
do not comply  with the data submission requirements of  this Notice. EPA has determined that
as a general policy, absent other relevant considerations, it will not suspend the registration of
a product of a registrant  who has in good faith sought and continues to seek to enter into a
joint data development/cost sharing program,  but the other registrant(s) developing the data
has refused to accept  your offer. To qualify for this option,  you must submit documentation
to the Agency proving that you have made an offer to another registrant (who has an
obligation to  submit data) to share  in the burden of developing that data. You must also
submit to the Agency a completed  EPA Form 8570-32, Certification of Offer to Cost Share in
the Development of Data, Attachment 7.   In addition, you must demonstrate that the other
registrant to whom the offer was made has not accepted  your offer to enter  into a cost sharing
agreement  by including a copy of your offer and proof of the other registrant's receipt of that
offer (such as a certified mail receipt).  Your  offer must, in addition to anything else, offer to
share in the burden of producing the data upon terms to  be agreed or failing agreement to be

                                           60

-------
 bound by binding arbitration as provided by FIFRA section 3(c)(2)(B)(iii) and must not
 qualify this offer.   The other registrant must also inform EPA of its election of an option to
 develop and submit the data required by this Notice by submitting a Data Call-in Response
 Fo.rm. an,d a Requirements Status and Registrant's Response Form committing to develop and
 submit  the data required by this Notice.             	

        In order for you to avoid suspension under this option, you may not withdraw your
 offer to share in the burdens of developing the data. In addition, the other registrant must
 fulfill its commitment to develop and submit the data as required by this Notice. If the other
 registrant fails to develop the data or for some other reason is subject to suspension vour
 registration as well  as that of the other registrant will normally be subject to initiation of
 suspension proceedings, unless you commit to submit, and do submit the required data in the
 specified time frame.  In such cases, the Agency generally will not grant a  time extension for
 submitting the data.

       Option 4 Submitting an Existing Study -- If you choose to submit an existing study in
 response to mis Notice, you must determine that the study satisfies the requirements imposed
 by this Notice.  You may only submit a study that has not been previously submitted to the
 Agency or previously cited by anyone. Existing studies are studies which predate issuance of
 mis Notice. Do not use this option if you are submitting data to upgrade a  study. (See Option


       You should be aware that if the Agency determines that the study is not acceptable the
Agency will require you to comply with this Notice, normally without an extension of the'
required date of submission.  The Agency may determine at any time that a study is not valid
and needs to be repeated.

      To meet the requirements of the DCI Notice for submitting an existing study all  of the
following three criteria must be clearly met:                                      	—

      a.     You must certify at the time that the existing study is submitted that the raw
             data and  specimens from the study are available for audit and review and you
             must identify where they are available. This must be done in accordance with
             the requirements of the Good Laboratory Practice (GLP)  regulation  40 CFR
             Pan 160. As stated in 40 CFR 160.3(j) " 'raw  data1 means any laboratory
             worksheets,  records, memoranda, notes, or exact copies thereof, that are the
             result of original observations and activities of  a study and are necessary for the
             reconstruction and evaluation of the report of that study.  In the event that exact
             transcripts of raw data have been prepared (e.g., tapes which have been
             transcribed verbatim, dated, and verified accurate by signature), the exact copy
             or exact transcript may be substituted for the original  source as raw data  'Raw
             data  may include photographs, microfilm or microfiche copies, computer
             printouts, magnetic media, including dictated observations, and recorded data
             (r°m automated instruments."  The term  "specimens", according to 40 CFR
             160 3(k)  means "any material derived from a test system for examination or
             analysis.

      b.     Health and safety studies completed after May 1984 must  also contain all GLP-
             required quality assurance and Quality control information, pursuant to the
             requirements of 40 CFR Part 160.  Registrants  must also certify at the time of
             submitting the existing study that such GLP information is available for post-
             May  1984 studies by  including an appropriate statement on or attached to the
             study signed by an  authorized official or representative of the registrant
                                          61

-------
       c.     You must certify that each study fulfills the acceptance criteria for the Guideline
             relevant to the study provided in the FIFRA Accelerated Reregistration Phase 3
             Technical Guidance and that the study has been conducted according to the
             Pesticide Assessment Guidelines (PAG) or meets the purpose of the PAG (both
             available from NTIS).  A study not conducted according to the PAG may be
             submitted to the Agency for consideration if the registrant believes that the
             study clearly meets the purpose of the PAG. The registrant is referred to 40
             CFR 158.70 which states the Agency's policy regarding acceptable protocols. If
             you wish to submit the study, you must, in addition to certifying that the
             purposes of the PAG are met by the study, clearly articulate the rationale why
             you believe the study meets the purpose of the PAG, including copies of any
             supporting information or data. It has been the Agency's experience that
             studies completed prior to January 1970 rarely satisfied the purpose of the PAG
             and that necessary raw data are usually not available for such studies.

       If you submit an existing study, you must certify that the study meets all requirements
of the criteria outlined above.

       If you know of a study pertaining to any requirement in this Notice which does not
meet -the criteria outlined above but does contain factual information regarding unreasonable
adverse effects, you must notify the Agency of such a study. If such  study is in the Agency's
files, you need only cite it along with the notification. If not in the Agency's files, you must
submit a summary and copies as required by PR Notice  86-5.

       Option 5, Upgrading a Study ~ If a study has been classified as partially acceptable and
upgradeable, you may submit data to  upgrade that study. The Agency will review the data
submitted and determine if the requirement is  satisfied.  If the Agency decides the requirement
is not satisfied,  you may still be required to submit new data normally without any time
extension.  Deficient, but upgradeable studies will normally be classified as supplemental.
However, it is important to note that not all studies classified as supplemental are upgradeable.
If you have questions regarding the classification of a study or  whether a study may be
upgraded, call or write the contact person listed in Attachment 1.  If you submit data to
upgrade an  existing study you must satisfy or supply information to correct all deficiencies in
the study identified by EPA.  You must provide a clearly articulated rationalefof how the
deficiencies have been remedied or corrected and why the study should be rated as acceptable
to EPA.  Your submission must also specify the MRID number(s) of the study which you are
attempting to upgrade and must be  in conformance with PR Notice 86-5.

       Do not submit additional data  for the purpose of upgrading a study classified as
unacceptable and determined by the Agency as not capable of being  upgraded.

       This option should also be used to cite data that has been previously submitted to
upgrade a study, but has not yet been reviewed by the Agency.  You must provide the MRID
number of the data submission as well as the MRID number of the study being upgraded.

       The criteria for submitting an  existing study, as specified in Option 4 above,  apply to
all data submissions intended to upgrade studies. Additionally your submission of data
intended to  upgrade studies must be accompanied by a certification that you comply with each
of those criteria as  well as a certification regarding protocol compliance with Agency
requirements.

       Option 6, Citing Existing Studies — If you choose to cite a study that has been
previously submitted to fcPA, that study must have been previously classified by EPA as
acceptable or it must be a study which has not yet been reviewed by the Agency. Acceptable

                                           62

-------
 toxicology studies generally will have been classified as "core-guideline" or "core minimum "
 hor all other disciplines the classification would be "acceptable."  With respect to any studies
 tor which you wish to select this option you must provide the MRID number of the study you
 are citing and, if the study has been reviewed by the Agency, you must provide the Agency's
 classification of the study.                                                          y

        If you are citing a study of which you are not the original data submitter, you must
 submit a completed copy of EPA Form 8570-31, Certification with Respect to Data
 Compensation Requirements.                                               —

        Registrants who  select one of the above 6 options must meet all of the requirements
 described in the instructions for completing the Data Call-in Response Form and the
 Requirements Status and Registrant's Response Form, as appropriate.

 III-D  REQUESTS FOR DATA WAIVERS

             If you request a waiver for product specific data because you believe it is
 inappropriate, you must attach a complete justification for the request, including technical
 reasons, data and references to relevant EPA regulations, guidelines or policies.  (Note- any
 supplemental data must be submitted in the format required by PR Notice 86-5). This will be
 the only opportunity to state the reasons or provide information in support of your request  If
 the Agency approves your waiver request, you will not be required to supply the data pursuant
 to section 3(c)(2)(B) of FIFRA.  If the Agency denies your waiver request, you must choose
 an option for meeting the data requirements of this Notice within 30 days of the receipt of the
 Agency s decision.  You must indicate and submit the option chosen on the Requirements
 Status  and Registrant's Response Form.  Product specific data requirements tor product
 cnemistry, acute toxicity and etticacy (where appropriate) are required for all products  and the
 Agency would grant a waiver only under extraordinary circumstances.  You should also be
 aware  that submitting a waiver request will not automatically extend the due date for the study
 in question.  Waiver requests submitted without adequate supporting rationale will be denied
 and the original due date will remain in force.

 IV.  CONSEQUENCES OF FAILURE TO COMPLY WITH THIS NOTICE

 IV-A NOTICE OF INTENT TO SUSPEND

       The Agency may issue a Notice of Intent to Suspend products subject to this Notice due
!° miUoAby a.registrant to comply with the requirements of this Data Call-in Notice, pursuant
to HhRA section 3(c)(2)(B). Events which may be the basis for issuance of a Notice of Intent
to Suspend include, but are not limited to, the following:

       1.     Failure to respond as required by this Notice within 90 days of your receipt of
             this Notice.                                                         r

       2.     Failure to submit on the required schedule an acceptable proposed or final
             protocol when such is  required to be submitted to the Agency for review.

       3.     Failure to submit on the required  schedule an adequate progress report on a
             study as required by this Notice.

       4.     Failure to  submit on the required  schedule acceptable data as  required by this
             Notice.
                                          63

-------
       5.     Failure to take a required action or submit adequate information pertaining to
             any option chosen to address the data requirements (e.g., any required action or
             information pertaining to submission or citation of existing studies or offers,
             arrangements, or arbitration on the sharing of costs or the formation of Task
             Forces, failure to comply with the terms of an agreement or arbitration
             concerning joint data development or failure to comply with any terms of a data
             waiver).

       6.     Failure to submit supportable  certifications as to the conditions of submitted
             studies, as required by Section III-C of this Notice.

       7.     Withdrawal of an offer to share in the cost of developing required data.

       8.     Failure of the registrant to whom you have tendered an offer to share in the cost
             of developing data  and provided proof of the registrant's receipt of such offer
             or failure of a registrant on whom you rely for a generic data exemption either
             to:

             a.     inform EPA of intent to develop and submit the data required by this
                    Notice on a Data Call-In Response Form and a Requirements Status and
                    Registrant's Response  Form;

             b.     fulfill the commitment to develop and submit the data as required by this
                    Notice; or

             c.     otherwise take appropriate steps to meet the requirements stated in this
                    Notice, unless you commit to submit and do submit the required data in
                    the specified time frame.

       9.     Failure to take any required or appropriate steps, not mentioned above, at any
             time following the  issuance of this Notice.

IV-B.  BASIS FOR DETERMINATION THAT SUBMITTED STUDY IS
UNACCEPTABLE	

       The Agency may determine that a study (even if submitted within the required time) is
unacceptable and constitutes a basis for issuance of a Notice of Intent to Suspend. The
grounds for suspension include, but are not limited to, failure to meet any of the following:

       1.  EPA requirements specified in the Data Call-In Notice or other documents
       incorporated by  reference  (including, as applicable, EPA Pesticide Assessment
       Guidelines,  Data Reporting Guidelines, and GeneTox Health  Effects Test Guidelines)
       regarding the design, conduct, and reporting of required studies.  Such requirements
       include,  but are  not limited to, those  relating to test material, test procedures, selection
       of species, number of animals, sex and distribution of animals,  dose and effect levels to
       be tested or attained, duration of test, and, as applicable, Good Laboratory Practices.
       2.  EPA requirements regarding the submission of protocols, including the
       incorporation of any changes required by the Agency following review.

       3.  EPA requirements regarding the reporting of data, including the manner of
       reporting, the completeness of results, and the adequacy of any required supporting (or
       raw) data, including, but not limited to, requirements referenced or included in this
       Notice or contained in PR 86-5.  All  studies must be submitted in the form of a final


                                          64

-------
        report; a preliminary report will not be considered to fulfill the submission
        requirement.

 IV-C  EXISTING STOCKS OF SUSPENDED OR CANCELLED PRODUCTS

        EPA has statutory authority to permit continued sale, distribution and use of existing
 stocks of a pesticide product which has been suspended or cancelled if doing so would be
 consistent with the purposes of the Act.

        The Agency has determined that such disposition by  registrants of existing stocks for a
 suspended registration when a section 3(c)(2)(B) data request is outstanding would generally
 not be consistent with the Act's purposes.  Accordingly, the Agency anticipates granting
 registrants permission to sell, distribute, or use existing stocks of suspended product(s) only in
 exceptional circumstances.  If you believe such disposition of existing stocks of your
 product(s) which may be suspended for failure to comply with this Notice should be permitted
 you have the burden of clearly demonstrating to EPA that granting such permission would be '
 consistent with the Act.  You must also explain why an "existing stocks" provision is
 necessary, including a statement of the quantity of existing stocks and your estimate of the
 time required for their sale, distribution, and use.  Unless you meet this burden the Agency
 will not consider any request pertaining to the continued sale, distribution, or use of your
 existing stocks after suspension.

       If you request a voluntary cancellation of your product(s) as a response  to this Notice
 and your  product is in full compliance with all  Agency requirements, you will have under
 most circumstances, one year from the date your 90 day response to this Notice is due to sell
 distribute, or use existing stocks. Normally, the Agency will allow persons other than'the
 registrant such as independent distributors, retailers and end users to sell, distribute or use
 such existing stocks until the stocks are exhausted.  Any sale, distribution or use of stocks of
 voluntarily cancelled products containing an active ingredient for which the Agency has
 particular risk concerns will be determined on case-by-case basis.

       Requests for voluntary cancellation received after the 90 day response period required
 by this Notice will  not result in the Agency granting any additional time to sell, distribute or
 use existing stocks  beyond a year from the date the 90 day response was due unless you
 demonstrate to the Agency that you are in full compliance with all Agency requirements
 including  the requirements of this Notice. For example, if you decide to voluntarily cancel
 your registration six months before a 3 year study is scheduled to be submitted, all progress
 reports and other information  necessary to establish that you have been conducting the study in
 an acceptable and good faith manner must have been submitted to the Agency, before  EPA
 will consider granting  an existing stocks provision.

 SECTION V. REGISTRANTS' OBLIGATION TO REPORT POSSIBLE UNREASONABLE
             AUVfcKSb EFFECTS        ~	"	—

       Registrants are reminded that FIFRA section 6(a)(2) states that if at any  time after a
pesticide is registered a registrant has  additional factual information regarding unreasonable
adverse effects on the environment by the pesticide, the  registrant shall submit the information
to the Agency.  Registrants must notify the Agency of any factual information they have, from
whatever source, including but not limited to interim or  preliminary results of studies
regarding  unreasonable adverse effects on man  or the environment. This requirement
continues  as long as the products are registered by the Agency.

SECTION VI.  INQUIRIES AND RESPONSES TO THIS NOTICE


                                          65

-------
       If you have any questions regarding the requirements and procedures established by
this Notice, call the contact person(s) listed in Attachment 1, the Data Call-In Chemical Status
Sheet.                                                      	

       All responses to this Notice (other than voluntary cancellation requests and generic data
exemption claims) must include a completed Data Call-in Response Form and a completed
Requirements Status and Registrant's Response horm (Attachment 2 and Attachment 3  for
product specific data) and any other documents required by this Notice, and should be
submitted to the contact person(s) identified in Attachment 1.  If the voluntary cancellation or
generic data exemption option is chosen, only the Data Call-In Response Form need be
submitted.

       The Office of Compliance Monitoring (OCM) of the Office of Pesticides and Toxic
Substances (OPTS), EPA, will be monitoring the data being generated in response to this
Notice.

                                        Sincerely yours,
                                        Lois Rossi, Division Director
                                        Special Review and
                                         Reregistration Division
Attachments

       1  -   Data Call-In Chemical Status Sheet
       2  -   Product-Specific Data Call-in Response Form
       3  -   Requirements Status and Registrant's Response Form
       4  -   fcFA Batching ot bnd-Use Products tor Meeting Acute Toxicology Data
             Requirements lor Reregistration
       5  -   List of Registrants ReceivingThis Notice
       6  -   Cost Share and Data Compensation Forms, and Product Specific Data Report
             Form
                                          66

-------
 SODIUM FLUOROACETATE DATA CALL-IN CHEMICAL STATUS SHEET

 INTRODUCTION

       You  have been sent this  Generic Data Call-In Notice because  you have product(s)
 containing sodium fluoroacetate.                                              F  um,iw

 .   .. This. Generic Data Call-in Chemical Status Sheet, contains an overview of data required
 £T iiASD???%'?A0^111^ C0mact ror m(luines Pertaining to the reregistration of SODIUM
 £ iff  *T  •   ,ix TE;, Thls attachment is to be used in conjunction with (1) the Generic Data
 Call-In Notice, (2) the Generic Data Call-In Respnse Form (Attachment 2),  (3) the Requirements
 Status and Registrant s Form (Attachment 5), (4) a list of registrants receiving this DCI
 (Attachment 4) (5) the EPA Acceptance Criteria (Attachment 5), and (6) the Cost Share and Data
 Lompnsation Forms in replying to this sodium fluoroacetate Generic Data Call In (Attachment
 r). Instructions and guidance accompany each form.

 DATA REQUIRED BY THIS NOTICE
 ~      me additional data requirements needed to complete the generic  database for sodium
 fluoroacetate are contained in the Requirements Status and Registrant's Response. Attachment C
 The Agency has  concluded that additional product chemistry data on sodium tluoroacetate are
 fluoroacet      d    ^  ******  l° ^ complete the ^registration  of all eligible sodium

 INQUIRIES AND RESPONSES TO THIS NOTICE

   u,- 1J 7?u !l?ve.Tany Questions regarding  the  generic  data  requirements and  procedures
established by this Notice,  please contact Leonard Ryan at (703) 308-8067.

      All responses to this Notice for the generic data requirements should be submitted to:

             Leonard Ryan, Chemical Review Manager
             Accelerated  Reregistration Branch
             Special Review and Registration Division (H7508W)
             Office of Pesticide Programs
             U.S.  Environmental Protection Agency
             Washington, D.C.  20460
             RE:  SODIUM FLUOROACETATE
                                        67

-------
 INSTRUCTIONS FOR COMPLETING THE DATA CALL-IN RESPONSE FORM FOR
                            PRODUCT SPECIFIC DATA

Item 1-4.     Already completed by EPA.

Item 5.       If you wish to voluntarily cancel your product, answer "yes." If you choose this
             option, you will not have to provide the data required by the  Data Call-In Notice
             and you will not have to complete any other forms. Further sale and distribution
             of your product after the effective date of cancellation must be in accordance with
             the  Existing Stocks provision of the Data Call-In Notice (Section IV-C).

Item 6.       Not applicable since this form calls in product specific data only.  However, if
             your product is identical to another product and you qualify for a data exemption,
             you must respond with "yes" to Item 7a (MUP) or 7B (EUP) on this form, provide
             the  EPA registration numbers of your source(s); you would not complete  the
             "Requirements  Status and Registrant's Response" form.   Examples of such
             products include repackaged products  and Special Local Needs (Section 24c)
             products  which are identical to federally registered products.

Item 7a.      For each manufacturing use product  (MUP) for which you wish to maintain
             registration, you must agree to satisfy the data requirements by responding "yes."


Item 7b.      For each end use product (EUP) for which you wish to maintain registration, you
             must agree to satisfy the data  requirements by responding  "yes."  If you  are
             requesting a data waiver, answer "yes"  here; in addition, on the "Requirements
             Status  and Registrant's Response" form under  Item 9,  you must respond with
             Option 7 (Waiver Request) for each study for which you are requesting  a waiver.
             See Item 6 with regard to identical products and  data exemptions.

Items 8-11. Self-explanatory.

NOTE:       You may provide additional information that does not fit on this form in a signed
             letter that accompanies this form. For example, you may wish to report that your
             product has already been transferred to another company or that you have already
             voluntarily canceled  this product.  For these cases, please  supply all relevant
             details  so that EPA can ensure that its records are correct.
                                         68

-------
      INSTRUCTIONS FOR COMPLETING THE REQUIREMENTS STATUS AND
        REGISTRANT'S RESPONSE FORM FOR PRODUCT SPECIFIC DATA

Item 1-3     Completed by EPA. Note the unique identifier number assigned by EPA in Item
             3.  This number must be used in the transmittal document for any data
             submissions in response to this Data Call-In Notice.

Item 4.       The guideline reference numbers of studies required to  support the product's
             continued registration  are  identified.   These  guidelines,  in  addition  to the
             requirements specified in the Notice, govern the conduct of the required studies.
             Note that series  61 and 62 in product  chemistry are now listed under 40 CFR
             158.155 through  158.180, Subpart C.

Item 5.       The study title associated with the guideline reference number is identified.

Item 6.       The use pattern(s) of the pesticide associated with the product specific requirements
             is (are) identified. For most product specific data requirements, all  use patterns
             are covered by the data requirements.  In the case of efficacy data, the  required
             studies only pertain to products which have the use sites and/or pests indicated.

Item 7.       The substance to be tested is identified by EPA. For product specific  data, the
             product as formulated for sale and distribution is the test substance, except in rare
             cases.

Item 8.       The due date for  submission of each study is identified. It is normally  based on
             8 months after issuance of the Registration Eligibility Document unless EPA
             determines that a longer time period is necessary.

Item 9.       Enter only one of the following response codes for each data requirement to
             show how you intend to comply with the data requirements listed in this table.
             Fuller descriptions of each option are contained in the Data Call-In Notice.

       1.     I will generate and submit data by the specified due date (Developing Data). By
             indicating that I have chosen this option, I certify that I will comply with  all the
             requirements pertaining to the conditions for submittal of this study as outlined in
             the Data Call-In  Notice. By  the specified due date,  I will also submit: (1) a
             completed "Certification With  Respect  To Data Compensation Requirements11
             form  (EPA Form 8570-29) and (2) two completed and signed copies  of the
             Confidential Statement of Formula (EPA Form 8570-4).

      2.     I  have entered into an agreement with  one or more registrants to develop data
             jointly (Cost Sharing).  I am submitting a copy of this agreement.  I understand
             that this option is available only for acute toxicity or certain efficacy data and only
             if EPA indicates in an attachment to this  Notice that my product is similar enough
             to another product to qualify for this option.  I certify that another  party in the
             agreement is committing to submit or provide the required data; if the  required
             study is not submitted on time,  my product may be subject to suspension. By the
             specified due date, I will also submit: (1) a completed "Certification With
             Respect To Data  Compensation Requirements" form (EPA Form 8570-29) and
             (2) two completed and signed copies of  the Confidential Statement of Formula
             (EPA Form 8570-4).
             I have made offers to share in the cost to develop data (Offers to Cost Share).
             I understand that this option is available only for acute toxicity or certain efficacy
3.
       I understand that this option is a^

                                   69

-------
       data and only if EPA indicates in an attachment to this Data Call-In Notice that my
       product is similar enough to another product  to qualify for this option.  I am
       submitting evidence that I have made an offer to another registrant (who has an
       obligation to submit data) to share in the cost of that data. I am also submitting a
       completed "Certification of Offer to Cost  Share in the  Development Data"
       form. I am including a copy of my offer and proof of the other registrant's receipt
       of that offer.  I am identifying the party which is committing to submit or provide
       the required data; if the required study is not submitted on time,  my product may
       be subject to suspension. I understand that other  terms under Option 3 in the Data
       Call-In Notice (Section ffl-C.l.) apply as well.  By the specified due date, I will
       also submit: (1) a completed "Certification With Respect To Data Compensation
       Requirements" form (EPA Form  8570-29) and (2)  two completed and signed
       copies of the Confidential Statement of Formula (EPA Form 8570-4).

4.     By the specified due date,  I will submit  an existing study that has not  been
       submitted previously to the Agency by anyone (Submitting an Existing Study).
       I certify that this study will meet all the requirements for submittal of existing data
       outlined in Option 4 in the Data Call-In Notice  (Section III-C. 1.) and will meet the
       attached acceptance criteria (for acute tpxicity and product chemistry data). I will
       attach the needed supporting information along  with this response.  I also certify
       that I have determined that this study will fill the data requirement  for which I have
       indicated this choice.  By the specified due date, I will also submit a completed
       "Certification With Respect To Data Compensation Requirements" form (EPA
       Form 8570-29) to  show what data  compensation option I have chosen. By the
       specified due date,  I will also  submit: (1)  a  completed  "Certification With
       Respect To Data Compensation Requirements" form  (EPA Form 8570-29) and
       (2) two completed and signed copies of the  Confidential Statement of Formula
       (EPA Form 8570-4).

5.     By the specified due date, I will submit or  cite data to upgrade a study classified
       by the Agency as partially acceptable and upgradable (Upgrading a Study). I will
       submit evidence  of the Agency's review indicating that the study may be upgraded
       and what information is  required to do so. I will provide the MRID or Accession
       number of the study at the due  date. I understand that the  conditions for this
       option outlined Option 5 in the Data Call-in Notice (Section III-C. 1.) apply. By
       the specified due date, I will also submit:  (1) a completed  "Certification With
       Respect To Data Compensation Requirements" form  (EPA Form 8570-29) and
       (2) two completed and signed copies of the  Confidential Statement of Formula
       (EPA Form 8570-4).

6.     By the specified due date,  I will cite an existing study that  the Agency has
       classified as acceptable or an existing  study that has been  submitted but not
       reviewed by the Agency  (Citing an Existing  Study). If I am  citing another
       registrant's study, I understand that this option is available only for acute toxicity
       or certain efficacy data and only if the cited study was  conducted on my product,
       an identical product or a product which EPA has "grouped" with one or more
       other products for purposes of depending on the same data. I may also choose this
       option if I am citing my own data.  In either case, I will provide the MRID or
       Accession number(s) for the cited data on a  "Product Specific Data Report"  form
       or in a  similar  format.  By the specified due date,  I will also submit: (1) a
       completed "Certification With Respect To  Data Compensation Requirements"
       form (EPA Form  8570-29) and (2) two  completed  and signed copies of the
       Confidential Statement of Formula (EPA Form  8570-4).
                                   70

-------
       7.     I request a waiver for this study because it is inappropriate for  my  product
             (Waiver Request).  I am attaching a complete justification for this request,
             including technical reasons, data and references to relevant  EPA  regulations,
             guidelines or policies.   [Note: any supplemental data must be submitted in the
             format required by P.R.  Notice  86-5].   I  understand  that this  is my only
             opportunity to state the  reasons or provide information in support of my request.
             If the Agency approves my waiver request, I will not be required to supply the
             data pursuant to Section 3(c)(2)(B) of FIFRA.  If the Agency  denies my waiver
             request, I must choose  a method of meeting the data requirements of this Notice
             by the  due  date stated by this Notice.  In this case, I must, within 30 days of my
             receipt of the Agency's written decision, submit a revised "Requirements Status
             and Registrant's Response" Form indicating the option chosen.  I also understand
             that the deadline for submission  of data as specified by the original data call-in
             notice  will not change.  By the specified due  date, I  will also submit:  (1) a
             completed "Certification With Respect To Data Compensation Requirements"
             form (EPA Form 8570-29) and (2) two  completed and  signed copies of the
             Confidential Statement of Formula (EPA Form 8570-4).

Items 10-13.  Self-explanatory.

NOTE:      You may provide additional information that does not fit on this form in a signed
             letter that accompanies this form.   For example, you may wish to report that your
             product has already been transferred to another company or that you have already
             voluntarily canceled this product.  For these cases, please supply all relevant
             details  so that EPA can ensure that its records are correct.
                                          71

-------
INSTRUCTIONS  FOR  COMPLETING  THE  "REQUIREMENTS  STATUS  AND
REGISTRANT'S RESPONSE" FORM FOR PRODUCT SPECIFIC DATA

Item 1-3.     Completed by EPA.  Note the unique identifier number assigned by EPA in item
             3.  Tnis number must be used in the transmittal document for any data submissions
             in response to this Data Call-In Notice.

Item 4.       The guidelines reference numbers of studies required to support the product's
             continued  registration are identified.   These guidelines, in  addition to the
             requirements specified in the Notice, govern the conduct of the required studies.
             Note that series 61 and  62 in product chemistry are now listed under  40 CFR
             158.155 through 158.180, Subpartc.

Item 5.       The study title associated with the guideline reference number is identified.

Item 6.       The  use  patters  (s)  of the  pesticide associated  with the product  specific
             requirements is (are) identified.  For most product specific data requirements, all
             use patterns are covered by the data requirements. In the case of efficacy data, the
             required studies only pertain to products which have the use sites and/  or pests
             indicated.

Item 7.       The substance to be  tested is  identified by EPA. For product specific data, the
             product as formulated for sale and distribution is the test substance, except in rare
             cases.

Item 8.       The due date for submission of each study is identified. It is normally based on  8
             months after issuance of the Reregistration Eligibility  Documents unless EPA
             determines that a longer time period is necessary.

Item 9.       Enter Only one of the following response codes for each data requirement to show
             how you intend to comply with the data requirements listed in this table.  Fuller
             descriptions of each option are contained in the Data Call-In Notice.

             1.     I will generate and submit data by the specified due date (Developing Data).
             By indicating  that I have chosen this option, I certify that I will comply with all the
             requirements pertaining to the conditions for submittal of this study as outlined in
             the Data Call-in Notice.

             2.     I have entered into an agreement with one or more registrants to  develop
             data jointly (Cost Sharing).   I  am submitting a copy of this  agreement.   I
             understand that this option is available on for acute toxicity or certain efficacy data
             and only if EPA indicates in an attachment to this notice that my product is  similar.
             Enough to another product to qualify for this option.  I certify that another party
             in the agreement is committing to  submit or provide the required data;  if the
             required study is not submitted on time, my product my be subject to suspension.

             3.     I have made  offers to share in the cost to develop data (Offers  to Cost
             Share).  I understand that this option is available only for acute toxicity or certain
             efficacy data and only if EPA indicates in an attachment to this Data Call-In Notice
             that my product is similar enough to another product to qualify for this option.  I
             am submitting evidence that I have made an offer to another registrant (who has
             an obligation to submit data) to share in the cost of that data.  I am also submitting

                                          72

-------
a completed " Certification of offer to Cost Share in the Development Data" form.
I am including a copy of my offer and proof of the other registrant's receipt of that
offer.  I am identifying the party which is committing to submit or provide the
require data; if the required study is not submitted on time, my product may be
subject to suspension.  I understand that other terms under Option 3 in the Data
Call-In Notice (Section  III-C.l.) apply as well.

4.     By the specified due date, I will submit an existing study that has not been
submitted previously to  the Agency by anyone (submitting an Existing Study). I
certify that this study will meet all the requirements for submittal of existing data
outlined in option 4 in the Data Call-In Notice (Section III-C.l.) and will meet the
attached acceptance criteria (for acute toxicity and product chemistry data).  I will
attach the needed supporting information along with this response.  I also certify
that I have determined that this  study will fill the data requirement for which I have
indicated this choice.

5.     By the specified due date,  I will submit or cite data to upgrade a study
classified by the Agency as partially acceptable and upgrade (upgrading a study).
I will  submit evidence  of the Agency's review indicating that the study may be
upgraded and what information is required to do so.  I will provide the MRID or
Accession number of the study  at the due date.  I understand that the conditions for
this Option outlined Option 5 in the Data Call-In Notice (Section III-C.l.) apply.

6.     By the specified due date, I will cite an  existing study that the Agency has
classified as acceptable or  an existing study that has been submitted but not
reviewed by the Agency (Citing  an  Existing Study).   If I am  citing another
registrant's  study, I understand that this option  is available only for acute toxicity
or certain efficacy data and only if the cited study was conducted on my product,
an identical product or  a product which EPA has "grouped"  with one or  more
other products  for purposes of depending on the  same data. I may also choose this
option if I am citing my own data.  In either case, I will provide the MRID or
Accession number (s) number (s) for the cited data on a "Product Specific Data
Report" form or in a similar format.  If I cite another registratrant's data, I will
submit a  completed   "Certification   With Respect  To  Data  Compensation
Requirements" form.

7.     I request a waiver for this study because it is inappropriate for my product
(Waiver Request).   I am attaching a complete justification  for  this  request,
including technical reasons, data  and references to relevant  EPA regulations,
guidelines or  policies.  [Note: any  supplemental data must be submitted  in the
format required  by P.R.  Notice  86-5].  I  understand that  this is  my only
opportunity  to state the reasons or provide information in support of my request.
If the Agency approves my waiver request, I will not be require to supply the data
pursuant to Section 3(c) (2) (B) of FIFRA.   If the Agency denies my waiver
request, I must choose a method of meeting the data requirements of this Notice
by the due date stated by this Notice.  In this case, I  must, within 30 days of my
receipt of the Agency's written decision, submit a revised "Requirements Status
chosen. I also understand that  the deadline for  submission of data  as specified by
the original  data cal-in notice will not change.
                              73

-------
Items 10-13.   Self-explanatory.

       NOTE: You may provide additional information that does not fit on this form in a signed
letter that accompanies this form.  For example, you may wish to report that your product has
already been transferred to another company or that you have already voluntarily cancelled this
product.  For these cases, please supply all relevant details so that EPA can ensure that its records
are correct.
                                           74

-------

<£>
CTv
i
rH
m
i
n
o
r- r-
0 Lfl CO
rH 0 01
00 rl
TJ i i -H
41 o o ft
> r- r~ X
O o o u
rl MO)
ft -H
ft • ro
< O >
Z 0

0 i ft
[i. O <





























>>1
u
f""l
(U
01
^J


o
-H
4-> 0
U U3
dO ^ H
4-) 0 CO
O fN S3
^ o
Pi . (ll
U CO
(Tl * Qu
4J Q
£ S3
0) - M
E £ i
ao . n
\J HH
O 4J J
•H CJ U
> -H
£ rC ,
4J ro
C CO
•H CO
rl 41
ft U
41
rl C
O
4) -H
4J 0]
41 4-1
in 01
ro oi
4) .C
rH CO
o,
• • ro
w c
Z 0
O -rl
rH 4J
B 3
D TJ
OS ffl
H
W 41
Z 01










, .
^-^'
M

M-4
i i
M r *
U M
° H

O "
0) ^
9; _
r»
T3 ^
ro p
oj O
4J ^^
TJ M<
Q P,

m








•


^>

-H
*.
rH
0)
TJ


	
rU
-H
U
n5

u
-H

4— '
(U
u
rO
0
V i
0
^ fc
•o
c
ro
* ro
r-^
41
to O
5 ro

(N















0
0
CO 0
CO 0
W o
3 >H On1
(U J^^ f^
a <3 Q x
< fi. ^
ro b] |V F-H
c j pll |l_|
^ (^ CO U
l§ O O
8 W S5 S5


rH





























ITJ
4J
ro
Q
u
-H
4H
•H
4)
ft
CO

4J
U
3
•o
O

cx
r^


























4J
«
P
U
-H
41
C
41
O

10

T3 -a
C 41 CO
ro o< x; 4J
Don
& u ro 41
ID 4-i E co
W 0) 4-1 4) -
x: ro ri 4J
C 4J -H C
>, XJ & rl
01 MH 4-1 11 4-1
•rl 01 OS CO
•H C - -H
4J 4J O Dl
u ro TD 41
3 CO CO D OS
T3 4J rH
0 O C 4-1 T) =
rl 4J 4) -H C
ft E 4-i ro oi
01 01 c w
>, oi in i) tn c
£ M -ri 30
tn 3 E 4J ft
• ro tr M ro co
XI 0) O 4J 0)
f~ M rl *4H CO OS


T)
•a 41 in
c o< x; 4->
ro D u c
S ro 01
CX 4-> E co
g 41 4-1 4) -
£ x; ro M 4-i
4-1 -H C3
n) 01 3 ro
rX XI CT rl
01 4H 4J 41 4-1
•H 01 OS CO
4-i 4J o tn
u ro TJ oi
3 W CO 41 OS
T3 4-1 rH
O O C 4J T) =
rl 4-> 41 -rl C
ft E 4J ro 4)
41 41 C CO
>1 4) rl 41 CO C
2 rl -H 30
tn 3 E 4-1 a
• ro tr ri ro co
ro 41 O 4J 4)
r- M vi 4H co a



O T)
•rl 41 T!
rl 4J 41
oi ro r-i
C U 4-1
4) -H -rH
O T) 4J T3
C C C =
>, -H 41 ro •
*4H 41
0) 01 E W CO
•H m rl 3 C
4-1 O 4J O
ro 01 MH ro ft
01 4-1 4-1 CO
C T) W 41
O 41 41 OS
4J E x; co
41 U 4-1 CO
01 IH ro c -
01 -H 4J 41 4-1
rl 3 4J 6 C
tn &1 ro 41 ro
ro 01 rl rl
rl 41 -rl 4J
M X! 3 W
ro 4J & -H
• 4-1 4) 01
X) ro c os 41
U) P O s OS



4-1
0 C 3
•H 01 1 O
rl -H 0) rH
41 rH T3 -H 4)
C 41 01 XI
41 41 rl 41
O 01 01 M TD
3 C 4)
U Oi CO
01 41 4) W -rl
E X) > rH
•H -rl 4)
E C 4J U rl
••H O U »H 01
« -H ro 3 xi
rH 4J O E
U ft 01 CO 3
f E £ C
E 4) 4-) 4)
ro x x; c
W C 4-1 O
M -rt -H
ro ro E 4J
• 4J 4J o ro
ro ro xi rt M
VO P O <4-l 4J

, ,
tn c
O -H 3
4J 01 Dl rH
•rl 0) O
x; x; ri >
en 4J
•rl 4-1 C
3 rH U O >1
0) 3 -rl rH
rH U T) 4J -rl
C O ro rl
ro ri ri ro
Lfl U ft 4-1 4J





U
3 C
•a o
O -H
rl 4J
d, ro
rl
a. 01
tn
• 01
•* os































































.
S3










.
^^
g















g
L^j
z
z
1
g
g
z
>^j
































01
4J
ro
Q

en


















4J
• c
01 01
4-> E
4) C
rH O
ft tn
E -H
O rl
U ft
E
T3 -H
C
ro
41
4) -H
4J HH
ro
3 XI
u
U 41
X)
- ro
41 x:
3 CO
4-1 C
3
41 ft
rt
ro oi
XI
en
4J >,
c ro
41 E
£ 4J
u c
ro 41
4J E
4J 01 01
ro 4-> >
ro -H
rH 4J 4J
rH 01 ro
ro 4-i
tn c
•a c 01
c -H tn
ro t! CD
ro VH
E 41 ft
rl rH 41
O CO OS
IH -H
E T)
CO 01
•H H N
x; o -H
01 O
c in x:
O rH 4J
ro 3
41 MH *£
T3
ro >, tn
E rH
01 >,
CO C C
4-> -H 3 m
c 3 ro ft
41 O rH E
EC 0
41 .y 41 a
4J rH
ro >, xi MH
4-1 c ro o
CO « U
•rl 4)
4) 4J rH rH
x; ro ft 4J
c 4J x: ft -H
o 4J ro f-i
4J ro 41 rl TJ
ro x; tn 41 c
u 4-j TJ TJ ro
-H 0) C
4H >» rH 3 4)
•H MH 3 ri
4J -H o x; 3
rl 4J C 4J 4J
41 ri ji o ro
U 4) O XI C
o ro tn
rl -rH
00 M M O W
























rl
41
"P
3
z
4)

O
x;
a

^
t






















































4-1
U
ro
c
o
o
c
ro
ft
E
O
CJ
o
41
E
ro
z

o


-------
U3
cn
rH
m
p
m
o
t— t—
o in 01
rH O 4)
oo IH
T) P I -H
> r- i> x
O o o M
ri 
2 0


O 2 ft
[1. O <






















>i W
U CO
c z
(!) O
cn &
 -H EH
PH r-i >
r-H ri-l rH|
H cn H
rC CO
CO &
Q) CO
-P EH
fO Z

CO §
rVT
HM
TJ K
,
rH

4)
rfl
U
T)
41
4)
01
rH
O.


J
-1
or print ir
E necessary.
4) -H
& ~
JJ 01
fl) ij
0] 41
rfl 4)
4) x;
rH 01
a,
, — i
•• rfl
W C
2 0
O -H
M Jj
^STRUCT
se addi
M D






^2
Hy
X^
r ) ^F
V— / ^—4
f~H ^^
CL i
M Q
t— ( •" f— <
° w '
0 co z
4) C

p E-i Z
c B Z
rfl Q
m Cd Q
0 (Hj M

'
rn





.
cn

-H
C.

(D
T! Z

T! p

U g
rO i
U Z
GO S
rO
0
r-l O
° ^

M i
zfe cn
c OJ
* ro
iTX^ ^**H
4. ^ H
| W Pd H
c j E-" M
^ dj co u
|< o o
CJ *^-* ^~*
rH

C
rfl
jj
01 41
•H 01
cn c
4) 0
p£ ft
to

 CO












41 !H
01 U
D u
jj
• 18
VD Cli

01
4) JJ
01 0 "
O J-i
On Ct
rH
liQ^OE-'OCJO*J


















rH
JJ
•rH
H
TJ
W





4)
C J
•H H
4) =
T) J
•H 4 VH
3 -H 4)
^ D'1 2














COCO CO CQCQCQCQCQCQWCQcn
oo o ooooooooo


0000 00 OOOOOOOOOOCOOOOOOO











f\j fi j ^ i f^j o . ^\ . o, /^| iQ . ^ . /^.
ww pa wHwwwpaww
aTaT a? cu araTaTcu araTaTaT
s s s sssssssss











UO CJ CJUUUUOUOU
















fN n ^ in — —»
r-( rH rH rHi-HrHrH C^lrH
c
0
-H (0
JJ rH
>H -H ro M-I
(fl W .rl 0 01
O O rl PJ
•d 9- <" c w -H
8 6 u C 0 JJ jj
O O rfl jj -H -H crj
D U E rH m -H -H 'M
^ CT1 3 6 01 »-H (U
H C E JH 5s t3 ^*> JJ
rH JJJJO !*H rflOX! -H(8
P-^*HHH Cjjtu i-Hri
D jJrfl 14-1 rflC4) JJ -HrO
U CjJiJJ Offl OE rfl XIX!
Tl C C'HMjJrH 01 JJ
JJUW-H-ftCUCJ rH W 0
B JJ ft 3 4> 01 M -H -r< -H 18 >, ,C Ori
P Q< Q P CJ.CJp§UO.DftWCJ
£




- 2
•— — (N r-- o
II 1 1 1 1 1 1 1 1 1 1
rHrH rH cNCNCNcorororororo
^•D VD ^X) V^D V.O V^O LA V.O in Vf) VjO V^5

























4)
JJ
(8
p

.
H













JJ
• c
4) 4)
4) C
rH O
ft 01
E -H
O rl
0 ft
Tl -H
ro -
4)
- C
4) -H
JJ <4H
rfl
rl >,
3 XI
U 4)
XI
- ro
41 x:
3 01
r4 -H
4) ft
VH
rfl 4)
XI
01
C rfl
4) E
X! 4J
U C
m 41
JJ E
JJ 4) 4)
rfl JJ >
rH JJ JJ
rH 01 (0
rfl 4J
cn c
Tl C 4)
C -H 01
rfl T) 41
E 4) ft
r4 rH 4)
o 01 oi

E Tl
01 41
•H rl N
x: o -H
JJ rl
4) O
CO] £
O rH JJ
rfl 3
41 I*H <
m >, 01
E rH
Cn >,
01 C • C
JJ -rl S rfl
asm ft
4) O rH £
EC 0
41 M 4) U
4J rH
rfl >-, XI !4H
JJ C (8 O
01 ro CJ
•H 4)
41 JJ i— 1 rH
C x; ro ft jj
o jj x; ft -ri
-H JJ rfl H
JJ JJ
(8 ro 4> »H T3
0 XI Cn 4) C
•H JJ TJ Tl ro
IH 4) C
-rl >, rH p 4)
4J «H 3 M
rl -rl O £ D
41 JJ C JJ 4J
o u .y o m
4) U X! C
U rfl Cn
o i-i -H
rH P— 1 P-H O C/l



















^
4)
3
2
4)
C
O
x;
a

'
rH










































JJ
U
rfl
JJ
c
O
CJ
18
ft
0
CJ
14H
O
0)
m
CN
""

-------
U3
cn
,_,
r*i
i
fi
o
r~ r-
o in w
rH 0 01
O O tH
TJ 1 1 -H
4) o o U,
> r- r- X
O O O CL)
in CN rsi
Q4 rH
P! • (TJ
< 0 >
2 O

o § a,
(K O <






















U CO
£ 2
OJ O
tn CM
H H
CM • CO
U M
rH 0
fd • W
-P Q 2
c
d) * Q
1 0 2
0 4J
JH tn CO
•H G D
> -H H
C^ C~! fCfl
W CQ EH
fC CO
CQ 12
(U CO
1 \ t^
4-J ^^
nj z

4— ' CM
co £
T! S
0) H
-p D
•H O
£ H
D 2







































E
)H
o

0]
••H
JJ

C
O
T!
01
Bl
01
&
01
tH
c
o
-rl
JJ
E
0
IJH

•rl
0>
u

a
3
01

TJ
(T)
01
C
O
-H
JJ
U
3
jj
01
C

TJ
01
U
m
jj
«
01
jj
x
3
IJH
0)
(TJ
U
TJ
(TJ
0)
*"*
01
01
m
01
rH
a.
•s
-H
•H >.
JJ (TJ
C W
•H 01
tH 01
a u
Ol
tH C
o
0) -H
& -
jj cn
0> jJ
01 0)
(TJ 01
0) X!
rH 01
a.
, — i
•• m
w c
2 O
O -H
U TJ
D TJ
Oi (TJ
H
C/1 01
2 0)
M D




_
^^
tjj
^^
U g
I-H 2
|"T. 1
UH 1
M/~v
r-, 1— 1
u n Dd
° W i

° CO S

£ EH g
c B §
* Q
ai o 4£
Id P^ Q
Q CM M

m






CQ

-H
^_l
(L)
Tl g


T) 2
U 2
03 i
u 1
"H §
4— ' ^^
(U 2
O <^i
OJ
0
^ O
O 2
0) —(
e -j
2 rH
2 fc cn
"S ^
(O Q^
* m
(U *• ^N
wo CM
5 rn W

CM














o
o
CO 0
CO O
W O
01 s_i (V
tn ^ K
TJ <
TJ W tt< E"1
C ^^ r^
I— \ t~^ ri
^0. CO U
•" S
i-9 o o
8 CO 2 2

-
Jj
c
m
jj
D] 01
•H 01
cn c
0) O
f£ CX
01
• 01
CT> Oi





01
E
•H 01
H E
(T!
00 t.









u
JJ C
01 (0
01 JJ
H W
. •§
r- co










c
01 tH
0) 01
D JJ
• (TJ
*^> ex


01

0) JJ
tn o ^
o a
p, p£

X*OHOUOJ

















01
•H
H
>^
T)
CO

in








01
C JJ
rH 01
0> E
T! 0)
3 -H 0)
° 2, •§

• 0) 3














CQ CQ CQ CQ CQ
O 0 000
e e e e e

CO CO CO CO CO










CM CM CM CM CM
W W WWW
""•*•» ^~» ^'^ "^^^s^^
CM CM CM CM CM
IS S S S S











u u u u u
















CN CN
rH rH (N rH ^T 4J
— — — — — q
3
jj H
H -H
8 "° "o
•rj (0 C S
B >H O 4J
V JJ i-H C
fi , tH JJ -H 0 «
IB JJ ~^» (TJ tH -
O (TJ tH JJ 0) T) 01
•H tH 01 -tH 01 1
8 O TJ U X >i
H aioj'xwffl'm C
JJ JJ O E E E IB
V 3 3 JJ -H -H In O
U U U tH M 0) -H
p < < a, (X Q IH
U IU
ja ^











H CN 
-------

















































^N
*•*•
U

0)
tn

^N

r"!


i
*
-P
U
Vl/
0
^1

f\ 1


rH
fO
1 t
4—1
C
ronme
•H
>

W
CQ
(D

trt
i\)
1 )

CO

T3
0)
4J
-H
d
D














































































0
>*./
o
Ol



*
u



Q
c
O
-P
tn
c

id
to
fC
*^































































CO

t"^
5^
^H
DL]
^3
^£4
Py^
^J
CM
ii
pH
8
M*4
^•yj

p n
pLj
Hp
^4
H

W
Q
H
th

^^

^^
o

pL^

CO
B
H
H
l_l
fe

Cn
w
Q
^^
M
j^^
>^H

^k
^^
§
CO
W
EH
O
^^
8
fc



























































-


^
	 i
•H

•H
JJ
0
IB


•rl
01
A
jj
01
01
iB
x;
u
M
a
01
IH
o
JJ
IB
rH
E
O
4H
73
01
73
•rl
0
VH
a

•*
Jj
u
73
o
V4
a
41
01
3
73
01
II
0,
W
JJ
U
3
73
O
VH
a
41
01
3
01
•rH
IH
3
jJ
U
IB
4H
3

II
Cu
ji,
tS
JJ
c
41
E
41
tH
-H
2,
61
11
IH 01

IB -H
JJ JJ
(B U
73 IB

r>^ =
C 01
IB IH
3
o a
jj =

jj n
u
ii <
•n p2
XI M
3 *(
01 O.

JJ •-
0 JJ
C C
01
01 -H
VH 73
18 01
IH
01 01
JJ C
C -H
IB
VH 11
JJ >
tn -H
•rl JJ
01 U
11 iB
VH
r
- 41
JJ tH
U 3
3 a
73 =
o
IH II
a
n
73 <
01 O.
IH
D —
jJ JJ
01 C
•H 0)
01 -H
01 73
VH 01
M
VH 01
0) C
A -H
jJ
O 41
C >
IB -rl
JJ
4H O
O IB

01 01
01 x;
IB JJ
X
U 4H
(B O
a
01 41
VJ 73
IB
C 01
01
U rH
tH IB
11 U
a -n
o A
o u
rH 41
JJ
IB
II
01
•H rH
rij
jJ O
U H
3 -
73 JJ
O U
In 3
a 73
o
iB IH
a
4H
M 41
Ol
U I
(-> 73
O C
Z 41
JJ (B
U U
3 -H
73 a
o !x
IH 4J
a
II
73
01 Cu
0) U
IB H
U •-
3 "
a n
01
0) rH
JJ IB
Jj
O
JJ 01
x:
01 4J
c
-H C
i pertain
itified i
>U V-*
JJ 0)
IB T>
73 -rl

































































































73
U
rH
11
XI
iB
rH
0
•H
73
IB
U
redient ,
M
01
C
•H



































































































"
S
n
t>
Categori
01
3







M
O
O
73
JJ
3
0

73
O
0
4H
C
O
c

u
•rH
JJ
IB
&
ic£

I

W












a
o
tH
U

73
O
O
U
-rl
JJ
IB
&
rfj

1

Q



a
0
o

73
o
o
4H
c
o
c

rH
IB
errestri
H

u
a
o
u

73
01
41
4H
73
O
O
estrial f
M
41
H
to




a
o
u
73
o
o
4H
IB
-rl
)H
jJ
- Terres
<













r-H
IB
•H
4J
C
1)
73

01
01
>< IH
VH
JJ r4
01 O
01 O
IH 73
0 C
tJL, M

i i

>T3 O






a
o
IH
u

73
O
O
4H
C ' — i
O (B
C U

01 73
0) 11
3 2
O
A V4
C O
01 O
01 73
VH C
O M

i i

n Z





a
o
rH
U
73
O 73
O O
4H O
4H
0) C
reenhous
ndoor no
0 rH

a: .E
r— 1
IB
•H
JJ
C
01
73
•H
01
01
IH
73
O
O
4H
C 73
0 O
C 0
4H
O
•rH |H
JJ 0
(B O
&T3
^ c
< M
O -J



rH
IB
d Industri
tdoor
0 3
o o
C -H
O IB
C rl
0 C
- Aquati
- Reside
fi, $6



























, — 1
E

O
4H

[V|
W
Z
o
ex
C/3
W
cd

CO
-
FH
fe

11
T)
1)

(0

tn
jj
C
11
73
0)
IH
01
C


4-J
O
c
o

4_J
u
JJ
rH
1)
U
73
C
IB

in
in
rH
IB
C
IB
~
C
o
•H
4J
• H
01
O
a
E
O
u
.v,
-H
4J
C
01
73
-H
4J
0
3
•d
O
IH
a
Chemical
taining to
V4
In D
IB a
iH
3 0)
Dl 4J
(* 41
E
1 41
V4
A &
u 0)
a
S




4J
c
01
E
01
V4 U
0 VH
4H O
4H
r- C
VD 41
rH
V4
ao O
in 4n
rH
« 0
00
rH

. — . GO
,
oo IB
in c
rH -H
E
73 -H
C rH
IB 41
tH
- a
CN
rH O
• 4H
OO
in o
rH r-
rH
u> in
•H rH
00
in •-
rH ~
« ro
rH
. — . — '
rH
1 01
rH 41
VO -H
— JJ
-H
C V4
0 3
•H (1,
JJ E
•rl -rl
01
and compo
rmation of
:x o
4J 44
•H
C O
01
•H O
product
discussi



































































































IN
01
73
O
x;
D
E
iB
analytic





rH
IB
JJ
C
41
E
-H
tH
01
a
x
4)

C
IB

73
C
iB

C
O
•rl
Jj
U
3
73
O
|H
a

01
r-H
IB
O
01

rH
, — |
3


^
4)
73
C
3

^
73
IB
4)
IH
IB

JJ
0

01
-H

41
73
-rl
O
-rl
JJ
01
01
a

41
x;


•H

41
U
•H
4H
4H
01
r-H
rH
-rl
01
01
01
u
o
a
c
o
•H
4J
U
3
73
O

a
D
o
0
•H
Jj
a
•rH
tH
0
01
41
T3
4H
01
•H
m
X)
0 A
\ 01
73 3
C 0
IB 01
E 01
IB C
V4 -H
01 41
IB XI
•H
73 01
O
JJ -H
A schema
use perm

IN

o
jj

73
41
JJ
jJ
•H
E
XI
3
0)

1)
XI

, — i
^
IB
Xi
01

01

c
0)
•rl
73
01

01
C
•rl

rH
IB
C
O
•rl
JJ
C
1)
JJ
c
•H
c
3

4H
O

C
o
-rH
01
01
3
U
0]
-H
73

IB

^
jj
A
01
3
O
01
01
-rH

4J
•H
E
IH
0)
a

01
01
3
rimental
41
&
41
C
IB
73
IB

C
O
-rH
JJ
U
3
73
O
a
11
(B
u
01
3 41
MH rH
XI
V4 IB
4) rH
73 -H
C IB
3 >
IB
^
73 01
(TJ -rl
01
is not al
informatio
01
73 01
-rl -rl
u x;
-rl JJ
JJ
OJ C
a oi
41 X
A 41
JJ
0)
rH iJ

r*l

rH
IB
U
-rH
C
S
U
0)
4J

0)
x;
jj

4-1




73
11
N
>,
rH
IB
c
IB
11
XI

Jj
tn
3
E

JJ
c
1)
•rl
73
U
VH
01
C
rH

01
>
•H
4J
U
<
4-1
O
4)
73
IB
IH
01

rH
IB
U
•rH
C
u
1)
JJ
11
A
4J


JJ
O
c

^
o
E
01
JJ
01
01
73
41
jj
IB
01
41
C
C
IB

X)

73
01
U
3
73
0
IH
a
whether
..
a,
w
IH
o
5£

c
iB
tration of
01
-rH
01
1)
tH
I-I
O
a
a
3
tn
O
H

T



T)
41
JJ

•rl
E
X)
3
01

01
XI

jj
01
3
E

jj
C
1)
•rl
73
U
01

M

41
>
•H
JJ
U
<

4H
O

0)
73
(B
l-l


, — i
IB
U
•H
C
x;
u
0)
jj
0)
A
JJ
4H
O

OJ
C
0)
r- 1
IB
-rl
&
01

rH
(B
U
-H
JJ
U
IB
tH
a
41
x;
jj
4H
O
O
•rl
JJ
•rl
01
o
a
o
o
4H
o
tn
JJ -rl
C 01
41 IB
E X)
41
JJ 0)
IB 01
JJ (B
01 U
olated, a
a case -by
01
-rl C
O
01
Xl 73
11
O -H

5 D1
IB 41
U VH
Ingredient
Ps will be
jr
0)
> IH
•H 0
jJ
U 01
W
4H
0 C
o
01
73 IB
IB JJ
V4 IB
01 Q

































































41
01
3
IB
jj
C
41

•H
IH
41
a
X
01

o
4H
73
0)
01
0
a
o
V4
a

0)
jj
u
73
0
a
c
-rl

01
JJ M
C 01
01 JJ
•rl IB
73 3
01
IH Xi
01 JJ
C -rl
JJ 01
VH rH
41 X)
C -H
•rl 01
M
lH 41
o a
4-1 01
-H
73 73
u
V4 41
•H VH
&(B
41 Ol
are not r
substance
01 4J
JJ 01
-rH 1)
E JJ
•H
rH 4H
73
Certifie
Required

in cr\


41

•rl
JJ
U
IB

41
x;
4J

JJ
IB

JJ

>
o

01

IB
jJ
(B
73

jj
•H
rH
•rl
XI
IB
4J
01

01
01
IB

O
JJ
01

41
A
JJ

. 	 .
XI


73
41
U
JJ
•rl
1
P
01

11
XI

o
JJ
73
11
•rl
3

11
tH

11
tH
IB

IB
jJ
(B
73
is
O
(B
U
•rl
44
4H
41
	 ^
(B
01
01
41
C
3
0.
U

V4
O
4H
73
01
e quired.
e submit t
VH XJ
41 JJ
VH O
IB C
, 01
O
IB JJ
U 3
•H XI
4H
41 (d
01 73
01 C
01 IB

C O.
3 S
73 M
01 0
•H
Not requ
Required

P- 00
r-l rH



01
JJ
C
41
73
•H
O
C
•rl

",-1
O

73
41

U
41
a
01
3
01

01
•H
^
JJ
-rl
rH
•H
XI
(B
JJ
01
C
•rl

4J
O
3
73
o

a

. 	 .
u


VH
0
73
41
jJ
O
41
ij
41
73

01
VH
IB
01
01
JJ
(B
73
 4J
•rl 41
01
O C
M O
IH -ri
O JJ
U (B
jj
01 -H
•H VH

rH -rl
IB
•H rH
IH IB
Ol E
JJ V4
IB 01
E 73
jJ 73
01 a
01 IB
D
4H >,
-H 01
73 rH
11 IB
V4 -H
W 41
01 JJ
M O
a
4J
O 4H
Z 0

CN












































































0)
01
3
44
0
0]
c
o
-rl
AJ
-H
73
c
O
u
1-1
0)
73
3

!_,
3
U
U
O
XJ
o
c
01
01
o
73
01
1-1
3
01
o
a
x
41
, 	 (
IB
g
IH

-------
CN



11 i
T—l
o


(N



Q)
tn

05
d4




















































K^-l
PU

O
U



_
[•H
fa


Washing











































































CO

^H
^v
^H
CxD
53
JL
Cd
^^j
H
s
3
u
GUIDELIN
0

CO
8
EH
i__i
!Y DEFIN]
HM
Q
HH
-
LJ
§

CO
r*
^
j^x
^^
F"
pH
8
fa



































































•
CQ
^
•H
M
-8

TJ
•H
acetic ac
0
M
0

rH
fa
m
o
m
1


73
^2
C
OJ
4*:
0)

CQ
»o
CJ



























x;
o
3
in
—

tn
OJ
4J
rfl
1^
XI
0>
4J
01
>

o
^1
4J
c
0
u

0
4J

f.
• H
rfl

U

rfl

tn
^j
(0
OJ
XI

4-1
u
3
TJ
0
pt
OJ
•H
U
•H
4J
0)
0)
a
01
gents unless th
rfl
rH
o
rl
4J
O
U
OJ
4J
rfl
M
XI
4-1
01
0
MH
4-1
rfl
TJ

^,
O
(0
O
•rl
MH
MH
OI
4J
XI
3
tn
o
4J

to
4J
C
01
OJ
^1
•rl
&
OJ
1 t
rH
^•^ , — |
1 m

4-> "S
C >
0 '5
U 3
• — tn
(0
x;
to
-. >•
d; o
4J £
o 
0)
3
C
01
i
tn
3
O
-rH
CJ
rfl
CJ
•H
MH
0)
01
rfl
in
4-1
u
3
o
IH
a.

0)
-C




tn
0)
tn
3

3
0)
c
4J
c
rfl
U
•H
MH
-rl
d
•H
tn

~

Oi

OJ
—

tn
•H
0)
ro
XI

OJ
0)
(0
O

^>,
XI
t
01
0)
rfl
U
rfl

0
IH
•H
&
0)
O
4J
4J
OI
0)
4J
0)
eserv

Agency
x:
TJ
m
rfl
XI
tn
-H

U
rfl
U
•rl
MH
MH
0)
MH
0
0
•rH
4->
rfl
C
•rl
E
M
01
4->
OJ
TJ
OJ
x:
4J
x;
u
rl
X!
3

C
O
a
rfl
4J
rfl
T)
4J
C
rfl
>
rH
OJ
IH

0)
4-1











X

rfl
tn
tn
OJ
CJ
OJ
c
C
O
r",
3

C
O
•r-l
4J
ro
l-i
4->
W
•H
Oi
0)
IH

^4
O


T)
0)
tn
o
a
o


0
TJ
rl
01
4-1
tn
Oi
OJ
cide product, r
-H
4J
tn
OJ

X
rfl
O
(0
rfl
Tl
CJ
ro
CJ
• H
M-l
M-i
0)
M-i
O

0
-H
tn
-H
E
XI
3
0)
0]
3
• H
>

]M
rfl
• H
CJ
0)
G
01
M-l
O

0)
0)
in

CJ
c
"H
ro
4J
m
T)

in
4-J
•H
OJ
OJ
Xl
^
o









c
o
•H
• 4-1
X U
rH OJ
OJ 4J
> 0
•rl IH
4-> O<
u
01 ,*
MH O
MH 0
OJ 4J
0)
0] OJ
OJ >
4-1 -H
O J
X
O o
U 00
o
X rH
|^
O M
4-1 O
(0 MH
T)
OJ Oi
M Ti
a ro
OJ E
Tl
tn
in E
( — 1 -rl
rH ro
•rl r— 1
J£ O
0) rH
rl 0
(0 IH
rH 4J
0 0
U U
C W
O 4J
-H O
4-> X
O O
OJ CJ
Livestock Prot
ted to support
C -H
•H CJ
OJ OJ
4J Xl
rfl
Droacet
-01 may
3 1-
f-H <7>
f.Tt ^j*
r-
E IN
3 <*
TJ T)
O C
OT rfl
4J in
X! i
4J *t
01 f
E H
-rl O
rfl o
rH
u • 01
IH
4J OJ
M 4
O E
a 3
a z
0) P
hH
s i

TJ TJ
0) C
4J rfl
4J
•H
E o\
XI oo
3 o
0) U>
M CN
0
TJ
TJ C
OJ rfl
4J
-rt in
O «3
VD
0) ro
XI t
(N
4J
0) OJ
i &
rfl^
4J 3
rfl 2
TJ
C
U -rl
ro tn
CJ 0)
-rl OJ
MH U
w <

o
in
























































































0)
rfl
rH
rH
O
U



-------

-------
EPA'S BATCHING OF SODIUM FLUOROACETATE PRODUCTS FOR MEETING
ACUTE TOXICITY DATA REQUIREMENTS FOR REREGISTRATION

       In an effort to reduce the time, resources and number of animals needed to fulfill the
acute toxicity data requirements for reregistration  of products containing sodium fluoroacetate
as the active ingredient, the Agency has batched products which can be considered similar for
purposes of acute toxicity. Factors considered in the sorting process include each product's
active and inert ingredients (identity, percent composition and biological activity), type of
formulation (e.g., emulsifiable concentrate, aerosol, wettable powder, granular, etc.), and
labeling (e.g., signal word, use classification, precautionary labeling, etc.). Note that the
Agency is not describing batched products as "substantially similar" since some products
within a batch may not be considered chemically similar or have identical use  patterns.

       Using available information, batching has been accomplished by the process described
in the preceding paragraph. Notwithstanding the batching process, the Agency reserves the
right to require, at any time, acute toxicity data for an individual product should the need
arise.

       Registrants of products within a batch may choose to cooperatively generate, submit or
cite a single battery or six acute toxicological studies to represent all the products within that
batch. It is the registrants' option to participate  in the process with all other registrants,  only
some of the other registrants, or only their own products within a  batch, or to generate all the
required acute toxicological studies for each of their own products.  If a registrant chooses  to
generate the data for a batch, he/she must use one of the products  within the batch as the test
material.  If a registrant chooses to rely upon previously submitted acute toxicity data, he/she
may do so provided that the data base is complete and valid by today's standards  (see
acceptance criteria attached), the formulation tested is considered by EPA to be similar for
acute toxicity, and the formulation has not been significantly altered since submission and
acceptance of the acute toxicity data. Regardless of whether new data is generated or existing
data is referenced, registrants must clearly identify the test material by EPA Registration
Number. If more than one confidential statement of formula  (CSF) exists for a product, the
registrant must indicate the formulation actually tested by identifying the corresponding CSF.

       In deciding how to meet the product specific data requirements, registrants must follow
the directions given in the Data Call-In Notice and its attachments appended to the RED. The
DCI Notice contains two response forms  which are to be completed and submitted to the
Agency within 90 days of receipt.  The first form, "Data Call-in Response," asks whether the
registrant will meet the data requirements for each product.  The second form, "Requirements
Status and Registrant's Response," lists the product specific data required for  each product,
including the standard six acute toxicity tests. A registrant who wishes to participate in a
batch must decide whether he/she will provide the data or depend  on someone else to do so.
If a registrant supplies the data to support a batch  of products, he/she must select one of the
following options: Developing Data (Option 1), Submitting an  Existing Study (Option 4),
Upgrading an Existing Study (Option 5) or Citing an Existing Study (Option 6). If a registrant
depends  on another's data, he/she  must choose among: Cost Sharing (Option 2),  Offers to
Cost Share (Option 3) or Citing an Existing Study (Option 6). If a registrant does not want to
participate in a batch, the  choices are Options 1,  4, 5 or 6. However, a registrant should
know that choosing not to participate in a batch does not preclude other registrants in the batch
from citing his/her studies and offering to cost share (Option 3) those studies.

       Seven products were found which contain  sodium fluoroacetate as the  active ingredient.
The products have been placed into one batch and a "no batch" category in accordance with

                                           75

-------
the active and inert ingredients, type of formulation and current labeling. Table 1 identifies the
products in the batch. Table 2 lists the product which has been placed in the "no batch"
category.

 Table 1
Batch
l
EPA Reg. No,
13808-7
35975-4
35978-8
39508-2
46779-1
56228-22
% Active lagrediea*
1.0
1.0
1.0
1.0
1.0
1.0
Formulation Type
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
       The following table lists a product that was either considered not to be similar or the
Agency lacked sufficient information for decision making and were not placed in any batch.
The registrant of this product is responsible for meeting the acute toxicity data requirements
separately.

 Table 2  (No Batch)
EPA Reg, No.
56228-26
% Active Ingredient
90.0
Formulation Type
Solid
                                           76

-------
Attachment  5.  List of All Registrants Sent This Data
Cair-ln (insert) Notice         6
                           77

-------





























































CQ
J>
•H
^_l
CU
TJ

-H
U
05
U
•H
roacet
0
E 3
ifl r— )
* PL,
T3
CO
at 00
W O
"> ~->
u ro






































































01
E
2
T3
C
ifl
*
,-H
rfl
CJ
•H
E
QJ
a































































0)
.p
05
4-»
Q)
roac
o
rH
4-1
E
-H
o
w


m
o
o
in
r-
0


p,
•H

0)
oj
m
ij
CO

Ljj

>^
4J
•H
U















W
W
0)
^
T3
T)










OJ
E
m

rH
CO
C
O
-H
^j
-H
T)
T)









CD
Company Na

M

J
PL,
O
H
PARTM
MONTANA DE






in
r-
m
in
n
0
CN
o
o
CN
00

>H
5;

W
2
2
W
^H
W
g







r,]
P
5s
M
I
>H
U

II?
(J

ON
rH
CN
CN



























fa
p
J
M
u.
a
o
EH
o.
WYOMING DE






00
0^
in
m
o
<•*>
0
0
00
00


CO

CJ
D

CJ

C/5












(X
\
in
o
o
o
ro

X
O
m

CO
S
8

a
j
2
|
hH
O

a,
o

2
O

W
M
£>
M
Q
e
5
^
«;
8
PL,
O
RTMENT
<
IX
a
NEW MEXICO






CO
o
in
m
o

ro
CO

r-
o
CN
CO
f^
O
CN

W

( ~]
M
^>
CO
H
H

X
m
m
in
§
CQ
CQ
CJL,

Q
s!

H
CO
S
CJ

W
CQ

in
o
in

O
M
W
IX
co
2
t-H
X
H
X
i
k-3
a,
Q
5?
^

1 1

2
M
p2
s
3





u
p
I-H
O
O
Q
CO
D






00
CN
CN
in
o

-------
Instructions for Completing the Confidential Statement of Formula

The Confidential Statement of Formula (CSF) Form 8570-4 must be used. Two legible, signed
copies of the form are required.  Following are basic instructions:

      a. All the blocks on the form must be filled in and answered completely.

      b.     If any block is not applicable, mark it N/A.

      c.     The CSF must be signed, dated and the telephone number of the responsible party
             must be provided.

      d.     All applicable information which is on the product specific data submission must
             also be reported on the CSF.

      e.     All weights reported under  item 7 must be in pounds per gallon for liquids and
             pounds per cubic feet for solids.

      f.     Flashpoint must be in degrees Fahrenheit and flame extension in inches.

      g.     For  all active  ingredients,  the EPA Registration Numbers  for the currently
             registered source products must be reported under column 12.

      h.     The Chemical Abstracts Service (CAS) Numbers for all actives and inerts and all
             common names for the trade names must be  reported.

      i.     For  the active  ingredients,  the percent purity of the source products must be
             reported under column 10 and must be exactly the same as on the source product's
             label.
      j.     All the weights in columns 13.a. and 13.b. must be in pounds, kilograms, or
             grams. In no case will volumes be accepted. Do not mix English and metric system
             units (i.e., pounds and kilograms).

      k.     All the items under column  13.b. must total  100 percent.

       1.     All items under columns 14.a. and 14.b.  for the active ingredients must represent
             pure active form.

      m.    The upper and lower certified limits for ail active and inert ingredients must follow
             the 40 CFR 158.175 instructions. An explanation must be provided if the proposed
             limits are different than standard certified limits.

      n.     When  new CSFs are  submitted and  approved,  all previously submitted CSFs
             become obsolete for that specific formulation.
                                          79

-------
80

-------


5j
w
CO
c
~K
UJ



i
P
8
6
Z
CD

0
1
o
a.
i
o


«0
O
2
•
o
Hi
c
.§
|
•5
>
5
0
Q|
CO
*g
e
5
M
•i
^
§
0
%•
i

8
a
1
«J
1
VI
«l
1

00

I
a



















~Q



$
co £
^
O
1 1
- f
1 i
E ^
1 I
OD <
DD
•^





(Q
"5
tl

cJS ^
•* »
1
^
•
b.
M
9C
.2
1
"o
M
|j^

•o
0
z





1
•0
3
E
o
u.
V
1
c
3
O
u

E
n
C
'o
ft.
u>
»
u.
o>








0.
06


'M
%
&
i
o
c3
Pounds/
^



























c
- c
S |
IB
a j
>A if
""
1
| _|
?*!
1^1
S*!

I
i *
V g A
C *
03
og-
*~ m


6
Z
E
UJ
^



M
i
i
z
.5
&
3
*?
^!



|S

||
.^
fl
V ^*
III
111
3.^5
1°^
:ompon«ntt in
r/>« formultttc
t. tnd* n*m*. ,
a P
of*
"" '* c
z
O
lu
V)
3
<
IX
UJ





































































































































































































































































































































































































































































































*
§


o»
1
1
,s;
^~






























roving Officil



0
a
z
a.
CD
~







O

c
w
(7>
CO
*"
^
Q.
§"

m
.£
(•k
U.
.
J2
>


1
f

>•
o
O
IT
0.
LU
,
S
$
1

1
2
IS
m
«
1
3
I
wf
£

g
o
B
•£.
C
8
s=

jj
Jj)
I
o
S
•
c
.2
i
1
Z

o
o>
•
OC
*""
T
o
r-
«
0
u.
a.
UJ
81

-------
82

-------
   ?/EPA
United States  Environmental  Protection Agency
            Washington,  DC  20460
   CERTIFICATION OF  OFFER  TO COST
 SHARE  IN THE  DEVELOPMENT OF  DATA
Form Approved

OMB No.  2070-0106
         207MK157

Approval  Expires  3-31-96
 Public reporting burden for this collection of information is estimated to average 15 minutes per response, including
 time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and
 completing and reviewing the collection of information.  Send comments regarding the burden estimate or any other
 aspect of this collection of information, including suggestions for reducing this burden, to Chief, Information Policy
 Branch, PM-223, U.S. Environmental Protection Agency, 401 M St., S.W., Washington, DC 20460: and to the Office
 of Management and Budget, Paperwork Reduction Project (2070-0106), Washington, DC 20503.

 Please fill in  blanks below.
Company Name
Product Name
Company (Number
F.PA Reg. No.
I  Certify that:

My company is willing to develop and submit the data required by EPA under the authority of the Federal
Insecticide, Fungicide and Rodenticlde Act (FIFRA), if necessary.  However, my company would prefer to
enter into an agreement with one or more registrants to develop jointly or share in the cost of developing
data.

My firm has offered in writing to enter into such an  agreement. That offer was irrevocable and  included an
offer  to be bound  by arbitration decision under section  3{c)(2)(B)(iii) of FIFRA if final agreement on all
terms could not be reached otherwise.  This offer was made to the following firm(s) on the following
date(s):
  Nam* of Flrm(a)
                                                                            Oat* of Offer
Certification:

I certify that 1 am duly authorized to represent the company named above, and that the statements that I have made on
this form and all attachments therein are true, accurate, and complete. I acknowledge that any knowingly false or
misleading statement may be punishable by fine or imprisonment or both under applicable law.
Signature of Company' a Authorized Rapr*aantatlv*
Dat*
Nama and Tit la (Picas* Typ* or Print)
 EPA Form 8570-32 (5/91)    Replaces EPA Form 8580, which i* obsolete
                                                  83

-------
84

-------
                        United States Environmental Protection Agency
                                    Washington, DC 20460
                              CERTIFICATION WITH RESPECT TO
                           DATA COMPENSATION REQUIREMENTS


Form Approved
OMB No. 2070-0107,
2070-0057
Approval Expires
3-31-96
 Public reporting burden for this collection of information is estimated to average 15 minutes per response, including time for
 reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the
 collection of information.  Send comments regarding the burden estimate or any other aspect of this collection of information,
 including suggestions for reducing this burden to, Chief Information Policy Branch, PM-233, U.S.  Environmental Protection
 Agency, 401 M St., S.W., Washington, DC 20460; and to the Office of Management and Budget,  Paperwork Reduction Project
 (2070-0106), Washington, DC 20503.

 Please fill in blanks below.
Company Name
Product Name
Company Number
EPA Reg. No.
 I Certify that:

 1.   For each study cited in support of registration or reregistratiion under the Federal Insecticide, Fungicide and Rodenticide Act
 (FIFRA) that is an exclusive use study, I am the original data submitter, or I have obtained the written permission of the original
 data submitter to cite that study.

 2.   That for each study cited in support of registration or reregistration under  FIFRA that is NOT an exclusive use study, I am the
 original data submitter, or I have obtained the written permission of the original data submitter, or I have notified in writing the
 company(ies) that submitted data I  have cited and have offered to: (a) Pay compensation for those data in accordance with sections
 3(c)(1)(F) and 3(c)(2)(D) of FIFRA;  and (b) Commence negotiation to determine which data are subject to the compensation
 requirement of FIFRA and the amount of compensation due, if any. The companies I have notified are.  (check one)

  [ ] The companies who have submitted the studies listed on the back of this form or attached sheets, or indicated on the attached
 "Requirements Status and Registrants' Response Form,"

 3.   That I have previously complied with section 3(c)(1)(F) of FIFRA for the studies I have cited in support of registration or
 reregistration under FIFRA.
Signature
Date
  Name and Title (Please Type or Print)
  GENERAL OFFER TO PAY: I hereby offer and agree to pay compensation to other persons, with regard to the registration or
  reregistration of my products, to the extent required by FIFRA section 3(c)(1)(F) and 3(c)(2)(D).
Signature
Date
  Name and Title (Please Type or Print)
:PA Form 8570-31 (4-96)
                                                          85

-------
    The following is a list of available documents related to sodium fluoroacetate.  It's purpose
is to provide a path to more detailed information if it is needed. These accompanying documents
are part of the Administrative Record for Sodium fluoroacetate and are included in the EPA's
Office of Pesticide Programs Public Docket.
    1.        Health and Environmental Effects Science Chapters
    2.        Detailed Label Usage Information System (LUIS) Report
    3.        Sodium fluoroacetate RED Fact Sheet
    4.        PR Notice 86-5 (included in this appendix)
    5.        PR Notice 91-2  (included in  this appendix) pertains to the Label Ingredient
              Statement
                                          86

-------